[
  {
    "search_code": "93000723",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Paracetamol 120 mg/5 mL Sirup (MERSIFARMA TIRMAKU MERCUSANA)",
      "kfa_code": "93000723",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2023-09-16 08:36:00",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS055",
        "name": "Sirup"
      },
      "controlled_drug": {
        "code": "1",
        "name": "Obat Bebas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GBL1533312737A1",
      "nama_dagang": "PARACETAMOL",
      "manufacturer": "MERSIFARMA TIRMAKU MERCUSANA",
      "registrar": "MERSIFARMA TIRMAKU MERCUSANA",
      "generik": true,
      "rxterm": 525,
      "dose_per_unit": 12,
      "fix_price": 0,
      "het_price": 9625,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": false,
      "kode_lkpp": "48830442",
      "score_tkdn": 32.44,
      "score_bmp": 0,
      "score_tkdn_bmp": 32.44,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": 60,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "3 g - O"
      },
      "atc_l1": {
        "code": "N",
        "name": "NERVOUS SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "N02",
        "name": "ANALGESICS",
        "level": "2",
        "comment": null,
        "parent_code": "N"
      },
      "atc_l3": {
        "code": "N02B",
        "name": "OTHER ANALGESICS AND ANTIPYRETICS",
        "level": "3",
        "comment": null,
        "parent_code": "N02"
      },
      "atc_l4": {
        "code": "N02BE",
        "name": "Anilides",
        "level": "4",
        "comment": null,
        "parent_code": "N02B"
      },
      "atc_l5": {
        "code": "N02BE01",
        "name": "Paracetamol",
        "level": "5",
        "comment": null,
        "parent_code": "N02BE"
      },
      "description": "<p><span style='font-size:12.0pt;line-height:107%;\nfont-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:Calibri;\nmso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Analgesik-Antipiretik.</span><br>- Sebagai Analgesik, bekerja dengan meningkatkan ambang rangsang rasa sakit.</p><p>- Sebagai Antipiretik, diduga bekerja langsung pada pusat pengatur panas di hipotalamus.</p>",
      "indication": "<p>Meringankan rasa sakit kepala, sakit gigi, dan menurunkan demam</p>",
      "warning": "<p>1. Hati - hati penggunaan obat ini pada penderita penyakit ginjal dan hati</p><p>2. Bila setelah 2 hari demam tidak menurun atau setelah 5 hari nyeri tidak menghilang, segera hubungi Unit Pelayanan Kesehatan</p><p>3. Penggunaan obat ini pada penderita yang mengkonsumsi alkohol, dapat meningkatkan resiko kerusakan fungsi hati</p>",
      "side_effect": "<p>1. Penggunaan jangka lama dan dosis besar dapat menyebakan kerusakan hati </p><p>2. Reaksi hipersensitivitas</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93000723",
          "name": "Paracetamol 120 mg / 5 mL Sirup",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GBL1533312737A1",
          "name": "PARACETAMOL",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/1478936?lang=id&type=province",
          "code": "1478936",
          "name": "Paracetamol/ Parasetamol sirup 120 mg / 5 ml\t",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94000853",
          "pack_price": 1189
        }
      ],
      "product_template": {
        "name": "Paracetamol 120 mg/5 mL Sirup",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000511",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Paracetamol 120 mg/5 mL Sirup"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000101",
          "zat_aktif": "Paracetamol",
          "updated_at": "2022-07-06 11:25:27",
          "kekuatan_zat_aktif": "120 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 2.5,
          "name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 2.5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 10,
          "name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 15,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 15,
          "name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 20,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93000725",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Paracetamol 120 mg/5 mL Sirup (AFI FARMA, STRAWBERRY)",
      "kfa_code": "93000725",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-07-07 13:19:57",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS055",
        "name": "Sirup"
      },
      "controlled_drug": {
        "code": "1",
        "name": "Obat Bebas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GBL1701707337A1",
      "nama_dagang": "PARACETAMOL (RASA STRAWBERRY)",
      "manufacturer": "AFI FARMA",
      "registrar": "AFI FARMA",
      "generik": true,
      "rxterm": 525,
      "dose_per_unit": 12,
      "fix_price": null,
      "het_price": null,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": 60,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "3 g - O"
      },
      "atc_l1": {
        "code": "N",
        "name": "NERVOUS SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "N02",
        "name": "ANALGESICS",
        "level": "2",
        "comment": null,
        "parent_code": "N"
      },
      "atc_l3": {
        "code": "N02B",
        "name": "OTHER ANALGESICS AND ANTIPYRETICS",
        "level": "3",
        "comment": null,
        "parent_code": "N02"
      },
      "atc_l4": {
        "code": "N02BE",
        "name": "Anilides",
        "level": "4",
        "comment": null,
        "parent_code": "N02B"
      },
      "atc_l5": {
        "code": "N02BE01",
        "name": "Paracetamol",
        "level": "5",
        "comment": null,
        "parent_code": "N02BE"
      },
      "description": "<p><span style='font-size:12.0pt;line-height:107%;\nfont-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:Calibri;\nmso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Analgesik-Antipiretik.</span><br>- Sebagai Analgesik, bekerja dengan meningkatkan ambang rangsang rasa sakit.</p><p>- Sebagai Antipiretik, diduga bekerja langsung pada pusat pengatur panas di hipotalamus.</p>",
      "indication": "<p>Meringankan rasa sakit kepala, sakit gigi, dan menurunkan demam</p>",
      "warning": "<p>1. Hati - hati penggunaan obat ini pada penderita penyakit ginjal dan hati</p><p>2. Bila setelah 2 hari demam tidak menurun atau setelah 5 hari nyeri tidak menghilang, segera hubungi Unit Pelayanan Kesehatan</p><p>3. Penggunaan obat ini pada penderita yang mengkonsumsi alkohol, dapat meningkatkan resiko kerusakan fungsi hati</p>",
      "side_effect": "<p>1. Penggunaan jangka lama dan dosis besar dapat menyebakan kerusakan hati </p><p>2. Reaksi hipersensitivitas</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93000725",
          "name": "Paracetamol 120 mg / 5 mL Sirup",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GBL1701707337A1",
          "name": "PARACETAMOL (RASA STRAWBERRY)",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94000855",
          "pack_price": 0
        }
      ],
      "product_template": {
        "name": "Paracetamol 120 mg/5 mL Sirup",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000511",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Paracetamol 120 mg/5 mL Sirup"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000101",
          "zat_aktif": "Paracetamol",
          "updated_at": "2022-07-06 11:25:27",
          "kekuatan_zat_aktif": "120 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 2.5,
          "name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 2.5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 10,
          "name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 15,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 15,
          "name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 20,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001920",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Paracetamol 120 mg/5 mL Sirup (LUCAS DJAJA)",
      "kfa_code": "93001920",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-10-24 07:37:33",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS055",
        "name": "Sirup"
      },
      "controlled_drug": {
        "code": "1",
        "name": "Obat Bebas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GBL9113600237A1",
      "nama_dagang": "PARACETAMOL",
      "manufacturer": "LUCAS DJAJA",
      "registrar": "LUCAS DJAJA",
      "generik": true,
      "rxterm": 525,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": null,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "3 g - O"
      },
      "atc_l1": {
        "code": "N",
        "name": "NERVOUS SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "N02",
        "name": "ANALGESICS",
        "level": "2",
        "comment": null,
        "parent_code": "N"
      },
      "atc_l3": {
        "code": "N02B",
        "name": "OTHER ANALGESICS AND ANTIPYRETICS",
        "level": "3",
        "comment": null,
        "parent_code": "N02"
      },
      "atc_l4": {
        "code": "N02BE",
        "name": "Anilides",
        "level": "4",
        "comment": null,
        "parent_code": "N02B"
      },
      "atc_l5": {
        "code": "N02BE01",
        "name": "Paracetamol",
        "level": "5",
        "comment": null,
        "parent_code": "N02BE"
      },
      "description": "<p><span style='font-size:12.0pt;line-height:107%;\nfont-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:Calibri;\nmso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Analgesik-Antipiretik.</span><br>- Sebagai Analgesik, bekerja dengan meningkatkan ambang rangsang rasa sakit.</p><p>- Sebagai Antipiretik, diduga bekerja langsung pada pusat pengatur panas di hipotalamus.</p>",
      "indication": "<p>Meringankan rasa sakit kepala, sakit gigi, dan menurunkan demam</p>",
      "warning": "<p>1. Hati - hati penggunaan obat ini pada penderita penyakit ginjal dan hati</p><p>2. Bila setelah 2 hari demam tidak menurun atau setelah 5 hari nyeri tidak menghilang, segera hubungi Unit Pelayanan Kesehatan</p><p>3. Penggunaan obat ini pada penderita yang mengkonsumsi alkohol, dapat meningkatkan resiko kerusakan fungsi hati</p>",
      "side_effect": "<p>1. Penggunaan jangka lama dan dosis besar dapat menyebakan kerusakan hati </p><p>2. Reaksi hipersensitivitas</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001920",
          "name": "Paracetamol 120 mg / 5 mL Sirup",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GBL9113600237A1",
          "name": "PARACETAMOL",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94002326",
          "pack_price": 6688
        }
      ],
      "product_template": {
        "name": "Paracetamol 120 mg/5 mL Sirup",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000511",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Paracetamol 120 mg/5 mL Sirup"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000101",
          "zat_aktif": "Paracetamol",
          "updated_at": "2022-07-06 11:25:27",
          "kekuatan_zat_aktif": "120 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 2.5,
          "name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 2.5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 10,
          "name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 15,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 15,
          "name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 20,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001926",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Paracetamol 120 mg/5 mL Sirup (CASETAMOL)",
      "kfa_code": "93001926",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-10-13 07:03:46",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS055",
        "name": "Sirup"
      },
      "controlled_drug": {
        "code": "1",
        "name": "Obat Bebas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DBL8513602737A1",
      "nama_dagang": "CASETAMOL",
      "manufacturer": "LUCAS DJAJA",
      "registrar": "LUCAS DJAJA",
      "generik": false,
      "rxterm": 525,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": null,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "3 g - O"
      },
      "atc_l1": {
        "code": "N",
        "name": "NERVOUS SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "N02",
        "name": "ANALGESICS",
        "level": "2",
        "comment": null,
        "parent_code": "N"
      },
      "atc_l3": {
        "code": "N02B",
        "name": "OTHER ANALGESICS AND ANTIPYRETICS",
        "level": "3",
        "comment": null,
        "parent_code": "N02"
      },
      "atc_l4": {
        "code": "N02BE",
        "name": "Anilides",
        "level": "4",
        "comment": null,
        "parent_code": "N02B"
      },
      "atc_l5": {
        "code": "N02BE01",
        "name": "Paracetamol",
        "level": "5",
        "comment": null,
        "parent_code": "N02BE"
      },
      "description": "<p><span style='font-size:12.0pt;line-height:107%;\nfont-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:Calibri;\nmso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Analgesik-Antipiretik.</span><br>- Sebagai Analgesik, bekerja dengan meningkatkan ambang rangsang rasa sakit.</p><p>- Sebagai Antipiretik, diduga bekerja langsung pada pusat pengatur panas di hipotalamus.</p>",
      "indication": "<p>Meringankan rasa sakit kepala, sakit gigi, dan menurunkan demam</p>",
      "warning": "<p>1. Hati - hati penggunaan obat ini pada penderita penyakit ginjal dan hati</p><p>2. Bila setelah 2 hari demam tidak menurun atau setelah 5 hari nyeri tidak menghilang, segera hubungi Unit Pelayanan Kesehatan</p><p>3. Penggunaan obat ini pada penderita yang mengkonsumsi alkohol, dapat meningkatkan resiko kerusakan fungsi hati</p>",
      "side_effect": "<p>1. Penggunaan jangka lama dan dosis besar dapat menyebakan kerusakan hati </p><p>2. Reaksi hipersensitivitas</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001926",
          "name": "Paracetamol 120 mg / 5 mL Sirup",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DBL8513602737A1",
          "name": "CASETAMOL",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94002317",
          "pack_price": 13209
        }
      ],
      "product_template": {
        "name": "Paracetamol 120 mg/5 mL Sirup",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000511",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Paracetamol 120 mg/5 mL Sirup"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000101",
          "zat_aktif": "Paracetamol",
          "updated_at": "2022-07-06 11:25:27",
          "kekuatan_zat_aktif": "120 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 2.5,
          "name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 2.5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 - 2.5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 10 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 5 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 10,
          "name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 15,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 10 - 15 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 15,
          "name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 20,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-12 07:36:57",
          "period_ucum": "hari",
          "display_name": "Anak: 15 - 20 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002151",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Ibuprofen 400 mg Tablet Salut Selaput (NOVAPHARIN)",
      "kfa_code": "93002151",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-01-12 01:35:31",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS077",
        "name": "Tablet Salut Selaput"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL0934008817B1",
      "nama_dagang": "IBUPROFEN",
      "manufacturer": "NOVAPHARIN",
      "registrar": "NOVAPHARIN",
      "generik": true,
      "rxterm": 6651,
      "dose_per_unit": 1,
      "fix_price": 208.5,
      "het_price": 640,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "47713915",
      "score_tkdn": 35.27,
      "score_bmp": 0,
      "score_tkdn_bmp": 35.27,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.2 g - O"
      },
      "atc_l1": {
        "code": "M",
        "name": "MUSCULO-SKELETAL SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "M01",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
        "level": "2",
        "comment": null,
        "parent_code": "M"
      },
      "atc_l3": {
        "code": "M01A",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
        "level": "3",
        "comment": null,
        "parent_code": "M01"
      },
      "atc_l4": {
        "code": "M01AE",
        "name": "Propionic acid derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "M01A"
      },
      "atc_l5": {
        "code": "M01AE01",
        "name": "Ibuprofen",
        "level": "5",
        "comment": null,
        "parent_code": "M01AE"
      },
      "description": "<p><font style=\"font-size: 12px;\"> Pemerian : </font><span style=\"text-align: inherit;\"><font style=\"font-size: 12px;\">Sachets of paper / aluminium / polyethylene foil containing a white granular with a characteristic mint-anise odour</font><font style=\"font-size: 12px;\"><br></font><font style=\"font-size: 12px;\"><br></font></span></p><div class=\"WordSection1\"><p class=\"MsoNormal\" style=\"margin-left:10.0pt;line-height:12.6pt;mso-line-height-rule:\nexactly\"><b><span style='font-family:\"Times New Roman\",serif'>Pharmacodynamic<span style=\"letter-spacing:-.2pt\"> </span>properties:</span></b></p><p></p><p></p><h1 style=\"line-height:12.6pt;mso-line-height-rule:exactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>General properties<p></p></span></h1><p class=\"MsoNormal\" style=\"margin-top:.2pt;margin-right:11.3pt;margin-bottom:\n8.0pt;margin-left:10.0pt;text-align:justify\"><i><span style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic<span style=\"letter-spacing:.05pt\"> </span>group</span></i><span style='font-family:\n\"Times New Roman\",serif'>:<span style=\"letter-spacing:.05pt\"> </span>Antiinflammatory<span style=\"letter-spacing:.05pt\"> </span>and<span style=\"letter-spacing:.05pt\"> </span>anti-rheumatic<span style=\"letter-spacing:.05pt\"> </span>products,<span style=\"letter-spacing:.05pt\"> </span>non-steroids,<span style=\"letter-spacing:.05pt\"> </span>Propionic acid derivatives.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"text-align:justify;line-height:12.6pt;mso-line-height-rule:\nexactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>ATC<span style=\"letter-spacing:-.1pt\"> </span>code: M01AE01.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"text-align:justify;line-height:12.6pt;mso-line-height-rule:\nexactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Ibuprofen<span style=\"letter-spacing:-.15pt\"> </span>is<span style=\"letter-spacing:-.05pt\"> </span>a<span style=\"letter-spacing:-.2pt\"> </span>synthetic<span style=\"letter-spacing:-.2pt\"> </span>analgesic-antiinflammatory<span style=\"letter-spacing:-.2pt\"> </span>drug<span style=\"letter-spacing:-.1pt\"> </span>with<span style=\"letter-spacing:-.1pt\"> </span>a<span style=\"letter-spacing:-.05pt\"> </span>marked<span style=\"letter-spacing:-.2pt\"> </span>antipyretic<span style=\"letter-spacing:-.1pt\"> </span>action.</span><br><br><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'></span></p><p></p><i><span style='font-family:\"Times New Roman\",serif'>Mechanism<span style=\"letter-spacing:-.05pt\"> </span>of<span style=\"letter-spacing:-.1pt\"> </span>action </span></i><br><i><span style='font-family:\"Times New Roman\",serif'><p></p></span></i><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Ibuprofen is the first phenylpropionic acid derivative. It is a prostaglandin synthetase inhibitor<span style=\"letter-spacing:.05pt\"> </span>with<span style=\"letter-spacing:\n-.05pt\"> </span>analgesic,<span style=\"letter-spacing:.1pt\"> </span>antipyretic and<span style=\"letter-spacing:-.05pt\"> </span>anti-inflammatory<span style=\"letter-spacing:-.2pt\"> </span>properties.<p></p></span><p></p><p class=\"MsoBodyText\" style=\"text-align:justify;line-height:12.6pt;mso-line-height-rule:\nexactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>It<span style=\"letter-spacing:-.2pt\"> </span>possesses<span style=\"letter-spacing:-.2pt\"> </span>a<span style=\"letter-spacing:-.2pt\"> </span>non-narcotic<span style=\"letter-spacing:-.15pt\"> </span>analgesic<span style=\"letter-spacing:\n-.05pt\"> </span>activity.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:11.25pt;text-align:justify\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The mechanism of action of ibuprofen (in situ formation of L-arginine salt) is linked to the<span style=\"letter-spacing:.05pt\"> </span>reversible inhibition of the COX enzyme, responsible for conversion of arachidonic acid into<span style=\"letter-spacing:\n.05pt\"> </span>cyclic endoperoxydes, hence reducing the synthesis of thromboxane (TXA2), prostacyclines<span style=\"letter-spacing:.05pt\"> </span>(PGI2)<span style=\"letter-spacing:-.1pt\"> </span>and prostaglandines<span style=\"letter-spacing:\n.05pt\"> </span>(PG).</span><br><br><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'></span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:11.25pt;text-align:justify\"><i><span style='font-family:\"Times New Roman\",serif'>Pharmacodynamic<span style=\"letter-spacing:-.15pt\"> </span>effects</span></i></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:11.4pt;text-align:justify\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Experimental data suggest that ibuprofen may inhibit the effect of low dose acetylsalicylic acid<span style=\"letter-spacing:-2.95pt\"> </span>on<span style=\"letter-spacing:-.35pt\"> </span>platelet<span style=\"letter-spacing:-.25pt\"> </span>aggregation<span style=\"letter-spacing:\n-.3pt\"> </span>when<span style=\"letter-spacing:-.3pt\"> </span>they<span style=\"letter-spacing:-.35pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>dosed<span style=\"letter-spacing:-.3pt\"> </span>concomitantly.<span style=\"letter-spacing:\n-.25pt\"> </span>Some<span style=\"letter-spacing:-.25pt\"> </span>pharmacodynamics<span style=\"letter-spacing:-.3pt\"> </span>studies</span></p><p></p><p></p></div><p><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>show<span style=\"letter-spacing:-.3pt\"> </span>that<span style=\"letter-spacing:-.15pt\"> </span>when<span style=\"letter-spacing:-.15pt\"> </span>a<span style=\"letter-spacing:-.15pt\"> </span>single<span style=\"letter-spacing:-.25pt\"> </span>dose<span style=\"letter-spacing:-.15pt\"> </span>of<span style=\"letter-spacing:-.1pt\"> </span>ibuprofen<span style=\"letter-spacing:-.25pt\"> </span>400mg<span style=\"letter-spacing:-.15pt\"> </span>was<span style=\"letter-spacing:-.15pt\"> </span>taken<span style=\"letter-spacing:-.3pt\"> </span>within<span style=\"letter-spacing:-.15pt\"> </span>8<span style=\"letter-spacing:-.15pt\"> </span>h<span style=\"letter-spacing:-.15pt\"> </span>before<span style=\"letter-spacing:-.15pt\"> </span>or<span style=\"letter-spacing:-.25pt\"> </span>within<span style=\"letter-spacing:-.15pt\"> </span>30<span style=\"letter-spacing:-.15pt\"> </span>min<span style=\"letter-spacing:-2.95pt\"> </span>after immediate release acetylsalicylic acid dosing (81mg), a decreased effect of ASA on the<span style=\"letter-spacing:\n.05pt\"> </span>formation<span style=\"letter-spacing:-.05pt\"> </span>of<span style=\"letter-spacing:-.05pt\"> </span>thromboxane or<span style=\"letter-spacing:\n-.05pt\"> </span>platelet aggregation<span style=\"letter-spacing:-.1pt\"> </span>occurred.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:16.8pt;text-align:justify\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Although<span style=\"letter-spacing:-.3pt\"> </span>there<span style=\"letter-spacing:-.2pt\"> </span>are<span style=\"letter-spacing:-.2pt\"> </span>uncertainties<span style=\"letter-spacing:\n-.2pt\"> </span>regarding<span style=\"letter-spacing:-.1pt\"> </span>extrapolation<span style=\"letter-spacing:-.1pt\"> </span>of<span style=\"letter-spacing:-.15pt\"> </span>these<span style=\"letter-spacing:-.2pt\"> </span>data<span style=\"letter-spacing:-.3pt\"> </span>to<span style=\"letter-spacing:-.2pt\"> </span>the<span style=\"letter-spacing:-.1pt\"> </span>clinical<span style=\"letter-spacing:-.1pt\"> </span>situation,<span style=\"letter-spacing:\n-2.95pt\"> </span>the<span style=\"letter-spacing:-.1pt\"> </span>possibility<span style=\"letter-spacing:-.2pt\"> </span>that<span style=\"letter-spacing:-.15pt\"> </span>regular,<span style=\"letter-spacing:-.15pt\"> </span>long-term<span style=\"letter-spacing:\n-.15pt\"> </span>use<span style=\"letter-spacing:-.2pt\"> </span>of ibuprofen<span style=\"letter-spacing:-.2pt\"> </span>may<span style=\"letter-spacing:-.3pt\"> </span>reduce<span style=\"letter-spacing:-.2pt\"> </span>the<span style=\"letter-spacing:-.2pt\"> </span>cardio<span style=\"letter-spacing:-.1pt\"> </span>protective<span style=\"letter-spacing:\n-.1pt\"> </span>effect<span style=\"letter-spacing:-2.9pt\"> </span>of low-dose<span style=\"letter-spacing:-.1pt\"> </span>acetylsalicylic<span style=\"letter-spacing:\n-.1pt\"> </span>acid<span style=\"letter-spacing:-.25pt\"> </span>cannot<span style=\"letter-spacing:-.2pt\"> </span>be<span style=\"letter-spacing:-.25pt\"> </span>excluded.<span style=\"letter-spacing:-.05pt\"> </span>No<span style=\"letter-spacing:-.25pt\"> </span>clinically<span style=\"letter-spacing:-.2pt\"> </span>relevant<span style=\"letter-spacing:-.05pt\"> </span>effect<span style=\"letter-spacing:-.2pt\"> </span>is<span style=\"letter-spacing:-.1pt\"> </span>considered<span style=\"letter-spacing:\n-2.95pt\"> </span>to be likely for occasional ibuprofen use. (See Interaction with other medicinal products and<span style=\"letter-spacing:.05pt\"> </span>other<span style=\"letter-spacing:-.2pt\"> </span>forms<span style=\"letter-spacing:-.1pt\"> </span>of<span style=\"letter-spacing:.1pt\"> </span>interaction).</span></p><p></p><p></p><p><br></p>",
      "indication": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>SPEDIFEN is indicated for\nrelieving pain of various etiology: headache, pain after tooth extraction and\npostoperative pain, as well as for the treatment of primary dysmenorrhea.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-right:.7pt;text-align:justify;text-justify:\ninter-ideograph;mso-line-height-alt:1.15pt\">\n\n</p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>SPEDIFEN is also indicated for\nthe relief of signs and symptoms of rheumatoid arthritis and <i>osteoarthritis</i>, as well as for the\nmusculoskeletal and traumatic alterations implying pain and inflammation</span></p><p></p><p></p>",
      "warning": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:.45pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;\nmso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\";'><font style=\"font-size: 12px;\"><b>Undesirale effects :</b><br></font><font style=\"font-size: 12px;\">Undesirable\neffects may be minimized by using the lowest effective dose for the shortest\nduration necessary to control sym</font></span><span lang=\"IN\" style='\nmso-ansi-language:IN; font-family:\"Times New Roman\",\"serif\";'><font style=\"font-size: 12px;\">p</font></span><span style='font-family:\"Times New Roman\",\"serif\";'><font style=\"font-size: 12px;\">toms\n(see Posology and method of administration and GI and cardiovascular risk\nbelow)</font></span></p><p></p><p></p><p class=\"Default\" style=\"margin-right:21.25pt;text-align:justify\"><span lang=\"IN\" style='font-family: \"Times New Roman\", \"serif\"; font-size: 12px;'></span></p><p> </p><p></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"><font style=\"font-size: 12px;\">GI Effects </font></p><p></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"><font style=\"font-size: 12px;\">Concomitant use\nof SPEDIFEN and NSAIDs, including COX-2 selective inhibitors should be avoided.\n</font></p><p></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"><font style=\"font-size: 12px;\">Elderly patients: elderly\npatients may be exposed to a higher frequency of NSAID-related adverse\nreactions, especially gastrointestinal bleeding and perforation, sometimes with\nfatal outcome (see section “How to use SPEDIFEN 400 mg”). </font></p><p></p><p class=\"Default\" style=\"margin-right: 7.9pt;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"Default\" style=\"margin-right: 7.9pt;\"><font style=\"font-size: 12px;\">Gastrointestinal\nbleeding, ulceration and  perforation:\ngastrointestinal bleeding, ulceration or perforation, which may be fatal, have\nbeen reported with all NSAIDs, at any time during treatment, with or without\nwarning symptoms or previous history of serious GI events.The risk of GI\nbleeding, ulceration or perforation is higher with increasing NSAID doses, in\npatients with a history of ulcer, particularly if complicated with haemorrhage\nor perforation (See Contraindications), and in the elderly. These patients\nshould commence treatment on the lowest dose available. Combination therapy\nwith protective agents (e.g. misoprostol or proton pump inhibitors) should be\nconsidered for these patients, and also for patients requiring concomitant low\ndose aspirin, or other drugs likely to increase gastrointestinal risk (See\nInteractions with other medicinal products and other forms of interaction). </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\nnormal;mso-layout-grid-align:none;text-autospace:none\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.4pt; line-height: normal;\"><font style=\"font-size: 12px;\">Patients with a\nhistory of GI toxicity, particularly when elderly, should report any unusual abdominal\nsymptoms (especially GI bleeding) particularly in the initial stages of\ntreatment. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.4pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution should be\nadvised in patients receiving concomitant medications which could increase\nthe risk of ulceration or bleeding, such as oral corticosteroids,\nanticoagulants such as warfarin, selective serotonin-reuptake inhibitors or\nanti-platelet agents such as acetyl salicylic acid (See Interactions with other\nmedicinal products and other forms of interaction). </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.4pt; line-height: normal;\"><font style=\"font-size: 12px;\">When GI bleeding or\nulceration occurs, the treatment should be withdrawn. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">NSAIDs should be\ngiven with care to patients with a history of gastrointestinal disease\n(ulcerative colitis, Crohn’s disease) as their condition may be exacerbated\n(See Undesirable effects). </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Cardiovascular and cerebrovascular effects </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Appropriate\nmonitoring and advice are required for patients with a history of hypertension\nand or mild to moderate congestive heart failure. Fluid retention, hypertension\nand oedema have been reported in association with NSAIDs therapy. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Clinical studies\nsuggest that use of ibuprofen, particularly at a high dose (2400 mg/day) may be\nassociated with a small increased risk of arterial thrombotic event (for\nexample myocardial infarction or stroke). Overall, epidemiological studies do\nnot suggest that low dose ibuprofen (e.g. ≤ 1200 mg/day) is associated with an\nincreased risk of arterial thrombotic events. </font></p><p></p><p class=\"Default\"><font style=\"font-size: 12px;\">Patients with uncontrolled hypertension,\ncongestive heart failure (NYHA II-III), established ischaemic heart disease,\nperipheral arterial disease, and/or cerebrovascular disease should only be\ntreated with ibuprofen after careful consideration and high doses (2400 mg/day)\nshould be avoided. </font></p><p></p><p class=\"Default\"><font style=\"font-size: 12px;\">Careful consideration should also be\nexercised before initiating long-term treatment of patients with risk factors\nfor cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes\nmellitus, and smoking), particularly if high doses of ibuprofen (2400 mg/day)\nare required.</font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\nnormal;mso-layout-grid-align:none;text-autospace:none\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Skin reactions </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Serious skin\nreactions, some of them fatal, including exfoliative dermatitis,\nStevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported\nvery rarely in association with the use of NSAIDSs (see Undesirable effects).\nPatients appear to be at highest risk of these reactions early in the course of\ntherapy, the onset of the reaction occurring in the majority of cases within\nthe first month of treatment. SPEDIFEN should be discontinued at the first\nappearance of skin rash, mucosal lesions, or any other sign of\nhypersensitivity. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Other effects </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution is required in patients with\ncoagulation disorders and liver, cardiac or kidney insufficiency. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution should be used when initiating\ntreatment with ibuprofen in patients with considerable dehydration. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Risks of long-term habitual use of\nanalgesic are headache and analgesic nephropathy. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Ibuprofen may mask the objective and\nsubjective signs of an infection. In isolated cases an exacerbation of\ninfective inflammations (e.g. development of necrotizing fasciitis) has been\ndescribed in temporal connection with the use of NSAIDs. Therapy with ibuprofen\nin patients with an infection should therefore be used with care. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Bronchospasm may be precipitated in\npatients suffering from or with a previous history of bronchial asthma or\nallergic disease. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution is required in patients with\nsystemic lupus erythematosus or other collagen diseases. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">There is some evidence that drugs which\ninhibit cyclo-oxygenase/prostaglandin synthesis may cause impairment of female\nfertility by an effect on ovulation. This is reversible on withdrawal of\ntreatment. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Patients who experience visual\ndisturbances during ibuprofen therapy should discontinue the treatment and have\nan ophthalmologic examination. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">NSAIDs may produce an\nincrease of liver function test results. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Adolescents (age\nrange: ≥ 12 years to &lt; 18 years) </font></p><p></p><p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n</p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">There is a risk of\nrenal impairment in dehydrated children/adolescents. </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\"><br></font></p><p class=\"MsoNormal\" style=\"margin-top:9.95pt;margin-right:0in;margin-bottom:\n0in;margin-left:3.5pt;margin-bottom:.0001pt\"><b><span style='font-family:\"Arial\",sans-serif;mso-hansi-font-family:\"Arial MT\";\nmso-bidi-font-family:\"Arial MT\"'>Cardiovascular Risk</span></b></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-top:.05pt;margin-right:10.35pt;margin-bottom:\n0in;margin-left:39.5pt;margin-bottom:.0001pt;text-align:justify;text-indent:\n-.25in;mso-list:l0 level1 lfo1;tab-stops:39.55pt\"><!--[if !supportLists]-->-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span>NSAIDs may cause an increased risk of serious\ncardiovascular thrombotic events,<span style=\"letter-spacing:.05pt\"> </span>myocardial\ninfarction, and stroke, which can be fatal. This risk may increase with<span style=\"letter-spacing:.05pt\"> </span>duration of use. Patients with\ncardiovascular disease or risk factors for cardiovascular<span style=\"letter-spacing:-2.95pt\"> </span>disease<span style=\"letter-spacing:-.05pt\">\n</span>may<span style=\"letter-spacing:-.1pt\"> </span>be at<span style=\"letter-spacing:-.15pt\"> </span>greater<span style=\"letter-spacing:.05pt\">\n</span>risk</p><p></p><p class=\"MsoBodyText\" style=\"margin-top:.1pt;margin-right:10.2pt;margin-bottom:\n0in;margin-left:39.5pt;margin-bottom:.0001pt;text-align:justify;text-indent:\n-.25in;mso-list:l0 level1 lfo1;tab-stops:39.55pt\"><!--[if !supportLists]-->-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span>NSAIDs is contraindicated for the treatment of\nperioperative pain in the setting of<span style=\"letter-spacing:.05pt\"> </span>coronaryartery<span style=\"letter-spacing:-.15pt\"> </span>bypass<span style=\"letter-spacing:-.1pt\">\n</span>graft<span style=\"letter-spacing:-.05pt\"> </span>(CABG)<span style=\"letter-spacing:.05pt\"> </span>surgery</p><p></p><p class=\"MsoBodyText\" style=\"margin-top:.4pt;margin-right:0in;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt\"><span style=\"font-size:10.5pt;\nmso-bidi-font-size:11.0pt\"> </span></p><p class=\"MsoNormal\" style=\"margin-left:3.5pt\"><b><span style='font-family:\"Arial\",sans-serif;mso-hansi-font-family:\"Arial MT\";\nmso-bidi-font-family:\"Arial MT\"'>Gastrointestinal<span style=\"letter-spacing:\n-.15pt\"> </span>Risk</span></b></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">\n\n\n\n\n\n\n\n\n\n</font></p><p class=\"MsoBodyText\" style=\"margin-top:.2pt;margin-right:10.2pt;margin-bottom:\n0in;margin-left:39.5pt;margin-bottom:.0001pt;text-align:justify;text-indent:\n-.25in;mso-list:l0 level1 lfo1;tab-stops:39.55pt\"><!--[if !supportLists]-->-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span>NSAIDs cause an increased risk of serious gastrointestinal adverse events including<span style=\"letter-spacing:.05pt\"> </span>bleeding, ulceration, and perforation of the stomatch or intestines, which can be fatal<span style=\"letter-spacing:-2.95pt\"> </span><span style=\"letter-spacing:-.05pt\">These</span><span style=\"letter-spacing:-.7pt\"> </span>events<span style=\"letter-spacing:-.6pt\"> </span>can<span style=\"letter-spacing:-.55pt\"> </span>occur<span style=\"letter-spacing:-.7pt\"> </span>at<span style=\"letter-spacing:-.45pt\"> </span>any<span style=\"letter-spacing:-.75pt\"> </span>time<span style=\"letter-spacing:-.65pt\"> </span>during<span style=\"letter-spacing:-.5pt\">\n</span>use<span style=\"letter-spacing:-.55pt\"> </span>and<span style=\"letter-spacing:-.5pt\"> </span>without<span style=\"letter-spacing:-.45pt\">\n</span>warning<span style=\"letter-spacing:-.55pt\"> </span>symptoms.<span style=\"letter-spacing:-.55pt\"> </span>Elderly<span style=\"letter-spacing:-2.95pt\">\n</span>patients are at<span style=\"letter-spacing:-.2pt\"> </span>greater<span style=\"letter-spacing:-.05pt\"> </span>risk<span style=\"letter-spacing:-.15pt\"> </span>for<span style=\"letter-spacing:.05pt\"> </span>serious<span style=\"letter-spacing:-.1pt\">\n</span>gastrointestinal<span style=\"letter-spacing:-.05pt\"> </span>events.</p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\"><!--[if !vml]-->\n \n <!--[endif]--><br clear=\"ALL\"></font></p><p></p><p></p><p></p>",
      "side_effect": "<p style=\"font-family: Roboto, sans-serif;\"><span style='font-family:\"Times New Roman\",\"serif\"'><b>Undesirable effects </b></span><br><span style='font-family:\"Times New Roman\",\"serif\"'>Undesirable effects are primary linked to the pharmacological effect of ibuprofen on prostaglandin synthesis.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>The most commonly reported\nadverse events effect the gastrointestinal tract, ranging from nausea and\ndyspepsia to serious bleeding or activation of peptic ulcer (see special\nwarnings and precautions for use).</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>Bullous reaction including\nSteven-Jhonson’s syndrome and toxic epidermal Necrolysis where observed very\nseldom.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>Oedema, hypertension, and cardiac\nfailure have been reported in association with NSAIDs treatment. Clinical\nstudies suggest th</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";\nmso-ansi-language:IN'>at</span><span style='font-family:\"Times New Roman\",\"serif\"'>\nuse of ibuprofen, particularly at high dose (2400 mg/day) may be associated with\na small increased risk of arterial thrombotic events (for example myocardial\ninfraction or stroke) (see Special Warnings and precaution for use)</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>In the table below adverse re</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";mso-ansi-language:IN'>a</span><span style='font-family:\"Times New Roman\",\"serif\"'>ctions are listed by system organ\nclass , and frequency (very common (≥ 1/10). Common (≥1/100 to &lt; 1/10),\nuncommon (≥1/1.000 to 1/100), rare (≥1/10.000 to &lt;1/1.000), very rare\n(&lt;1/10.000) and not known (cannot be estimated from the available data)</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>Within each frequency grouping,\nundesirable effects are presented in order of decreasing seriousness.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><table class=\"MsoNormalTable\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\" width=\"505\">\n <tbody><tr style=\"mso-yfti-irow:0;mso-yfti-firstrow:yes;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><b><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Sytem Organ Class</span></b></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border:solid windowtext 1.0pt;\n  border-left:none;mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><b><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Frequency </span></b></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:1;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Blood and lymphatic system disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:2;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Thrombocytopenia, Agranulocytosis, Aplastic\n  Anaemia</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:3;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anaemia</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:4;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Immune system disorders </span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:5;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Allergic reaction </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:6;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anaphylaxis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:7;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anaphylactic Shock </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:8;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Nervous system Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:9;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Headache, dizzines </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Common</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:10;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Meningitis Aseptic</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:11;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Eye Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:12;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Visual Disturbance</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:13;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Papilloedema</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:14;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Ear and Labyrinth Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:15;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Ear Disorder</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:16;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Cardiac Disorders </span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:17;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Cardiac Failure</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:18;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Vascular Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:19;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Arterial thrombosis, Hypertension, Hypotension\n  </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:20;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Respiratory, Thoracic and Mediastinal\n  Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:21;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Asthma, Aggravated Asthma, Bronchospasm,\n  Dyspnea</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:22;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Throat irritation</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:23;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Gastrointestinal Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:24;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Dyspepsia, Diarrhoea</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Very Common </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:25;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Abdominal Pain, nausea, Flatulence</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Common</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:26;height:15.4pt\">\n  <td width=\"259\" style=\"width:2.7in;border:solid windowtext 1.0pt;border-top:\n  none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;\n  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;\n  height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Peptic Ulcer, Gastrointestinal, Haemorrhage,\n  Vomiting, mala</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";\n  mso-fareast-font-family:\"Times New Roman\";color:black;mso-ansi-language:IN'>ena</span><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\";\n  color:black'>, gastritis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:27;height:24.7pt\">\n  <td width=\"259\" style=\"width:2.7in;border:solid windowtext 1.0pt;border-top:\n  none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;\n  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Gastrointestinal Perforation, Constipation,\n  Haematemesis, Ulcerative stomatitis, Colitis Aggravated, Chron's Disease\n  Aggravated</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:28;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anorexia </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:29;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Hepato-biliary Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:30;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Hepatic disorders</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:31;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Liver Injury, Hepatitis, Jaundice </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:32;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Skin and Subcutaneous Tissue Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:33;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Skin Disorders, Rash</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Common</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:34;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Angioedema, Purpura, Pruritus, Urticaria</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:35;height:24.7pt\">\n  <td width=\"259\" style=\"width:2.7in;border:solid windowtext 1.0pt;border-top:\n  none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;\n  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Bullous Reaction, Erythema Multiforme,\n  Exfoliative Dermatitis, Steven Jhonson Syndrome, Toxic Epidermal Necrolysis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Very Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:36;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'></span></p><p> </p><p></p>\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Photosensitivity reaction, Skin Reaction\n  aggravated</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'></span></p><p> </p><p></p>\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:37;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Renal and urinary disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:38;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Hematuria </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:39;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Acute Renal Failure, Interstitial Nephritis,\n  Papillary Necrosis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Very Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:40;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>General Disorders and Administration Site\n  Conditions</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:41;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Oedema</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:42;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Investigations</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:43;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Liver Function Test Abnormal</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:44;mso-yfti-lastrow:yes;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Renal Function Test Abnormal</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n</tbody></table><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><i><span style='font-family:\"Times New Roman\",\"serif\"'>Pediatric\npopulation </span></i></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>From c</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";mso-ansi-language:IN'>u</span><span style='font-family:\"Times New Roman\",\"serif\"'>mulative clinical experience,\nthere is no clinically relevant difference in nature, frequency, seriousness\nand reversibility of adverse reactions between the safety profile in adult and\napproved paediatric population (≥12 years)</span></p><p></p><p></p><p class=\"Default\" style=\"text-align:justify\"><i><span lang=\"IN\" style='font-size:\n11.0pt;font-family:\"Times New Roman\",\"serif\";mso-ansi-language:IN'></span></i></p><p><i> </i></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><i><span style='font-family:\"Times New Roman\",\"serif\"'>If any of the side effects gets\nserious, or if you notice any side effects not listed in this leaflet, please\ntell your doctor or pharmacist.</span></i><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-left:19.45pt;text-align:justify;text-justify:\ninter-ideograph;text-indent:-.25in;mso-line-height-alt:1.15pt;mso-list:l0 level1 lfo1\">\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<br><span style=\"font-size:11.0pt\"></span></p><p></p><p></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002151",
          "name": "Ibuprofen 400 mg Tablet Salut Selaput",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL0934008817B1",
          "name": "IBUPROFEN",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/47713915?lang=id&type=province",
          "code": "47713915",
          "name": "Ibuprofen tablet/kapsul/kaplet 400 mg",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Tablet",
          "kfa_code": "94002403",
          "pack_price": 64000
        }
      ],
      "product_template": {
        "name": "Ibuprofen 400 mg Tablet Salut Selaput",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001081",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Ibuprofen 400 mg Tablet Salut Selaput"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000107",
          "zat_aktif": "IBUPROFEN",
          "updated_at": "2022-10-10 06:38:30",
          "kekuatan_zat_aktif": "400 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 200,
          "name": "Dewasa: 200 - 400 mg; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 400,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-11-21 01:38:21",
          "period_ucum": "hari",
          "display_name": "Dewasa: 200 - 400 mg; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 400,
          "name": "Dewasa: 400.0 mg; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-11-21 01:38:21",
          "period_ucum": "hari",
          "display_name": "Dewasa: 400.0 mg; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002163",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Ibuprofen 400 mg Tablet Salut Selaput (HOLI PHARMA)",
      "kfa_code": "93002163",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2023-10-30 04:50:17",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS077",
        "name": "Tablet Salut Selaput"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL9917107009A1",
      "nama_dagang": "IBUPROFEN",
      "manufacturer": "HOLI PHARMA",
      "registrar": "HOLI PHARMA",
      "generik": true,
      "rxterm": 6651,
      "dose_per_unit": 1,
      "fix_price": 0,
      "het_price": 2.1,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "1534396",
      "score_tkdn": 33,
      "score_bmp": 0,
      "score_tkdn_bmp": 33,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.2 g - O"
      },
      "atc_l1": {
        "code": "M",
        "name": "MUSCULO-SKELETAL SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "M01",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
        "level": "2",
        "comment": null,
        "parent_code": "M"
      },
      "atc_l3": {
        "code": "M01A",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
        "level": "3",
        "comment": null,
        "parent_code": "M01"
      },
      "atc_l4": {
        "code": "M01AE",
        "name": "Propionic acid derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "M01A"
      },
      "atc_l5": {
        "code": "M01AE01",
        "name": "Ibuprofen",
        "level": "5",
        "comment": null,
        "parent_code": "M01AE"
      },
      "description": "<p><font style=\"font-size: 12px;\"> Pemerian : </font><span style=\"text-align: inherit;\"><font style=\"font-size: 12px;\">Sachets of paper / aluminium / polyethylene foil containing a white granular with a characteristic mint-anise odour</font><font style=\"font-size: 12px;\"><br></font><font style=\"font-size: 12px;\"><br></font></span></p><div class=\"WordSection1\"><p class=\"MsoNormal\" style=\"margin-left:10.0pt;line-height:12.6pt;mso-line-height-rule:\nexactly\"><b><span style='font-family:\"Times New Roman\",serif'>Pharmacodynamic<span style=\"letter-spacing:-.2pt\"> </span>properties:</span></b></p><p></p><p></p><h1 style=\"line-height:12.6pt;mso-line-height-rule:exactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>General properties<p></p></span></h1><p class=\"MsoNormal\" style=\"margin-top:.2pt;margin-right:11.3pt;margin-bottom:\n8.0pt;margin-left:10.0pt;text-align:justify\"><i><span style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic<span style=\"letter-spacing:.05pt\"> </span>group</span></i><span style='font-family:\n\"Times New Roman\",serif'>:<span style=\"letter-spacing:.05pt\"> </span>Antiinflammatory<span style=\"letter-spacing:.05pt\"> </span>and<span style=\"letter-spacing:.05pt\"> </span>anti-rheumatic<span style=\"letter-spacing:.05pt\"> </span>products,<span style=\"letter-spacing:.05pt\"> </span>non-steroids,<span style=\"letter-spacing:.05pt\"> </span>Propionic acid derivatives.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"text-align:justify;line-height:12.6pt;mso-line-height-rule:\nexactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>ATC<span style=\"letter-spacing:-.1pt\"> </span>code: M01AE01.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"text-align:justify;line-height:12.6pt;mso-line-height-rule:\nexactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Ibuprofen<span style=\"letter-spacing:-.15pt\"> </span>is<span style=\"letter-spacing:-.05pt\"> </span>a<span style=\"letter-spacing:-.2pt\"> </span>synthetic<span style=\"letter-spacing:-.2pt\"> </span>analgesic-antiinflammatory<span style=\"letter-spacing:-.2pt\"> </span>drug<span style=\"letter-spacing:-.1pt\"> </span>with<span style=\"letter-spacing:-.1pt\"> </span>a<span style=\"letter-spacing:-.05pt\"> </span>marked<span style=\"letter-spacing:-.2pt\"> </span>antipyretic<span style=\"letter-spacing:-.1pt\"> </span>action.</span><br><br><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'></span></p><p></p><i><span style='font-family:\"Times New Roman\",serif'>Mechanism<span style=\"letter-spacing:-.05pt\"> </span>of<span style=\"letter-spacing:-.1pt\"> </span>action </span></i><br><i><span style='font-family:\"Times New Roman\",serif'><p></p></span></i><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Ibuprofen is the first phenylpropionic acid derivative. It is a prostaglandin synthetase inhibitor<span style=\"letter-spacing:.05pt\"> </span>with<span style=\"letter-spacing:\n-.05pt\"> </span>analgesic,<span style=\"letter-spacing:.1pt\"> </span>antipyretic and<span style=\"letter-spacing:-.05pt\"> </span>anti-inflammatory<span style=\"letter-spacing:-.2pt\"> </span>properties.<p></p></span><p></p><p class=\"MsoBodyText\" style=\"text-align:justify;line-height:12.6pt;mso-line-height-rule:\nexactly\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>It<span style=\"letter-spacing:-.2pt\"> </span>possesses<span style=\"letter-spacing:-.2pt\"> </span>a<span style=\"letter-spacing:-.2pt\"> </span>non-narcotic<span style=\"letter-spacing:-.15pt\"> </span>analgesic<span style=\"letter-spacing:\n-.05pt\"> </span>activity.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:11.25pt;text-align:justify\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The mechanism of action of ibuprofen (in situ formation of L-arginine salt) is linked to the<span style=\"letter-spacing:.05pt\"> </span>reversible inhibition of the COX enzyme, responsible for conversion of arachidonic acid into<span style=\"letter-spacing:\n.05pt\"> </span>cyclic endoperoxydes, hence reducing the synthesis of thromboxane (TXA2), prostacyclines<span style=\"letter-spacing:.05pt\"> </span>(PGI2)<span style=\"letter-spacing:-.1pt\"> </span>and prostaglandines<span style=\"letter-spacing:\n.05pt\"> </span>(PG).</span><br><br><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'></span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:11.25pt;text-align:justify\"><i><span style='font-family:\"Times New Roman\",serif'>Pharmacodynamic<span style=\"letter-spacing:-.15pt\"> </span>effects</span></i></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:11.4pt;text-align:justify\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Experimental data suggest that ibuprofen may inhibit the effect of low dose acetylsalicylic acid<span style=\"letter-spacing:-2.95pt\"> </span>on<span style=\"letter-spacing:-.35pt\"> </span>platelet<span style=\"letter-spacing:-.25pt\"> </span>aggregation<span style=\"letter-spacing:\n-.3pt\"> </span>when<span style=\"letter-spacing:-.3pt\"> </span>they<span style=\"letter-spacing:-.35pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>dosed<span style=\"letter-spacing:-.3pt\"> </span>concomitantly.<span style=\"letter-spacing:\n-.25pt\"> </span>Some<span style=\"letter-spacing:-.25pt\"> </span>pharmacodynamics<span style=\"letter-spacing:-.3pt\"> </span>studies</span></p><p></p><p></p></div><p><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>show<span style=\"letter-spacing:-.3pt\"> </span>that<span style=\"letter-spacing:-.15pt\"> </span>when<span style=\"letter-spacing:-.15pt\"> </span>a<span style=\"letter-spacing:-.15pt\"> </span>single<span style=\"letter-spacing:-.25pt\"> </span>dose<span style=\"letter-spacing:-.15pt\"> </span>of<span style=\"letter-spacing:-.1pt\"> </span>ibuprofen<span style=\"letter-spacing:-.25pt\"> </span>400mg<span style=\"letter-spacing:-.15pt\"> </span>was<span style=\"letter-spacing:-.15pt\"> </span>taken<span style=\"letter-spacing:-.3pt\"> </span>within<span style=\"letter-spacing:-.15pt\"> </span>8<span style=\"letter-spacing:-.15pt\"> </span>h<span style=\"letter-spacing:-.15pt\"> </span>before<span style=\"letter-spacing:-.15pt\"> </span>or<span style=\"letter-spacing:-.25pt\"> </span>within<span style=\"letter-spacing:-.15pt\"> </span>30<span style=\"letter-spacing:-.15pt\"> </span>min<span style=\"letter-spacing:-2.95pt\"> </span>after immediate release acetylsalicylic acid dosing (81mg), a decreased effect of ASA on the<span style=\"letter-spacing:\n.05pt\"> </span>formation<span style=\"letter-spacing:-.05pt\"> </span>of<span style=\"letter-spacing:-.05pt\"> </span>thromboxane or<span style=\"letter-spacing:\n-.05pt\"> </span>platelet aggregation<span style=\"letter-spacing:-.1pt\"> </span>occurred.</span></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-right:16.8pt;text-align:justify\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Although<span style=\"letter-spacing:-.3pt\"> </span>there<span style=\"letter-spacing:-.2pt\"> </span>are<span style=\"letter-spacing:-.2pt\"> </span>uncertainties<span style=\"letter-spacing:\n-.2pt\"> </span>regarding<span style=\"letter-spacing:-.1pt\"> </span>extrapolation<span style=\"letter-spacing:-.1pt\"> </span>of<span style=\"letter-spacing:-.15pt\"> </span>these<span style=\"letter-spacing:-.2pt\"> </span>data<span style=\"letter-spacing:-.3pt\"> </span>to<span style=\"letter-spacing:-.2pt\"> </span>the<span style=\"letter-spacing:-.1pt\"> </span>clinical<span style=\"letter-spacing:-.1pt\"> </span>situation,<span style=\"letter-spacing:\n-2.95pt\"> </span>the<span style=\"letter-spacing:-.1pt\"> </span>possibility<span style=\"letter-spacing:-.2pt\"> </span>that<span style=\"letter-spacing:-.15pt\"> </span>regular,<span style=\"letter-spacing:-.15pt\"> </span>long-term<span style=\"letter-spacing:\n-.15pt\"> </span>use<span style=\"letter-spacing:-.2pt\"> </span>of ibuprofen<span style=\"letter-spacing:-.2pt\"> </span>may<span style=\"letter-spacing:-.3pt\"> </span>reduce<span style=\"letter-spacing:-.2pt\"> </span>the<span style=\"letter-spacing:-.2pt\"> </span>cardio<span style=\"letter-spacing:-.1pt\"> </span>protective<span style=\"letter-spacing:\n-.1pt\"> </span>effect<span style=\"letter-spacing:-2.9pt\"> </span>of low-dose<span style=\"letter-spacing:-.1pt\"> </span>acetylsalicylic<span style=\"letter-spacing:\n-.1pt\"> </span>acid<span style=\"letter-spacing:-.25pt\"> </span>cannot<span style=\"letter-spacing:-.2pt\"> </span>be<span style=\"letter-spacing:-.25pt\"> </span>excluded.<span style=\"letter-spacing:-.05pt\"> </span>No<span style=\"letter-spacing:-.25pt\"> </span>clinically<span style=\"letter-spacing:-.2pt\"> </span>relevant<span style=\"letter-spacing:-.05pt\"> </span>effect<span style=\"letter-spacing:-.2pt\"> </span>is<span style=\"letter-spacing:-.1pt\"> </span>considered<span style=\"letter-spacing:\n-2.95pt\"> </span>to be likely for occasional ibuprofen use. (See Interaction with other medicinal products and<span style=\"letter-spacing:.05pt\"> </span>other<span style=\"letter-spacing:-.2pt\"> </span>forms<span style=\"letter-spacing:-.1pt\"> </span>of<span style=\"letter-spacing:.1pt\"> </span>interaction).</span></p><p></p><p></p><p><br></p>",
      "indication": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>SPEDIFEN is indicated for\nrelieving pain of various etiology: headache, pain after tooth extraction and\npostoperative pain, as well as for the treatment of primary dysmenorrhea.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-right:.7pt;text-align:justify;text-justify:\ninter-ideograph;mso-line-height-alt:1.15pt\">\n\n</p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>SPEDIFEN is also indicated for\nthe relief of signs and symptoms of rheumatoid arthritis and <i>osteoarthritis</i>, as well as for the\nmusculoskeletal and traumatic alterations implying pain and inflammation</span></p><p></p><p></p>",
      "warning": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:.45pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;\nmso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\";'><font style=\"font-size: 12px;\"><b>Undesirale effects :</b><br></font><font style=\"font-size: 12px;\">Undesirable\neffects may be minimized by using the lowest effective dose for the shortest\nduration necessary to control sym</font></span><span lang=\"IN\" style='\nmso-ansi-language:IN; font-family:\"Times New Roman\",\"serif\";'><font style=\"font-size: 12px;\">p</font></span><span style='font-family:\"Times New Roman\",\"serif\";'><font style=\"font-size: 12px;\">toms\n(see Posology and method of administration and GI and cardiovascular risk\nbelow)</font></span></p><p></p><p></p><p class=\"Default\" style=\"margin-right:21.25pt;text-align:justify\"><span lang=\"IN\" style='font-family: \"Times New Roman\", \"serif\"; font-size: 12px;'></span></p><p> </p><p></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"><font style=\"font-size: 12px;\">GI Effects </font></p><p></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"><font style=\"font-size: 12px;\">Concomitant use\nof SPEDIFEN and NSAIDs, including COX-2 selective inhibitors should be avoided.\n</font></p><p></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"Default\" style=\"margin-right: 21.25pt;\"><font style=\"font-size: 12px;\">Elderly patients: elderly\npatients may be exposed to a higher frequency of NSAID-related adverse\nreactions, especially gastrointestinal bleeding and perforation, sometimes with\nfatal outcome (see section “How to use SPEDIFEN 400 mg”). </font></p><p></p><p class=\"Default\" style=\"margin-right: 7.9pt;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"Default\" style=\"margin-right: 7.9pt;\"><font style=\"font-size: 12px;\">Gastrointestinal\nbleeding, ulceration and  perforation:\ngastrointestinal bleeding, ulceration or perforation, which may be fatal, have\nbeen reported with all NSAIDs, at any time during treatment, with or without\nwarning symptoms or previous history of serious GI events.The risk of GI\nbleeding, ulceration or perforation is higher with increasing NSAID doses, in\npatients with a history of ulcer, particularly if complicated with haemorrhage\nor perforation (See Contraindications), and in the elderly. These patients\nshould commence treatment on the lowest dose available. Combination therapy\nwith protective agents (e.g. misoprostol or proton pump inhibitors) should be\nconsidered for these patients, and also for patients requiring concomitant low\ndose aspirin, or other drugs likely to increase gastrointestinal risk (See\nInteractions with other medicinal products and other forms of interaction). </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\nnormal;mso-layout-grid-align:none;text-autospace:none\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.4pt; line-height: normal;\"><font style=\"font-size: 12px;\">Patients with a\nhistory of GI toxicity, particularly when elderly, should report any unusual abdominal\nsymptoms (especially GI bleeding) particularly in the initial stages of\ntreatment. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.4pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution should be\nadvised in patients receiving concomitant medications which could increase\nthe risk of ulceration or bleeding, such as oral corticosteroids,\nanticoagulants such as warfarin, selective serotonin-reuptake inhibitors or\nanti-platelet agents such as acetyl salicylic acid (See Interactions with other\nmedicinal products and other forms of interaction). </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.4pt; line-height: normal;\"><font style=\"font-size: 12px;\">When GI bleeding or\nulceration occurs, the treatment should be withdrawn. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">NSAIDs should be\ngiven with care to patients with a history of gastrointestinal disease\n(ulcerative colitis, Crohn’s disease) as their condition may be exacerbated\n(See Undesirable effects). </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Cardiovascular and cerebrovascular effects </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Appropriate\nmonitoring and advice are required for patients with a history of hypertension\nand or mild to moderate congestive heart failure. Fluid retention, hypertension\nand oedema have been reported in association with NSAIDs therapy. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Clinical studies\nsuggest that use of ibuprofen, particularly at a high dose (2400 mg/day) may be\nassociated with a small increased risk of arterial thrombotic event (for\nexample myocardial infarction or stroke). Overall, epidemiological studies do\nnot suggest that low dose ibuprofen (e.g. ≤ 1200 mg/day) is associated with an\nincreased risk of arterial thrombotic events. </font></p><p></p><p class=\"Default\"><font style=\"font-size: 12px;\">Patients with uncontrolled hypertension,\ncongestive heart failure (NYHA II-III), established ischaemic heart disease,\nperipheral arterial disease, and/or cerebrovascular disease should only be\ntreated with ibuprofen after careful consideration and high doses (2400 mg/day)\nshould be avoided. </font></p><p></p><p class=\"Default\"><font style=\"font-size: 12px;\">Careful consideration should also be\nexercised before initiating long-term treatment of patients with risk factors\nfor cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes\nmellitus, and smoking), particularly if high doses of ibuprofen (2400 mg/day)\nare required.</font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\nnormal;mso-layout-grid-align:none;text-autospace:none\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Skin reactions </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Serious skin\nreactions, some of them fatal, including exfoliative dermatitis,\nStevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported\nvery rarely in association with the use of NSAIDSs (see Undesirable effects).\nPatients appear to be at highest risk of these reactions early in the course of\ntherapy, the onset of the reaction occurring in the majority of cases within\nthe first month of treatment. SPEDIFEN should be discontinued at the first\nappearance of skin rash, mucosal lesions, or any other sign of\nhypersensitivity. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Other effects </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution is required in patients with\ncoagulation disorders and liver, cardiac or kidney insufficiency. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution should be used when initiating\ntreatment with ibuprofen in patients with considerable dehydration. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Risks of long-term habitual use of\nanalgesic are headache and analgesic nephropathy. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Ibuprofen may mask the objective and\nsubjective signs of an infection. In isolated cases an exacerbation of\ninfective inflammations (e.g. development of necrotizing fasciitis) has been\ndescribed in temporal connection with the use of NSAIDs. Therapy with ibuprofen\nin patients with an infection should therefore be used with care. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Bronchospasm may be precipitated in\npatients suffering from or with a previous history of bronchial asthma or\nallergic disease. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Caution is required in patients with\nsystemic lupus erythematosus or other collagen diseases. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">There is some evidence that drugs which\ninhibit cyclo-oxygenase/prostaglandin synthesis may cause impairment of female\nfertility by an effect on ovulation. This is reversible on withdrawal of\ntreatment. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 6.75pt; line-height: normal;\"><font style=\"font-size: 12px;\">Patients who experience visual\ndisturbances during ibuprofen therapy should discontinue the treatment and have\nan ophthalmologic examination. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">NSAIDs may produce an\nincrease of liver function test results. </font></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"></p><p><font style=\"font-size: 12px;\"> </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">Adolescents (age\nrange: ≥ 12 years to &lt; 18 years) </font></p><p></p><p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n</p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">There is a risk of\nrenal impairment in dehydrated children/adolescents. </font></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\"><br></font></p><p class=\"MsoNormal\" style=\"margin-top:9.95pt;margin-right:0in;margin-bottom:\n0in;margin-left:3.5pt;margin-bottom:.0001pt\"><b><span style='font-family:\"Arial\",sans-serif;mso-hansi-font-family:\"Arial MT\";\nmso-bidi-font-family:\"Arial MT\"'>Cardiovascular Risk</span></b></p><p></p><p></p><p class=\"MsoBodyText\" style=\"margin-top:.05pt;margin-right:10.35pt;margin-bottom:\n0in;margin-left:39.5pt;margin-bottom:.0001pt;text-align:justify;text-indent:\n-.25in;mso-list:l0 level1 lfo1;tab-stops:39.55pt\"><!--[if !supportLists]-->-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span>NSAIDs may cause an increased risk of serious\ncardiovascular thrombotic events,<span style=\"letter-spacing:.05pt\"> </span>myocardial\ninfarction, and stroke, which can be fatal. This risk may increase with<span style=\"letter-spacing:.05pt\"> </span>duration of use. Patients with\ncardiovascular disease or risk factors for cardiovascular<span style=\"letter-spacing:-2.95pt\"> </span>disease<span style=\"letter-spacing:-.05pt\">\n</span>may<span style=\"letter-spacing:-.1pt\"> </span>be at<span style=\"letter-spacing:-.15pt\"> </span>greater<span style=\"letter-spacing:.05pt\">\n</span>risk</p><p></p><p class=\"MsoBodyText\" style=\"margin-top:.1pt;margin-right:10.2pt;margin-bottom:\n0in;margin-left:39.5pt;margin-bottom:.0001pt;text-align:justify;text-indent:\n-.25in;mso-list:l0 level1 lfo1;tab-stops:39.55pt\"><!--[if !supportLists]-->-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span>NSAIDs is contraindicated for the treatment of\nperioperative pain in the setting of<span style=\"letter-spacing:.05pt\"> </span>coronaryartery<span style=\"letter-spacing:-.15pt\"> </span>bypass<span style=\"letter-spacing:-.1pt\">\n</span>graft<span style=\"letter-spacing:-.05pt\"> </span>(CABG)<span style=\"letter-spacing:.05pt\"> </span>surgery</p><p></p><p class=\"MsoBodyText\" style=\"margin-top:.4pt;margin-right:0in;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt\"><span style=\"font-size:10.5pt;\nmso-bidi-font-size:11.0pt\"> </span></p><p class=\"MsoNormal\" style=\"margin-left:3.5pt\"><b><span style='font-family:\"Arial\",sans-serif;mso-hansi-font-family:\"Arial MT\";\nmso-bidi-font-family:\"Arial MT\"'>Gastrointestinal<span style=\"letter-spacing:\n-.15pt\"> </span>Risk</span></b></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\">\n\n\n\n\n\n\n\n\n\n</font></p><p class=\"MsoBodyText\" style=\"margin-top:.2pt;margin-right:10.2pt;margin-bottom:\n0in;margin-left:39.5pt;margin-bottom:.0001pt;text-align:justify;text-indent:\n-.25in;mso-list:l0 level1 lfo1;tab-stops:39.55pt\"><!--[if !supportLists]-->-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span>NSAIDs cause an increased risk of serious gastrointestinal adverse events including<span style=\"letter-spacing:.05pt\"> </span>bleeding, ulceration, and perforation of the stomatch or intestines, which can be fatal<span style=\"letter-spacing:-2.95pt\"> </span><span style=\"letter-spacing:-.05pt\">These</span><span style=\"letter-spacing:-.7pt\"> </span>events<span style=\"letter-spacing:-.6pt\"> </span>can<span style=\"letter-spacing:-.55pt\"> </span>occur<span style=\"letter-spacing:-.7pt\"> </span>at<span style=\"letter-spacing:-.45pt\"> </span>any<span style=\"letter-spacing:-.75pt\"> </span>time<span style=\"letter-spacing:-.65pt\"> </span>during<span style=\"letter-spacing:-.5pt\">\n</span>use<span style=\"letter-spacing:-.55pt\"> </span>and<span style=\"letter-spacing:-.5pt\"> </span>without<span style=\"letter-spacing:-.45pt\">\n</span>warning<span style=\"letter-spacing:-.55pt\"> </span>symptoms.<span style=\"letter-spacing:-.55pt\"> </span>Elderly<span style=\"letter-spacing:-2.95pt\">\n</span>patients are at<span style=\"letter-spacing:-.2pt\"> </span>greater<span style=\"letter-spacing:-.05pt\"> </span>risk<span style=\"letter-spacing:-.15pt\"> </span>for<span style=\"letter-spacing:.05pt\"> </span>serious<span style=\"letter-spacing:-.1pt\">\n</span>gastrointestinal<span style=\"letter-spacing:-.05pt\"> </span>events.</p><p></p><p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; line-height: normal;\"><font style=\"font-size: 12px;\"><!--[if !vml]-->\n \n <!--[endif]--><br clear=\"ALL\"></font></p><p></p><p></p><p></p>",
      "side_effect": "<p style=\"font-family: Roboto, sans-serif;\"><span style='font-family:\"Times New Roman\",\"serif\"'><b>Undesirable effects </b></span><br><span style='font-family:\"Times New Roman\",\"serif\"'>Undesirable effects are primary linked to the pharmacological effect of ibuprofen on prostaglandin synthesis.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>The most commonly reported\nadverse events effect the gastrointestinal tract, ranging from nausea and\ndyspepsia to serious bleeding or activation of peptic ulcer (see special\nwarnings and precautions for use).</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>Bullous reaction including\nSteven-Jhonson’s syndrome and toxic epidermal Necrolysis where observed very\nseldom.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>Oedema, hypertension, and cardiac\nfailure have been reported in association with NSAIDs treatment. Clinical\nstudies suggest th</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";\nmso-ansi-language:IN'>at</span><span style='font-family:\"Times New Roman\",\"serif\"'>\nuse of ibuprofen, particularly at high dose (2400 mg/day) may be associated with\na small increased risk of arterial thrombotic events (for example myocardial\ninfraction or stroke) (see Special Warnings and precaution for use)</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>In the table below adverse re</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";mso-ansi-language:IN'>a</span><span style='font-family:\"Times New Roman\",\"serif\"'>ctions are listed by system organ\nclass , and frequency (very common (≥ 1/10). Common (≥1/100 to &lt; 1/10),\nuncommon (≥1/1.000 to 1/100), rare (≥1/10.000 to &lt;1/1.000), very rare\n(&lt;1/10.000) and not known (cannot be estimated from the available data)</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>Within each frequency grouping,\nundesirable effects are presented in order of decreasing seriousness.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><table class=\"MsoNormalTable\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\" width=\"505\">\n <tbody><tr style=\"mso-yfti-irow:0;mso-yfti-firstrow:yes;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><b><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Sytem Organ Class</span></b></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border:solid windowtext 1.0pt;\n  border-left:none;mso-border-top-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><b><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Frequency </span></b></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:1;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Blood and lymphatic system disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:2;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Thrombocytopenia, Agranulocytosis, Aplastic\n  Anaemia</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:3;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anaemia</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:4;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Immune system disorders </span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:5;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Allergic reaction </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:6;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anaphylaxis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:7;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anaphylactic Shock </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:8;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Nervous system Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:9;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Headache, dizzines </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Common</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:10;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Meningitis Aseptic</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:11;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Eye Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:12;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Visual Disturbance</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:13;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Papilloedema</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:14;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Ear and Labyrinth Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:15;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Ear Disorder</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:16;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Cardiac Disorders </span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:17;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Cardiac Failure</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:18;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Vascular Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:19;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Arterial thrombosis, Hypertension, Hypotension\n  </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:20;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Respiratory, Thoracic and Mediastinal\n  Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:21;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Asthma, Aggravated Asthma, Bronchospasm,\n  Dyspnea</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:22;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Throat irritation</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:23;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Gastrointestinal Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:24;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Dyspepsia, Diarrhoea</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Very Common </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:25;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Abdominal Pain, nausea, Flatulence</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Common</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:26;height:15.4pt\">\n  <td width=\"259\" style=\"width:2.7in;border:solid windowtext 1.0pt;border-top:\n  none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;\n  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;\n  height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Peptic Ulcer, Gastrointestinal, Haemorrhage,\n  Vomiting, mala</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";\n  mso-fareast-font-family:\"Times New Roman\";color:black;mso-ansi-language:IN'>ena</span><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\";\n  color:black'>, gastritis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:27;height:24.7pt\">\n  <td width=\"259\" style=\"width:2.7in;border:solid windowtext 1.0pt;border-top:\n  none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;\n  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Gastrointestinal Perforation, Constipation,\n  Haematemesis, Ulcerative stomatitis, Colitis Aggravated, Chron's Disease\n  Aggravated</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:28;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Anorexia </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:29;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Hepato-biliary Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:30;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Hepatic disorders</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:31;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Liver Injury, Hepatitis, Jaundice </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:32;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Skin and Subcutaneous Tissue Disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:33;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Skin Disorders, Rash</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Common</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:34;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Angioedema, Purpura, Pruritus, Urticaria</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Uncommon</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:35;height:24.7pt\">\n  <td width=\"259\" style=\"width:2.7in;border:solid windowtext 1.0pt;border-top:\n  none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:solid windowtext .5pt;\n  mso-border-right-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Bullous Reaction, Erythema Multiforme,\n  Exfoliative Dermatitis, Steven Jhonson Syndrome, Toxic Epidermal Necrolysis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.7pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Very Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:36;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'></span></p><p> </p><p></p>\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Photosensitivity reaction, Skin Reaction\n  aggravated</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'></span></p><p> </p><p></p>\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:37;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Renal and urinary disorders</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:38;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Hematuria </span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:39;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Acute Renal Failure, Interstitial Nephritis,\n  Papillary Necrosis</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Very Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:40;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>General Disorders and Administration Site\n  Conditions</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:41;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Oedema</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not known</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:42;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><i><u><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Investigations</span></u></i></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'> </span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:43;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Liver Function Test Abnormal</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Rare</span></p><p></p><p></p>\n  </td>\n </tr>\n <tr style=\"mso-yfti-irow:44;mso-yfti-lastrow:yes;height:15.4pt\">\n  <td width=\"259\" nowrap style=\"width:2.7in;border:solid windowtext 1.0pt;\n  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bottom-alt:\n  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:\n  0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Renal Function Test Abnormal</span></p><p></p><p></p>\n  </td>\n  <td width=\"246\" nowrap style=\"width:184.5pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  mso-border-bottom-alt:solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.4pt\">\n  <p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;line-height:\n  normal\"><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\n  \"Times New Roman\";color:black'>Not Known</span></p><p></p><p></p>\n  </td>\n </tr>\n</tbody></table><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p> </p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><i><span style='font-family:\"Times New Roman\",\"serif\"'>Pediatric\npopulation </span></i></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><span style='font-family:\"Times New Roman\",\"serif\"'>From c</span><span lang=\"IN\" style='font-family:\"Times New Roman\",\"serif\";mso-ansi-language:IN'>u</span><span style='font-family:\"Times New Roman\",\"serif\"'>mulative clinical experience,\nthere is no clinically relevant difference in nature, frequency, seriousness\nand reversibility of adverse reactions between the safety profile in adult and\napproved paediatric population (≥12 years)</span></p><p></p><p></p><p class=\"Default\" style=\"text-align:justify\"><i><span lang=\"IN\" style='font-size:\n11.0pt;font-family:\"Times New Roman\",\"serif\";mso-ansi-language:IN'></span></i></p><p><i> </i></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0in;margin-bottom:.0001pt;text-align:\njustify;line-height:normal;mso-layout-grid-align:none;text-autospace:none\"><i><span style='font-family:\"Times New Roman\",\"serif\"'>If any of the side effects gets\nserious, or if you notice any side effects not listed in this leaflet, please\ntell your doctor or pharmacist.</span></i><span style='font-family:\"Times New Roman\",\"serif\"'></span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-left:19.45pt;text-align:justify;text-justify:\ninter-ideograph;text-indent:-.25in;mso-line-height-alt:1.15pt;mso-list:l0 level1 lfo1\">\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<br><span style=\"font-size:11.0pt\"></span></p><p></p><p></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002163",
          "name": "Ibuprofen 400 mg Tablet Salut Selaput",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL9917107009A1",
          "name": "IBUPROFEN",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/1534396?lang=id&type=province",
          "code": "1534396",
          "name": "Ibuprofen tablet/kapsul/kaplet 400 mg",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Tablet",
          "kfa_code": "94002406",
          "pack_price": 210
        }
      ],
      "product_template": {
        "name": "Ibuprofen 400 mg Tablet Salut Selaput",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001081",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Ibuprofen 400 mg Tablet Salut Selaput"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000107",
          "zat_aktif": "IBUPROFEN",
          "updated_at": "2022-10-10 06:38:30",
          "kekuatan_zat_aktif": "400 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 200,
          "name": "Dewasa: 200 - 400 mg; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 400,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-11-21 01:38:21",
          "period_ucum": "hari",
          "display_name": "Dewasa: 200 - 400 mg; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 400,
          "name": "Dewasa: 400.0 mg; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-11-21 01:38:21",
          "period_ucum": "hari",
          "display_name": "Dewasa: 400.0 mg; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93010755",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Ibuprofen 200 mg/5 mL Suspensi (60 mL, ETAFEN FORTE)",
      "kfa_code": "93010755",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-12-10 08:52:36",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS060",
        "name": "Suspensi"
      },
      "controlled_drug": {
        "code": "2",
        "name": "Obat Bebas Terbatas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DTL0806505533B1",
      "nama_dagang": "ETAFEN FORTE",
      "manufacturer": "ERRITA PHARMA",
      "registrar": "ERRITA PHARMA",
      "generik": false,
      "rxterm": 6651,
      "dose_per_unit": 12,
      "fix_price": 0,
      "het_price": 29250,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 60,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.2 g - O"
      },
      "atc_l1": {
        "code": "M",
        "name": "MUSCULO-SKELETAL SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "M01",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
        "level": "2",
        "comment": null,
        "parent_code": "M"
      },
      "atc_l3": {
        "code": "M01A",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
        "level": "3",
        "comment": null,
        "parent_code": "M01"
      },
      "atc_l4": {
        "code": "M01AE",
        "name": "Propionic acid derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "M01A"
      },
      "atc_l5": {
        "code": "M01AE01",
        "name": "Ibuprofen",
        "level": "5",
        "comment": null,
        "parent_code": "M01AE"
      },
      "description": "<p>Ibuprofen adalah golongan antiinflamasi non steroid yang mempunyai efek sebagai analgesik (meringankan sakit) dan antipiretik (menurunkan demam). Aktivitas analgesik ibuprofen dengan cara menghambat enzim siklooksigenase dengan akibat terhambatnya sintesis prostaglandin, yaitu suatu zat yang bekerja pada ujung-ujung saraf jaringan tubuh yang sakit. Aktivitas antipiretiknya bekerja di hipotalamus dengan meningkatkan vasodilatasi dan aliran darah periferal.<br></p>",
      "indication": "<p>Menurunkan demam pada anak-anak dan meringankan rasa nyeri ringan sampai sedang pada kondisi : nyeri pada sakit gigi atau pencabutan gigi, nyeri kepala, nyeri setelah operasi, nyeri pada waktu menstruasi.<br></p>",
      "warning": "<p style=\"font-family: Roboto, sans-serif;\">- Tidak direkomendasikan pada anak-anak di bawah usia 1 tahun </p><p style=\"font-family: Roboto, sans-serif;\">- Tidak boleh melebihi dosis yang dianjurkan.</p><p style=\"font-family: Roboto, sans-serif;\">Sebelum menggunakan obat ini agar dikonsultasikan terlebih dahulu ke dokter apabila menderita penyakit-penyakit atau kelainan-kelainan sebagai berikut :</p><p style=\"font-family: Roboto, sans-serif;\">    - Riwayat penyakit saluran cerna bagian atas (ulkus peptik)</p><p style=\"font-family: Roboto, sans-serif;\">    - Gangguan fungsi ginjal karena eliminasi utamanya melalui ginjal</p><p style=\"font-family: Roboto, sans-serif;\">    - Gagal jantung, hipertensi dan penyakit-penyakit lain yang mengakibatkan retensi cairan tubuh</p><p style=\"font-family: Roboto, sans-serif;\">    - Asma karena dapat menyebabkan bronkospasme (Penyempitan bronkus)</p><p style=\"font-family: Roboto, sans-serif;\">    - Lupus Eritematosus Sistematik</p><p style=\"font-family: Roboto, sans-serif;\">- Selama minum obat ini jangan minum asetosal atau obat lain yang mengandung ibuprofen, juga obat antikoagulan (anti pembekuan darah) golongan warfarin </p><p style=\"font-family: Roboto, sans-serif;\">- Bila setelah 5 hari nyeri tidak menghilang, segera hubungi dokter unit pelayanan kesehatan</p><p style=\"font-family: Roboto, sans-serif;\">- Tidak dianjurkan pada kehamilan trimester pertama dan kedua, serta wanita menyusui</p>",
      "side_effect": "<p style=\"font-family: Roboto, sans-serif;\"> Walaupun jarang terjadi, tapi dapat timbul efek samping sebagai berikut : gangguan saluran pencernaan termasuk mual, muntah, diare, konstipasi dan nyeri lambung</p><p style=\"font-family: Roboto, sans-serif;\">- Juga pernah dilaporkan terjadi ruam kulit, penyempitan bronkus (bronkospasme), trombositopenia (penurunan sel pembeku darah), limfopenia (penurunan jumlah sel limfosit)</p><p style=\"font-family: Roboto, sans-serif;\">- Penurunan ketajaman penglihatan dan kesulitan membedakan warna dapat terjadi, tapi sangat jarang dan akan sembuh bila obat dihentikan.</p><p style=\"font-family: Roboto, sans-serif;\">Apabila terjadi gangguan penglihatan maka obat harus segera dihentikan da memeriksakan mata ke dokter</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93010755",
          "name": "Ibuprofen 200 mg / 5 mL Suspensi",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DTL0806505533B1",
          "name": "ETAFEN FORTE",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94002830",
          "pack_price": 29250
        }
      ],
      "product_template": {
        "name": "Ibuprofen 200 mg/5 mL Suspensi",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000224",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Ibuprofen 200 mg/5 mL Suspensi"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000107",
          "zat_aktif": "IBUPROFEN",
          "updated_at": "2022-06-22 08:48:03",
          "kekuatan_zat_aktif": "200 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 1.25,
          "name": "Anak: 1.25 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2023-12-20 05:07:48",
          "period_ucum": "hari",
          "display_name": "Anak: 1.25 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 2.5,
          "name": "Anak: 2.5 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5.0 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Anak: 5.0 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Dewasa: 5 - 10 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "adult",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Dewasa: 5 - 10 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002916",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Ibuprofen 200 mg/5 mL Suspensi (SALFENAL FORTE)",
      "kfa_code": "93002916",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-10-27 03:10:43",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS060",
        "name": "Suspensi"
      },
      "controlled_drug": {
        "code": "2",
        "name": "Obat Bebas Terbatas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DTL1010905733A1",
      "nama_dagang": "SALFENAL FORTE",
      "manufacturer": "ITRASAL",
      "registrar": "ITRASAL",
      "generik": false,
      "rxterm": 6651,
      "dose_per_unit": 1,
      "fix_price": 27918,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 60,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.2 g - O"
      },
      "atc_l1": {
        "code": "M",
        "name": "MUSCULO-SKELETAL SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "M01",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
        "level": "2",
        "comment": null,
        "parent_code": "M"
      },
      "atc_l3": {
        "code": "M01A",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
        "level": "3",
        "comment": null,
        "parent_code": "M01"
      },
      "atc_l4": {
        "code": "M01AE",
        "name": "Propionic acid derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "M01A"
      },
      "atc_l5": {
        "code": "M01AE01",
        "name": "Ibuprofen",
        "level": "5",
        "comment": null,
        "parent_code": "M01AE"
      },
      "description": "<p>Ibuprofen adalah golongan antiinflamasi non steroid yang mempunyai efek sebagai analgesik (meringankan sakit) dan antipiretik (menurunkan demam). Aktivitas analgesik ibuprofen dengan cara menghambat enzim siklooksigenase dengan akibat terhambatnya sintesis prostaglandin, yaitu suatu zat yang bekerja pada ujung-ujung saraf jaringan tubuh yang sakit. Aktivitas antipiretiknya bekerja di hipotalamus dengan meningkatkan vasodilatasi dan aliran darah periferal.<br></p>",
      "indication": "<p>Menurunkan demam pada anak-anak dan meringankan rasa nyeri ringan sampai sedang pada kondisi : nyeri pada sakit gigi atau pencabutan gigi, nyeri kepala, nyeri setelah operasi, nyeri pada waktu menstruasi.<br></p>",
      "warning": "<p style=\"font-family: Roboto, sans-serif;\">- Tidak direkomendasikan pada anak-anak di bawah usia 1 tahun </p><p style=\"font-family: Roboto, sans-serif;\">- Tidak boleh melebihi dosis yang dianjurkan.</p><p style=\"font-family: Roboto, sans-serif;\">Sebelum menggunakan obat ini agar dikonsultasikan terlebih dahulu ke dokter apabila menderita penyakit-penyakit atau kelainan-kelainan sebagai berikut :</p><p style=\"font-family: Roboto, sans-serif;\">    - Riwayat penyakit saluran cerna bagian atas (ulkus peptik)</p><p style=\"font-family: Roboto, sans-serif;\">    - Gangguan fungsi ginjal karena eliminasi utamanya melalui ginjal</p><p style=\"font-family: Roboto, sans-serif;\">    - Gagal jantung, hipertensi dan penyakit-penyakit lain yang mengakibatkan retensi cairan tubuh</p><p style=\"font-family: Roboto, sans-serif;\">    - Asma karena dapat menyebabkan bronkospasme (Penyempitan bronkus)</p><p style=\"font-family: Roboto, sans-serif;\">    - Lupus Eritematosus Sistematik</p><p style=\"font-family: Roboto, sans-serif;\">- Selama minum obat ini jangan minum asetosal atau obat lain yang mengandung ibuprofen, juga obat antikoagulan (anti pembekuan darah) golongan warfarin </p><p style=\"font-family: Roboto, sans-serif;\">- Bila setelah 5 hari nyeri tidak menghilang, segera hubungi dokter unit pelayanan kesehatan</p><p style=\"font-family: Roboto, sans-serif;\">- Tidak dianjurkan pada kehamilan trimester pertama dan kedua, serta wanita menyusui</p>",
      "side_effect": "<p style=\"font-family: Roboto, sans-serif;\"> Walaupun jarang terjadi, tapi dapat timbul efek samping sebagai berikut : gangguan saluran pencernaan termasuk mual, muntah, diare, konstipasi dan nyeri lambung</p><p style=\"font-family: Roboto, sans-serif;\">- Juga pernah dilaporkan terjadi ruam kulit, penyempitan bronkus (bronkospasme), trombositopenia (penurunan sel pembeku darah), limfopenia (penurunan jumlah sel limfosit)</p><p style=\"font-family: Roboto, sans-serif;\">- Penurunan ketajaman penglihatan dan kesulitan membedakan warna dapat terjadi, tapi sangat jarang dan akan sembuh bila obat dihentikan.</p><p style=\"font-family: Roboto, sans-serif;\">Apabila terjadi gangguan penglihatan maka obat harus segera dihentikan da memeriksakan mata ke dokter</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002916",
          "name": "Ibuprofen 200 mg / 5 mL Suspensi",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DTL1010905733A1",
          "name": "SALFENAL FORTE",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94003252",
          "pack_price": 27918
        }
      ],
      "product_template": {
        "name": "Ibuprofen 200 mg/5 mL Suspensi",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000224",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Ibuprofen 200 mg/5 mL Suspensi"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000107",
          "zat_aktif": "IBUPROFEN",
          "updated_at": "2022-06-22 08:48:03",
          "kekuatan_zat_aktif": "200 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 1.25,
          "name": "Anak: 1.25 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2023-12-20 05:07:48",
          "period_ucum": "hari",
          "display_name": "Anak: 1.25 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 2.5,
          "name": "Anak: 2.5 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5.0 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Anak: 5.0 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Dewasa: 5 - 10 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "adult",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Dewasa: 5 - 10 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93005212",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Ibuprofen 200 mg/5 mL Suspensi (60 mL, INSIC FORTE)",
      "kfa_code": "93005212",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2023-10-31 02:29:08",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS060",
        "name": "Suspensi"
      },
      "controlled_drug": {
        "code": "2",
        "name": "Obat Bebas Terbatas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DTL1817112633A1",
      "nama_dagang": "INSIC FORTE",
      "manufacturer": "HOLI PHARMA",
      "registrar": "HOLI PHARMA",
      "generik": false,
      "rxterm": 6651,
      "dose_per_unit": 1,
      "fix_price": 0,
      "het_price": 32500,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "47749822",
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 60,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.2 g - O"
      },
      "atc_l1": {
        "code": "M",
        "name": "MUSCULO-SKELETAL SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "M01",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
        "level": "2",
        "comment": null,
        "parent_code": "M"
      },
      "atc_l3": {
        "code": "M01A",
        "name": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
        "level": "3",
        "comment": null,
        "parent_code": "M01"
      },
      "atc_l4": {
        "code": "M01AE",
        "name": "Propionic acid derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "M01A"
      },
      "atc_l5": {
        "code": "M01AE01",
        "name": "Ibuprofen",
        "level": "5",
        "comment": null,
        "parent_code": "M01AE"
      },
      "description": "<p>Ibuprofen adalah golongan antiinflamasi non steroid yang mempunyai efek sebagai analgesik (meringankan sakit) dan antipiretik (menurunkan demam). Aktivitas analgesik ibuprofen dengan cara menghambat enzim siklooksigenase dengan akibat terhambatnya sintesis prostaglandin, yaitu suatu zat yang bekerja pada ujung-ujung saraf jaringan tubuh yang sakit. Aktivitas antipiretiknya bekerja di hipotalamus dengan meningkatkan vasodilatasi dan aliran darah periferal.<br></p>",
      "indication": "<p>Menurunkan demam pada anak-anak dan meringankan rasa nyeri ringan sampai sedang pada kondisi : nyeri pada sakit gigi atau pencabutan gigi, nyeri kepala, nyeri setelah operasi, nyeri pada waktu menstruasi.<br></p>",
      "warning": "<p style=\"font-family: Roboto, sans-serif;\">- Tidak direkomendasikan pada anak-anak di bawah usia 1 tahun </p><p style=\"font-family: Roboto, sans-serif;\">- Tidak boleh melebihi dosis yang dianjurkan.</p><p style=\"font-family: Roboto, sans-serif;\">Sebelum menggunakan obat ini agar dikonsultasikan terlebih dahulu ke dokter apabila menderita penyakit-penyakit atau kelainan-kelainan sebagai berikut :</p><p style=\"font-family: Roboto, sans-serif;\">    - Riwayat penyakit saluran cerna bagian atas (ulkus peptik)</p><p style=\"font-family: Roboto, sans-serif;\">    - Gangguan fungsi ginjal karena eliminasi utamanya melalui ginjal</p><p style=\"font-family: Roboto, sans-serif;\">    - Gagal jantung, hipertensi dan penyakit-penyakit lain yang mengakibatkan retensi cairan tubuh</p><p style=\"font-family: Roboto, sans-serif;\">    - Asma karena dapat menyebabkan bronkospasme (Penyempitan bronkus)</p><p style=\"font-family: Roboto, sans-serif;\">    - Lupus Eritematosus Sistematik</p><p style=\"font-family: Roboto, sans-serif;\">- Selama minum obat ini jangan minum asetosal atau obat lain yang mengandung ibuprofen, juga obat antikoagulan (anti pembekuan darah) golongan warfarin </p><p style=\"font-family: Roboto, sans-serif;\">- Bila setelah 5 hari nyeri tidak menghilang, segera hubungi dokter unit pelayanan kesehatan</p><p style=\"font-family: Roboto, sans-serif;\">- Tidak dianjurkan pada kehamilan trimester pertama dan kedua, serta wanita menyusui</p>",
      "side_effect": "<p style=\"font-family: Roboto, sans-serif;\"> Walaupun jarang terjadi, tapi dapat timbul efek samping sebagai berikut : gangguan saluran pencernaan termasuk mual, muntah, diare, konstipasi dan nyeri lambung</p><p style=\"font-family: Roboto, sans-serif;\">- Juga pernah dilaporkan terjadi ruam kulit, penyempitan bronkus (bronkospasme), trombositopenia (penurunan sel pembeku darah), limfopenia (penurunan jumlah sel limfosit)</p><p style=\"font-family: Roboto, sans-serif;\">- Penurunan ketajaman penglihatan dan kesulitan membedakan warna dapat terjadi, tapi sangat jarang dan akan sembuh bila obat dihentikan.</p><p style=\"font-family: Roboto, sans-serif;\">Apabila terjadi gangguan penglihatan maka obat harus segera dihentikan da memeriksakan mata ke dokter</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93005212",
          "name": "Ibuprofen 200 mg/5 mL Suspensi",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DTL1817112633A1",
          "name": "INSIC FORTE",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94006500",
          "pack_price": 32500
        }
      ],
      "product_template": {
        "name": "Ibuprofen 200 mg/5 mL Suspensi",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000224",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Ibuprofen 200 mg/5 mL Suspensi"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000107",
          "zat_aktif": "IBUPROFEN",
          "updated_at": "2022-06-22 08:48:03",
          "kekuatan_zat_aktif": "200 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 1.25,
          "name": "Anak: 1.25 mL; 3 - 4 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2023-12-20 05:07:48",
          "period_ucum": "hari",
          "display_name": "Anak: 1.25 mL; 3 - 4 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 2.5,
          "name": "Anak: 2.5 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5.0 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Anak: 5.0 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Dewasa: 5 - 10 mL; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "adult",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-28 09:20:06",
          "period_ucum": "hari",
          "display_name": "Dewasa: 5 - 10 mL; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93013069",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering (20 mL, PHARMA LABORATORIES)",
      "kfa_code": "93013069",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-12-01 08:03:11",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS056",
        "name": "Sirup Kering"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL2040702438C1",
      "nama_dagang": "AMOXICILLIN TRIHYDRATE",
      "manufacturer": "PHARMA LABORATORIES",
      "registrar": "PHARMA LABORATORIES",
      "generik": true,
      "rxterm": 1121,
      "dose_per_unit": 1,
      "fix_price": 15000,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 20,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.5 g - O"
      },
      "atc_l1": {
        "code": "J",
        "name": "ANTIINFECTIVES FOR SYSTEMIC USE",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "J01",
        "name": "ANTIBACTERIALS FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "J"
      },
      "atc_l3": {
        "code": "J01C",
        "name": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
        "level": "3",
        "comment": null,
        "parent_code": "J01"
      },
      "atc_l4": {
        "code": "J01CA",
        "name": "Penicillins with extended spectrum",
        "level": "4",
        "comment": null,
        "parent_code": "J01C"
      },
      "atc_l5": {
        "code": "J01CA04",
        "name": "Amoxicillin",
        "level": "5",
        "comment": null,
        "parent_code": "J01CA"
      },
      "description": "<p>Amoksisilin adalah aminopenisilin semisintetik yang menghambat langkah transpeptidasi akhir sintesis peptidoglikan di dinding sel bakteri dengan mengikat 1 atau lebih protein pengikat penisilin (PBP), sehingga menghambat biosintesis dinding sel dan akhirnya menyebabkan lisis bakteri.<br></p>",
      "indication": "<p><span style='font-size:10.5pt;line-height:107%;\nfont-family:Nunito;mso-fareast-font-family:\"Times New Roman\";mso-bidi-font-family:\n\"Times New Roman\";color:#53565A;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Penyakit infeksi kulit dan jaringan lunak,\ninfeksi saluran pernafasan, infeksi saluran genitourinari, dan gonore yang\ndisebabkan organisme Gram positif dan Gram Negatif yang peka terhadap\nAmoxicillin</span><br></p>",
      "warning": "<p>Hati - hati digunakan pada pasien dengan hipersensitivitas atau riwayat reaksi alergi berat (misalnya anafilaksis, sindrom Stevens-Johnson) terhadap amoksisilin atau -laktam lainnya (misalnya penisilin, sefalosporin, karbapenem, monobaktam). Mononukleosis menular (dicurigai atau dikonfirmasi).</p>",
      "side_effect": "<p>Signifikan: Kejang (dosis tinggi), reaksi Jarisch-Herxheimer (dalam pengobatan penyakit Lyme). Jarang, kristaluria (dosis parenteral tinggi); waktu protrombin memanjang.</p><p>Gangguan sistem darah dan limfatik: Jarang, trombositopenia, leukopenia.</p><p>Gangguan gastrointestinal: Mual, diare, muntah; perubahan warna gigi (coklat, kuning, abu-abu) terutama pada anak-anak.</p><p>Pemeriksaan penunjang: Peningkatan enzim hati, perubahan jumlah darah (terapi jangka panjang).</p><p>Gangguan sistem saraf: Sakit kepala, pusing, agitasi.</p><p>Gangguan kejiwaan: hiperaktif reversibel, kecemasan, insomnia, kebingungan, perubahan perilaku.</p><p>Gangguan sistem reproduksi dan payudara: Infeksi vulvovaginal.</p><p>Gangguan kulit dan jaringan subkutan: Ruam, urtikaria, pruritus.</p><p>Berpotensi Fatal: Reaksi hipersensitivitas termasuk anafilaksis, anafilaktoid, dan reaksi merugikan kulit yang parah (misalnya sindrom Stevens-Johnson, nekrolisis epidermal toksik, pustulosis eksantematosa generalisata akut, reaksi obat dengan eosinofilia dan gejala sistemik); C. diare terkait difficile atau kolitis pseudomembran. Jarang, hepatitis kolestatik.</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93013069",
          "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL2040702438C1",
          "name": "AMOXICILLIN TRIHYDRATE",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94015152",
          "pack_price": 15000
        }
      ],
      "product_template": {
        "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000234",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000237",
          "zat_aktif": "Amoxicillin",
          "updated_at": "2022-06-22 02:31:42",
          "kekuatan_zat_aktif": "100 mg/1 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 20,
          "name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "period": 8,
          "qty_uom": null,
          "category": "child",
          "duration": 0,
          "qty_high": 40,
          "qty_ucum": "milligram per kilogram",
          "use_ucum": true,
          "frequency": 1,
          "updated_at": "2024-10-11 07:33:47",
          "period_ucum": "jam",
          "display_name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 250,
          "name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "period": 8,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 500,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-25 06:56:17",
          "period_ucum": "jam",
          "display_name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93023127",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering (20 mL, MEPROFARM)",
      "kfa_code": "93023127",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-10-11 07:31:58",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS056",
        "name": "Sirup Kering"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL1815627236A1",
      "nama_dagang": "AMOXICILLIN TRIHYDRATE",
      "manufacturer": "Diproduksi Oleh: MEPROFARM",
      "registrar": "MEPROFARM",
      "generik": true,
      "rxterm": 1121,
      "dose_per_unit": 1,
      "fix_price": 13071.5,
      "het_price": 30000,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "45910573",
      "score_tkdn": 35.7,
      "score_bmp": 0,
      "score_tkdn_bmp": 35.7,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 20,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.5 g - O"
      },
      "atc_l1": {
        "code": "J",
        "name": "ANTIINFECTIVES FOR SYSTEMIC USE",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "J01",
        "name": "ANTIBACTERIALS FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "J"
      },
      "atc_l3": {
        "code": "J01C",
        "name": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
        "level": "3",
        "comment": null,
        "parent_code": "J01"
      },
      "atc_l4": {
        "code": "J01CA",
        "name": "Penicillins with extended spectrum",
        "level": "4",
        "comment": null,
        "parent_code": "J01C"
      },
      "atc_l5": {
        "code": "J01CA04",
        "name": "Amoxicillin",
        "level": "5",
        "comment": null,
        "parent_code": "J01CA"
      },
      "description": "<p>Amoksisilin adalah aminopenisilin semisintetik yang menghambat langkah transpeptidasi akhir sintesis peptidoglikan di dinding sel bakteri dengan mengikat 1 atau lebih protein pengikat penisilin (PBP), sehingga menghambat biosintesis dinding sel dan akhirnya menyebabkan lisis bakteri.<br></p>",
      "indication": "<p><span style='font-size:10.5pt;line-height:107%;\nfont-family:Nunito;mso-fareast-font-family:\"Times New Roman\";mso-bidi-font-family:\n\"Times New Roman\";color:#53565A;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Penyakit infeksi kulit dan jaringan lunak,\ninfeksi saluran pernafasan, infeksi saluran genitourinari, dan gonore yang\ndisebabkan organisme Gram positif dan Gram Negatif yang peka terhadap\nAmoxicillin</span><br></p>",
      "warning": "<p>Hati - hati digunakan pada pasien dengan hipersensitivitas atau riwayat reaksi alergi berat (misalnya anafilaksis, sindrom Stevens-Johnson) terhadap amoksisilin atau -laktam lainnya (misalnya penisilin, sefalosporin, karbapenem, monobaktam). Mononukleosis menular (dicurigai atau dikonfirmasi).</p>",
      "side_effect": "<p>Signifikan: Kejang (dosis tinggi), reaksi Jarisch-Herxheimer (dalam pengobatan penyakit Lyme). Jarang, kristaluria (dosis parenteral tinggi); waktu protrombin memanjang.</p><p>Gangguan sistem darah dan limfatik: Jarang, trombositopenia, leukopenia.</p><p>Gangguan gastrointestinal: Mual, diare, muntah; perubahan warna gigi (coklat, kuning, abu-abu) terutama pada anak-anak.</p><p>Pemeriksaan penunjang: Peningkatan enzim hati, perubahan jumlah darah (terapi jangka panjang).</p><p>Gangguan sistem saraf: Sakit kepala, pusing, agitasi.</p><p>Gangguan kejiwaan: hiperaktif reversibel, kecemasan, insomnia, kebingungan, perubahan perilaku.</p><p>Gangguan sistem reproduksi dan payudara: Infeksi vulvovaginal.</p><p>Gangguan kulit dan jaringan subkutan: Ruam, urtikaria, pruritus.</p><p>Berpotensi Fatal: Reaksi hipersensitivitas termasuk anafilaksis, anafilaktoid, dan reaksi merugikan kulit yang parah (misalnya sindrom Stevens-Johnson, nekrolisis epidermal toksik, pustulosis eksantematosa generalisata akut, reaksi obat dengan eosinofilia dan gejala sistemik); C. diare terkait difficile atau kolitis pseudomembran. Jarang, hepatitis kolestatik.</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93023127",
          "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL1815627236A1",
          "name": "AMOXICILLIN TRIHYDRATE",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/45910573?lang=id&type=province",
          "code": "45910573",
          "name": "Amoxicillin Trihydrate 100 mg/ mL Drops",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94027530",
          "pack_price": 30000
        }
      ],
      "product_template": {
        "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000234",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000237",
          "zat_aktif": "Amoxicillin",
          "updated_at": "2022-06-22 02:31:42",
          "kekuatan_zat_aktif": "100 mg/1 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 20,
          "name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "period": 8,
          "qty_uom": null,
          "category": "child",
          "duration": 0,
          "qty_high": 40,
          "qty_ucum": "milligram per kilogram",
          "use_ucum": true,
          "frequency": 1,
          "updated_at": "2024-10-11 07:33:47",
          "period_ucum": "jam",
          "display_name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 250,
          "name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "period": 8,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 500,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-25 06:56:17",
          "period_ucum": "jam",
          "display_name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93011613",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering (10 mL, BERNOFARM)",
      "kfa_code": "93011613",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2025-01-17 09:38:03",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS056",
        "name": "Sirup Kering"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL1802316238B1",
      "nama_dagang": "AMOXICILLIN TRIHYDRATE",
      "manufacturer": "BERNOFARM",
      "registrar": "BERNOFARM",
      "generik": true,
      "rxterm": 1121,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": 20535,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.5 g - O"
      },
      "atc_l1": {
        "code": "J",
        "name": "ANTIINFECTIVES FOR SYSTEMIC USE",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "J01",
        "name": "ANTIBACTERIALS FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "J"
      },
      "atc_l3": {
        "code": "J01C",
        "name": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
        "level": "3",
        "comment": null,
        "parent_code": "J01"
      },
      "atc_l4": {
        "code": "J01CA",
        "name": "Penicillins with extended spectrum",
        "level": "4",
        "comment": null,
        "parent_code": "J01C"
      },
      "atc_l5": {
        "code": "J01CA04",
        "name": "Amoxicillin",
        "level": "5",
        "comment": null,
        "parent_code": "J01CA"
      },
      "description": "<p>Amoksisilin adalah aminopenisilin semisintetik yang menghambat langkah transpeptidasi akhir sintesis peptidoglikan di dinding sel bakteri dengan mengikat 1 atau lebih protein pengikat penisilin (PBP), sehingga menghambat biosintesis dinding sel dan akhirnya menyebabkan lisis bakteri.<br></p>",
      "indication": "<p><span style='font-size:10.5pt;line-height:107%;\nfont-family:Nunito;mso-fareast-font-family:\"Times New Roman\";mso-bidi-font-family:\n\"Times New Roman\";color:#53565A;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Penyakit infeksi kulit dan jaringan lunak,\ninfeksi saluran pernafasan, infeksi saluran genitourinari, dan gonore yang\ndisebabkan organisme Gram positif dan Gram Negatif yang peka terhadap\nAmoxicillin</span><br></p>",
      "warning": "<p>Hati - hati digunakan pada pasien dengan hipersensitivitas atau riwayat reaksi alergi berat (misalnya anafilaksis, sindrom Stevens-Johnson) terhadap amoksisilin atau -laktam lainnya (misalnya penisilin, sefalosporin, karbapenem, monobaktam). Mononukleosis menular (dicurigai atau dikonfirmasi).</p>",
      "side_effect": "<p>Signifikan: Kejang (dosis tinggi), reaksi Jarisch-Herxheimer (dalam pengobatan penyakit Lyme). Jarang, kristaluria (dosis parenteral tinggi); waktu protrombin memanjang.</p><p>Gangguan sistem darah dan limfatik: Jarang, trombositopenia, leukopenia.</p><p>Gangguan gastrointestinal: Mual, diare, muntah; perubahan warna gigi (coklat, kuning, abu-abu) terutama pada anak-anak.</p><p>Pemeriksaan penunjang: Peningkatan enzim hati, perubahan jumlah darah (terapi jangka panjang).</p><p>Gangguan sistem saraf: Sakit kepala, pusing, agitasi.</p><p>Gangguan kejiwaan: hiperaktif reversibel, kecemasan, insomnia, kebingungan, perubahan perilaku.</p><p>Gangguan sistem reproduksi dan payudara: Infeksi vulvovaginal.</p><p>Gangguan kulit dan jaringan subkutan: Ruam, urtikaria, pruritus.</p><p>Berpotensi Fatal: Reaksi hipersensitivitas termasuk anafilaksis, anafilaktoid, dan reaksi merugikan kulit yang parah (misalnya sindrom Stevens-Johnson, nekrolisis epidermal toksik, pustulosis eksantematosa generalisata akut, reaksi obat dengan eosinofilia dan gejala sistemik); C. diare terkait difficile atau kolitis pseudomembran. Jarang, hepatitis kolestatik.</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93011613",
          "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL1802316238B1",
          "name": "AMOXICILLIN TRIHYDRATE",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Dus isi 10",
          "uom_id": "Botol",
          "kfa_code": "94015976",
          "pack_price": 180375
        }
      ],
      "product_template": {
        "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000234",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000237",
          "zat_aktif": "Amoxicillin",
          "updated_at": "2022-06-22 02:31:42",
          "kekuatan_zat_aktif": "100 mg/1 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 20,
          "name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "period": 8,
          "qty_uom": null,
          "category": "child",
          "duration": 0,
          "qty_high": 40,
          "qty_ucum": "milligram per kilogram",
          "use_ucum": true,
          "frequency": 1,
          "updated_at": "2024-10-11 07:33:47",
          "period_ucum": "jam",
          "display_name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 250,
          "name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "period": 8,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 500,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-25 06:56:17",
          "period_ucum": "jam",
          "display_name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93000256",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering (PHARMA LABORATORIES)",
      "kfa_code": "93000256",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-12-01 07:46:59",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS056",
        "name": "Sirup Kering"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL2040702438C1",
      "nama_dagang": "AMOXICILLIN TRIHYDRATE",
      "manufacturer": "PHARMA LABORATORIES",
      "registrar": "PHARMA LABORATORIES",
      "generik": true,
      "rxterm": 1121,
      "dose_per_unit": 1,
      "fix_price": 15000,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "1481938",
      "score_tkdn": 31.05,
      "score_bmp": 0,
      "score_tkdn_bmp": 31.05,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 15,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.5 g - O"
      },
      "atc_l1": {
        "code": "J",
        "name": "ANTIINFECTIVES FOR SYSTEMIC USE",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "J01",
        "name": "ANTIBACTERIALS FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "J"
      },
      "atc_l3": {
        "code": "J01C",
        "name": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
        "level": "3",
        "comment": null,
        "parent_code": "J01"
      },
      "atc_l4": {
        "code": "J01CA",
        "name": "Penicillins with extended spectrum",
        "level": "4",
        "comment": null,
        "parent_code": "J01C"
      },
      "atc_l5": {
        "code": "J01CA04",
        "name": "Amoxicillin",
        "level": "5",
        "comment": null,
        "parent_code": "J01CA"
      },
      "description": "<p>Amoksisilin adalah aminopenisilin semisintetik yang menghambat langkah transpeptidasi akhir sintesis peptidoglikan di dinding sel bakteri dengan mengikat 1 atau lebih protein pengikat penisilin (PBP), sehingga menghambat biosintesis dinding sel dan akhirnya menyebabkan lisis bakteri.<br></p>",
      "indication": "<p><span style='font-size:10.5pt;line-height:107%;\nfont-family:Nunito;mso-fareast-font-family:\"Times New Roman\";mso-bidi-font-family:\n\"Times New Roman\";color:#53565A;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Penyakit infeksi kulit dan jaringan lunak,\ninfeksi saluran pernafasan, infeksi saluran genitourinari, dan gonore yang\ndisebabkan organisme Gram positif dan Gram Negatif yang peka terhadap\nAmoxicillin</span><br></p>",
      "warning": "<p>Hati - hati digunakan pada pasien dengan hipersensitivitas atau riwayat reaksi alergi berat (misalnya anafilaksis, sindrom Stevens-Johnson) terhadap amoksisilin atau -laktam lainnya (misalnya penisilin, sefalosporin, karbapenem, monobaktam). Mononukleosis menular (dicurigai atau dikonfirmasi).</p>",
      "side_effect": "<p>Signifikan: Kejang (dosis tinggi), reaksi Jarisch-Herxheimer (dalam pengobatan penyakit Lyme). Jarang, kristaluria (dosis parenteral tinggi); waktu protrombin memanjang.</p><p>Gangguan sistem darah dan limfatik: Jarang, trombositopenia, leukopenia.</p><p>Gangguan gastrointestinal: Mual, diare, muntah; perubahan warna gigi (coklat, kuning, abu-abu) terutama pada anak-anak.</p><p>Pemeriksaan penunjang: Peningkatan enzim hati, perubahan jumlah darah (terapi jangka panjang).</p><p>Gangguan sistem saraf: Sakit kepala, pusing, agitasi.</p><p>Gangguan kejiwaan: hiperaktif reversibel, kecemasan, insomnia, kebingungan, perubahan perilaku.</p><p>Gangguan sistem reproduksi dan payudara: Infeksi vulvovaginal.</p><p>Gangguan kulit dan jaringan subkutan: Ruam, urtikaria, pruritus.</p><p>Berpotensi Fatal: Reaksi hipersensitivitas termasuk anafilaksis, anafilaktoid, dan reaksi merugikan kulit yang parah (misalnya sindrom Stevens-Johnson, nekrolisis epidermal toksik, pustulosis eksantematosa generalisata akut, reaksi obat dengan eosinofilia dan gejala sistemik); C. diare terkait difficile atau kolitis pseudomembran. Jarang, hepatitis kolestatik.</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93000256",
          "name": "Amoxicillin Trihydrate 100 mg / mL Sirup Kering",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL2040702438C1",
          "name": "AMOXICILLIN TRIHYDRATE",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/1481938?lang=id&type=province",
          "code": "1481938",
          "name": "Amoksisilin/Amoxicillin/Amoxicillin trihydrate 100 mg/mL  drops/  sirup kering, botol 15 mL",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94012082",
          "pack_price": 15000
        }
      ],
      "product_template": {
        "name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000234",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Amoxicillin Trihydrate 100 mg/mL Sirup Kering"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000237",
          "zat_aktif": "Amoxicillin",
          "updated_at": "2022-06-22 02:31:42",
          "kekuatan_zat_aktif": "100 mg/1 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 20,
          "name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "period": 8,
          "qty_uom": null,
          "category": "child",
          "duration": 0,
          "qty_high": 40,
          "qty_ucum": "milligram per kilogram",
          "use_ucum": true,
          "frequency": 1,
          "updated_at": "2024-10-11 07:33:47",
          "period_ucum": "jam",
          "display_name": "Anak: 20 - 40 milligram per kilogram; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 250,
          "name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "period": 8,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 500,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-25 06:56:17",
          "period_ucum": "jam",
          "display_name": "Dewasa: 250 - 500 mg; tiap 8 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002233",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Cetirizine Hydrochloride 5 mg/5 mL Sirup (RYDIAN)",
      "kfa_code": "93002233",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2025-03-07 08:03:07",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS055",
        "name": "Sirup"
      },
      "controlled_drug": {
        "code": "2",
        "name": "Obat Bebas Terbatas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DTL2108027037A1",
      "nama_dagang": "RYDIAN",
      "manufacturer": "GUARDIAN PHARMATAMA",
      "registrar": "GUARDIAN PHARMATAMA",
      "generik": false,
      "rxterm": 18132,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": 78144,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "66455294",
      "score_tkdn": 35.42,
      "score_bmp": 9.3,
      "score_tkdn_bmp": 44.72,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 60,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "R",
        "name": "RESPIRATORY SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "R06",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "R"
      },
      "atc_l3": {
        "code": "R06A",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "3",
        "comment": null,
        "parent_code": "R06"
      },
      "atc_l4": {
        "code": "R06AE",
        "name": "Piperazine derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "R06A"
      },
      "atc_l5": {
        "code": "R06AE07",
        "name": "Cetirizine",
        "level": "5",
        "comment": null,
        "parent_code": "R06AE"
      },
      "description": "<p><span style='font-family: Calibri, \"sans-serif\"; font-size: 14px; font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit; text-align: inherit;' class=\"text-black\"> </span><br></p><table class=\"MsoNormalTable\" style=\"margin-left: 8.8pt;\" width=\"631\" cellspacing=\"0\" cellpadding=\"0\" border=\"0\">\n <tbody><tr>\n  <td style=\"width:337.55pt;padding:2.75pt 2.75pt 2.75pt 2.75pt\" width=\"450\" valign=\"top\">\n  <p class=\"TableContents\" style=\"margin-right:.25pt;text-align:justify;\n  tab-stops:11.25pt;layout-grid-mode:char\"><span style=\"font-size:11.0pt;\n  color:black;mso-ansi-language:FR\" lang=\"FR\">Merupakan antihistamin selektif reseptor H\n  dengan sedatif yang rendah pada dosis aktif farmakologi dan mempunyai sifat\n  tambahan sebagai antialergi. Cetirizine menghambat pelepasan histamin pada\n  fase awal dan mengurangi migrasi sel inflamasi.</span></p><p></p><p></p>\n  </td>\n </tr>\n</tbody></table>",
      "indication": "<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><span style=\"font-size: 14px;\" class=\"text-black\"><br></span></p><p><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nmso-fareast-font-family:\"Batang\\, 바탕\";mso-ansi-language:EN-US;mso-fareast-language:\nKO;mso-bidi-language:AR-SA'>Cetirizine diindikasikan untuk mengobati perennial\nrhinitis, alergi rhinitis dan urtikaria idiopatik kronis</span><br></p>",
      "warning": "<p class=\"TableContents\" style=\"margin-top:0in;margin-right:.25pt;margin-bottom:\n0in;margin-left:9.25pt;margin-bottom:.0001pt;text-align:justify;text-indent:\n-8.25pt\"><span style=\"font-size:11.0pt;color:black;mso-ansi-language:\nFR\" lang=\"FR\">- Tidak dianjurkan meminum obat pada pasien yang sedang mengendarai\nkendaraan bermotor dan mengoperasikan mesin.</span></p><p></p><p></p><p style='padding: 0px; border: 0px; font-size: 15px; vertical-align: baseline; color: rgb(45, 45, 45); font-family: Arial, Helvetica, \"sans-serif\";'><font style=\"font-size: 14px;\" class=\"text-black\">\n\n<span style='font-size: 11pt; font-family: \"Times New Roman\", serif;' lang=\"FR\">- Hindari penggunaan pada wanita hamil dan menyusui karena diekresi\nmelalui air susu</span><br></font></p><p></p>",
      "side_effect": "<p class=\"TableContents\" style=\"text-align:justify;tab-stops:-3.75pt\"><span style=\"font-size:11.0pt\" lang=\"IN\">- Cetirizine mempunyai efek samping lemah\nbersifat sementara, antara lain: sakit kepala, pusing, rasa kantuk, agitasi,\nmulut kering, dan rasa tidak enak pada lambung.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\">\n\n<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nmso-fareast-font-family:\"Lucida Sans Unicode\";mso-bidi-font-family:Tahoma;\nmso-ansi-language:IN;mso-fareast-language:#1000;mso-bidi-language:#1000' lang=\"IN\">- Pada\nbeberapa individu dapat terjadi reaksi hipersensitivitas termasuk reaksi kulit\ndan angidoerma.</span><span style='font-family:\"Arial\",\"sans-serif\";'><font style=\"font-size: 14px;\" class=\"text-black\"><br></font></span></p><p></p><p></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002233",
          "name": "Cetirizine Hydrochloride 5 mg / 5 mL Sirup",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL2108027037A1",
          "name": "RYDIAN",
          "source_name": "NIE BPOM"
        },
        {
          "url": null,
          "code": "DTL2108027037A1",
          "name": "RYDIAN",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94002509",
          "pack_price": 78144
        }
      ],
      "product_template": {
        "name": "Cetirizine Hydrochloride 5 mg/5 mL Sirup",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000245",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Cetirizine Hydrochloride 5 mg/5 mL Sirup"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91001105",
          "zat_aktif": "Cetirizine Hydrochloride",
          "updated_at": "2022-10-28 06:27:01",
          "kekuatan_zat_aktif": "5 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 2.5,
          "name": "Anak: 2.5 - 5 mL; 1 - 2 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-10-13 05:49:19",
          "period_ucum": "hari",
          "display_name": "Anak: 2.5 - 5 mL; 1 - 2 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 2,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5 - 10 mL; 1 - 2 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-10-13 05:49:19",
          "period_ucum": "hari",
          "display_name": "Anak: 5 - 10 mL; 1 - 2 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 2,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 10,
          "name": "Dewasa: 10.0 mL; 1 - 1 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-10-13 05:49:19",
          "period_ucum": "hari",
          "display_name": "Dewasa: 10.0 mL; 1 - 1 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 1,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001983",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Cetirizine Hydrochloride 10 mg Tablet Salut Selaput (INTRIZIN)",
      "kfa_code": "93001983",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-01-02 09:22:49",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS077",
        "name": "Tablet Salut Selaput"
      },
      "controlled_drug": {
        "code": "2",
        "name": "Obat Bebas Terbatas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL0617622217A1",
      "nama_dagang": "INTRIZIN",
      "manufacturer": "INTERBAT",
      "registrar": "INTERBAT",
      "generik": false,
      "rxterm": 3064,
      "dose_per_unit": 1,
      "fix_price": 7692.3,
      "het_price": null,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": true,
      "kode_lkpp": "58363354",
      "score_tkdn": 0,
      "score_bmp": 0,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": null,
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "R",
        "name": "RESPIRATORY SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "R06",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "R"
      },
      "atc_l3": {
        "code": "R06A",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "3",
        "comment": null,
        "parent_code": "R06"
      },
      "atc_l4": {
        "code": "R06AE",
        "name": "Piperazine derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "R06A"
      },
      "atc_l5": {
        "code": "R06AE07",
        "name": "Cetirizine",
        "level": "5",
        "comment": null,
        "parent_code": "R06AE"
      },
      "description": "<p><span style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;mso-fareast-font-family:\"Lucida Sans Unicode\";\nmso-bidi-font-family:Tahoma;color:black;mso-ansi-language:FR;mso-fareast-language:\n#1000;mso-bidi-language:#1000' lang=\"FR\">Merupakan antihistamin selektif reseptor H\ndengan sedatif yang rendah pada dosis aktif farmakologi dan mempunyai sifat\ntambahan sebagai antialergi. Cetirizine menghambat pelepasan histamin pada fase\nawal dan mengurangi migrasi sel inflamasi.</span><br></p>",
      "indication": "<p><span style=\"font-family: Poppins, sans-serif;\">rinitis menahun, rinitis alergi seasonal, konjungtivitis, pruritus, urtikaria idiopati kronis.</span><br></p>",
      "warning": "<p><span style=\"font-family: Poppins, sans-serif;\">Antihistamin yang menyebabkan kantuk mempunyai aktivitas antimuskarinik yang nyata dan harus digunakan dengan hati-hati pada hipertrofi prostat, retensi urin, pasien dengan risiko galukoma sudut sempit, obstruksi pyloroduodenal, penyakit hati dan epilepsi. Dosis mungkin perlu diturunkan pada gangguan ginjal. Anak dan lansia lebih mudah mendapat efek samping. Penggunaan pada anak di bawah 2 tahun tidak dianjurkan kecuali atas petunjuk dokter dan tidak boleh digunakan pada neonatus. Banyak antihistamin harus dihindari pada porfiria, meskipun beberapa (misalnya klorfenamin dan setirizin) diperkirakan aman.</span><br></p>",
      "side_effect": "<p><span style=\"font-family: Poppins, sans-serif;\">sakit kepala, pusing, mengantuk, agitasi, mulut kering, rasa tidak nyaman di perut, reaksi hipersensitif seperti reaksi kulit dan angioudem.</span><br></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001983",
          "name": "Cetirizine Hydrochloride 10 mg Tablet Salut Selaput",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL0617622217A1",
          "name": "INTRIZIN",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/58363354?lang=id&type=province",
          "code": "58363354",
          "name": "INTRIZIN 10 MG Cetirizine hydrochloride(HCl)/ Cetirizine/ Setirizin tablet/kapsul/kaplet 10 mg",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94004184",
          "pack_price": 0
        },
        {
          "qty": 30,
          "name": "Dus isi 30",
          "uom_id": "Tablet",
          "kfa_code": "94004185",
          "pack_price": 0
        }
      ],
      "product_template": {
        "name": "Cetirizine Hydrochloride 10 mg Tablet Salut Selaput",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000122",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Cetirizine Hydrochloride 10 mg Tablet Salut Selaput"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000127",
          "zat_aktif": "Cetirizine",
          "updated_at": "2022-06-13 11:17:09",
          "kekuatan_zat_aktif": "10 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 10,
          "name": "Dewasa: 10.0 mg; tiap 1 per hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-10-24 00:48:59",
          "period_ucum": "per hari",
          "display_name": "Dewasa: 10.0 mg; tiap 1 per hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001985",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Cetirizine Hydrochloride 10 mg/mL Tetes Oral (INTRIZIN)",
      "kfa_code": "93001985",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-01-12 06:55:58",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS087",
        "name": "Tetes Oral (Oral Drops)"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL0617621636A1",
      "nama_dagang": "INTRIZIN",
      "manufacturer": "INTERBAT",
      "registrar": "INTERBAT",
      "generik": false,
      "rxterm": 3064,
      "dose_per_unit": 1,
      "fix_price": 103896,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": false,
      "kode_lkpp": "74410165",
      "score_tkdn": 0,
      "score_bmp": 0,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "R",
        "name": "RESPIRATORY SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "R06",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "R"
      },
      "atc_l3": {
        "code": "R06A",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "3",
        "comment": null,
        "parent_code": "R06"
      },
      "atc_l4": {
        "code": "R06AE",
        "name": "Piperazine derivatives",
        "level": "4",
        "comment": null,
        "parent_code": "R06A"
      },
      "atc_l5": {
        "code": "R06AE07",
        "name": "Cetirizine",
        "level": "5",
        "comment": null,
        "parent_code": "R06AE"
      },
      "description": "<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><span style=\"font-size: 12px;\">Cetirizine\nadalah antihistamin selektif reseptor H1 dengan efek mengantuk lebih kecil pada\ndosis aktif farmakologi dan mempunyai sifat tambahan sebagai antialergi.\nCetirizine menghambat mediator histamin fase awal dari reaksi alergi dan\nmenurunkan migrasi sel inflamasi.</span></p><p></p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><br><br></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><br></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><br></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><br></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><br></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><br></p>",
      "indication": "<p><span style=\"font-size: 12px; text-align: justify;\">Pengobatan perennial rhinitis, alergi rhinitis musiman dan urtikaria idiopatik kronik.</span><br></p>",
      "warning": "<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-13.5pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>      \n</span></span><!--[endif]-->Tidak dianjurkan\nmeminum obat pada pasien yang mengendarai mobil atau mengoprasikan mesin.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-13.5pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>      \n</span></span><!--[endif]-->Hindari penggunaan\npada wanita hamil dan menyusui karena dieksresi melalui air susu.</p><p></p><p>\n\n\n\n</p><p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-13.5pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>      \n</span></span><!--[endif]-->Hati-hati\npenggunaan pada penderita epilepsi.</p><p></p>",
      "side_effect": "<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"><span style='font-family:\"Arial\",\"sans-serif\"'>Cetirizine\nmempunyai efek samping ringan dan sementara, misalnya sakit kepala, pusing,\nmengantuk, gelisah, kering mulut dan ketidaknyamanan pada pencernaan. Pada\nbeberapa individu terjadi reaksi hipersensitif, termasuk reaksi kulit dan\nangiodema</span><span style='font-size:12.0pt;font-family:\"Times New Roman\",\"serif\"'>.</span></p><p></p><p></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001985",
          "name": "Cetirizine Hydrochloride 10 mg/mL Tetes Oral",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL0617621636A1",
          "name": "INTRIZIN",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/58362150?lang=id&type=province",
          "code": "58362150",
          "name": "INTRIZIN DROP Cetirizine hydrochloride(HCl)/ Cetirizine/ Setirizin 10 mg per 1 mL",
          "source_name": "LKPP"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/74410165?lang=id&type=province",
          "code": "74410165",
          "name": "INTRIZIN DROP CETIRIZINE HYDROCHLORIDE(HCL)/ CETIRIZINE/ SETIRIZIN 10 MG PER 1 ML",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Botol",
          "kfa_code": "94002158",
          "pack_price": 0
        }
      ],
      "product_template": {
        "name": "Cetirizine Hydrochloride 10 mg/mL Tetes Oral",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001162",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Cetirizine Hydrochloride 10 mg/mL Tetes Oral"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000127",
          "zat_aktif": "Cetirizine",
          "updated_at": "2022-10-11 08:29:32",
          "kekuatan_zat_aktif": "10 mg/1 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 5,
          "name": "Anak: 5.0 mg; 1 - 2 kali tiap 12 jam",
          "period": 12,
          "qty_uom": "mg",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-30 07:28:30",
          "period_ucum": "jam",
          "display_name": "Anak: 5.0 mg; 1 - 2 kali tiap 12 jam",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 2,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 10,
          "name": "Anak: 10.0 mg; tiap 1 hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-30 07:28:30",
          "period_ucum": "hari",
          "display_name": "Anak: 10.0 mg; tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002262",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Loperamide 2 mg Tablet Salut Selaput (OPOX)",
      "kfa_code": "93002262",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2025-03-07 07:46:49",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS077",
        "name": "Tablet Salut Selaput"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL9408001617A1",
      "nama_dagang": "OPOX",
      "manufacturer": "GUARDIAN PHARMATAMA",
      "registrar": "GUARDIAN PHARMATAMA",
      "generik": false,
      "rxterm": 7683,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": 2273.3,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": 32.83,
      "score_bmp": 9.3,
      "score_tkdn_bmp": 42.129999999999995,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A07",
        "name": "ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A07D",
        "name": "ANTIPROPULSIVES",
        "level": "3",
        "comment": null,
        "parent_code": "A07"
      },
      "atc_l4": {
        "code": "A07DA",
        "name": "Antipropulsives",
        "level": "4",
        "comment": null,
        "parent_code": "A07D"
      },
      "atc_l5": {
        "code": "A07DA03",
        "name": "Loperamide",
        "level": "5",
        "comment": null,
        "parent_code": "A07DA"
      },
      "description": "<p>Loperamid merupakan antispasmodic, dimana mekanisme kerjanya</p><p>yang pasti belum dapat dijelaskan. Secara invitro dan pada binatang</p><p>Loperamid menghambat motilitas/peristaltik usus. Secara invitro dan</p><p>pada hewan coba, Loperamid menghambat motilitas saluran cerna</p><p>dan mempengaruhi pergerakan air dan elektrolit di usus besar.</p><p>Pada manusia, Loperamid memperpanjang waktu transit isis saluran</p><p>cerna. Loperamid menurunkan volume feses, meningkatkan</p><p>viskositas dan kepadatan feses dan menghentikan kehilangan cairan</p><p>dan elektrolit.</p>",
      "indication": "<p>Diare akut yang tidak diketahui penyebabnya dan diare kronik.<br></p>",
      "warning": "<p> Hati-hati pemberian pada penderita insufiensi hati dan penyakit</p><p>ginjal seperti gagal ginjal.</p><p> Tidak dianjurkan diberikan pada diare akut karena infeksi E.coli,</p><p>Salmonella, Shigella.</p><p> Jangan diberikan pada hari pertama diare, karena kotoran justru</p><p>harus dikeluarkan.</p><p> Jangan digunakan melebihi dosis yang dianjurkan karena bisa</p><p>menyebabkan konstipasi.</p><p> Jangan digunakan jika diare diikuti dengan demam tinggi atau</p><p>tinja mengandung darah.</p><p> Jauhkan dari jangkauan anak-anak.</p><p> Pada keadaan overdosis dapat diberikan Naloxon bila terjadi</p><p>gejala atau tanda yang mirip keracunan morfin.</p><p> Hati-hati penggunaan pada wanita hamil dan menyusui.</p>",
      "side_effect": "<p> Flatulen, konstipasi, mual, muntah, nyeri abdomen.</p><p> Reaksi hipersensitif termasuk kemerahan pada kulit.</p><p> Letih, mengantuk, pusing, megalocon.</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002262",
          "name": "Loperamide 2 mg Tablet/Kaplet Salut Selaput",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL0408013617A1",
          "name": "OPOX",
          "source_name": "NIE BPOM"
        },
        {
          "url": null,
          "code": "DKL0408013617A1",
          "name": "RYDIAN",
          "source_name": "NIE BPOM"
        },
        {
          "url": null,
          "code": "DKL9408001617A1",
          "name": "OPOX",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94002549",
          "pack_price": 22733
        },
        {
          "qty": 60,
          "name": "Dus isi 60",
          "uom_id": "Tablet",
          "kfa_code": "94002550",
          "pack_price": 136397
        }
      ],
      "product_template": {
        "name": "Loperamide 2 mg Tablet Salut Selaput",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000838",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Loperamide 2 mg Tablet Salut Selaput"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000211",
          "zat_aktif": "Loperamide",
          "updated_at": "2022-10-19 03:52:33",
          "kekuatan_zat_aktif": "2 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 4,
          "name": "Dewasa: 4.0 mg",
          "period": 0,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 0,
          "updated_at": "2022-10-19 03:52:33",
          "period_ucum": null,
          "display_name": "Dewasa: 4.0 mg",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93006817",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Loperamide Hydrochloride 2 mg Tablet (OZELA)",
      "kfa_code": "93006817",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-12-11 02:17:23",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS066",
        "name": "Tablet"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL2025906010A1",
      "nama_dagang": "OZELA",
      "manufacturer": "TRIMAN",
      "registrar": "TRIMAN",
      "generik": false,
      "rxterm": 7683,
      "dose_per_unit": 1,
      "fix_price": 36.303,
      "het_price": 1501.5,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "73516658",
      "score_tkdn": 32.44,
      "score_bmp": 0,
      "score_tkdn_bmp": 32.44,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A07",
        "name": "ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A07D",
        "name": "ANTIPROPULSIVES",
        "level": "3",
        "comment": null,
        "parent_code": "A07"
      },
      "atc_l4": {
        "code": "A07DA",
        "name": "Antipropulsives",
        "level": "4",
        "comment": null,
        "parent_code": "A07D"
      },
      "atc_l5": {
        "code": "A07DA03",
        "name": "Loperamide",
        "level": "5",
        "comment": null,
        "parent_code": "A07DA"
      },
      "description": "<p><span style='font-family: Calibri, \"sans-serif\"; font-size: 11pt; color: rgb(0, 0, 0); font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit; text-align: inherit;'>Loperamide HCl merupakan antispasmodik, dimana mekanisme kerjanya yang\npasti belum dapat dijelaskan. Pada percobaan binatang, Loperamide menghambat\nmotilitas/peristaltik usus dengan mempengaruhi secara langsung pada otot\nsirkular dan longitudinal dinding usus. Pada pemberian oral sebagian besar obat\ntidak diabsorbsi, tidak menembus jaringan otak dengan baik.</span><br></p>",
      "indication": "<p>Diare non - spesifik akut dan diare kronik.<br></p>",
      "warning": "<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Hati – hati pemberian pada penderita\ninsufiensi hati dan penyakit ginjal seperti gagal ginjal.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Tidak dianjurkan diberikan pada disre akut\nkarena infeksi E. Coli, Salmonella, Shigella.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-8.1pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>  \n</span></span><!--[endif]-->Jangan diberikan pada hari pertama diare,\nkarena kotoran justru harus dikeluarkan.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-8.1pt;line-height:normal;mso-list:l0 level1 lfo1;\ntab-stops:12.6pt\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";\nmso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span></span><!--[endif]-->Jangan\ndigunakan melebihi dosis yang dianjurkan ,  pada posologi karena dapat menyebabkan\nkonstipasi.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Jangan digunakan jika diare diikuti dengan\ndemam tinggi atau jika tinja mengandung darah.</p><p></p><p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-8.1pt;line-height:normal;mso-list:l0 level1 lfo1;\ntab-stops:8.1pt\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";\nmso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span></span><!--[endif]-->Jauhkan\ndari jangkaun anak - anak. </p><p></p><p class=\"MsoNormal\" style=\"margin-top:0cm;margin-right:0cm;margin-bottom:0cm;\nmargin-left:8.1pt;margin-bottom:.0001pt;text-align:justify;line-height:normal\">\n\n\n\n\n\n\n\n\n\n\n\n<span style='font-size:11.0pt;line-height:107%;font-family:\"Calibri\",\"sans-serif\";\nmso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:\nminor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>Pada\nkeadaan overdosis dapat diberikan Naloxon bila terjadi gejala atau tanda yang\nmirip keracunan morfin.</span><br></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"> </p><p></p>",
      "side_effect": "<p class=\"MsoNormal\" style=\"margin-top:0cm;margin-right:0cm;margin-bottom:0cm;\nmargin-left:8.1pt;margin-bottom:.0001pt;text-align:justify;line-height:normal\">Umun: </p><p></p><p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:17.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Flatulen,\nkonstipasi, mual, muntah, nyeri perut.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:17.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Reaksi\nhipersensitif termasuk ruam kulit.</p><p></p><p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:17.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Letih, mengantuk,\npusing, megakolon toksik.</p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\">   Overdosis:</p><p></p><p>\n\n\n\n\n\n\n\n\n\n</p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\">      Konstipasi, mual ,depresi susunan saraf\npusat. </p><p></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93006817",
          "name": "Loperamide Hydrochloride 2 mg Tablet",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL2025906010A1",
          "name": "OZELA",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94009547",
          "pack_price": 363.03
        },
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Tablet",
          "kfa_code": "94009546",
          "pack_price": 363.03
        }
      ],
      "product_template": {
        "name": "Loperamide Hydrochloride 2 mg Tablet",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001154",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Loperamide Hydrochloride 2 mg Tablet"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000211",
          "zat_aktif": "Loperamide",
          "updated_at": "2022-10-11 07:59:18",
          "kekuatan_zat_aktif": "2 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 4,
          "name": "Dewasa: 4 - 2 mg",
          "period": 0,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 2,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 0,
          "updated_at": "2022-11-12 15:06:26",
          "period_ucum": null,
          "display_name": "Dewasa: 4 - 2 mg",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93024032",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Loperamide Hydrochloride 2 mg Tablet (SAMPHARINDO PERDANA)",
      "kfa_code": "93024032",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-12-13 03:38:52",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS066",
        "name": "Tablet"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL2323416610A1",
      "nama_dagang": "Loperamide Hydrochloride",
      "manufacturer": "SAMPHARINDO PERDANA",
      "registrar": "SAMPHARINDO PERDANA",
      "generik": true,
      "rxterm": 7683,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A07",
        "name": "ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A07D",
        "name": "ANTIPROPULSIVES",
        "level": "3",
        "comment": null,
        "parent_code": "A07"
      },
      "atc_l4": {
        "code": "A07DA",
        "name": "Antipropulsives",
        "level": "4",
        "comment": null,
        "parent_code": "A07D"
      },
      "atc_l5": {
        "code": "A07DA03",
        "name": "Loperamide",
        "level": "5",
        "comment": null,
        "parent_code": "A07DA"
      },
      "description": "<p><span style='font-family: Calibri, \"sans-serif\"; font-size: 11pt; color: rgb(0, 0, 0); font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit; text-align: inherit;'>Loperamide HCl merupakan antispasmodik, dimana mekanisme kerjanya yang\npasti belum dapat dijelaskan. Pada percobaan binatang, Loperamide menghambat\nmotilitas/peristaltik usus dengan mempengaruhi secara langsung pada otot\nsirkular dan longitudinal dinding usus. Pada pemberian oral sebagian besar obat\ntidak diabsorbsi, tidak menembus jaringan otak dengan baik.</span><br></p>",
      "indication": "<p>Diare non - spesifik akut dan diare kronik.<br></p>",
      "warning": "<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Hati – hati pemberian pada penderita\ninsufiensi hati dan penyakit ginjal seperti gagal ginjal.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Tidak dianjurkan diberikan pada disre akut\nkarena infeksi E. Coli, Salmonella, Shigella.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-8.1pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>  \n</span></span><!--[endif]-->Jangan diberikan pada hari pertama diare,\nkarena kotoran justru harus dikeluarkan.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-8.1pt;line-height:normal;mso-list:l0 level1 lfo1;\ntab-stops:12.6pt\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";\nmso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span></span><!--[endif]-->Jangan\ndigunakan melebihi dosis yang dianjurkan ,  pada posologi karena dapat menyebabkan\nkonstipasi.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Jangan digunakan jika diare diikuti dengan\ndemam tinggi atau jika tinja mengandung darah.</p><p></p><p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:8.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-8.1pt;line-height:normal;mso-list:l0 level1 lfo1;\ntab-stops:8.1pt\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";\nmso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   </span></span><!--[endif]-->Jauhkan\ndari jangkaun anak - anak. </p><p></p><p class=\"MsoNormal\" style=\"margin-top:0cm;margin-right:0cm;margin-bottom:0cm;\nmargin-left:8.1pt;margin-bottom:.0001pt;text-align:justify;line-height:normal\">\n\n\n\n\n\n\n\n\n\n\n\n<span style='font-size:11.0pt;line-height:107%;font-family:\"Calibri\",\"sans-serif\";\nmso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:\nminor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;\nmso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>Pada\nkeadaan overdosis dapat diberikan Naloxon bila terjadi gejala atau tanda yang\nmirip keracunan morfin.</span><br></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\"> </p><p></p>",
      "side_effect": "<p class=\"MsoNormal\" style=\"margin-top:0cm;margin-right:0cm;margin-bottom:0cm;\nmargin-left:8.1pt;margin-bottom:.0001pt;text-align:justify;line-height:normal\">Umun: </p><p></p><p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:17.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Flatulen,\nkonstipasi, mual, muntah, nyeri perut.</p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:17.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Reaksi\nhipersensitif termasuk ruam kulit.</p><p></p><p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0cm;margin-right:0cm;\nmargin-bottom:0cm;margin-left:17.1pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:\"Times New Roman\"'>-<span style='font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: \"Times New Roman\";'>   \n</span></span><!--[endif]-->Letih, mengantuk,\npusing, megakolon toksik.</p><p></p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\">   Overdosis:</p><p></p><p>\n\n\n\n\n\n\n\n\n\n</p><p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;text-align:\njustify;line-height:normal\">      Konstipasi, mual ,depresi susunan saraf\npusat. </p><p></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93024032",
          "name": "Loperamide Hydrochloride 2 mg Tablet",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL2323416610A1",
          "name": "LOPERAMIDE HYDROCHLORIDE",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94029437",
          "pack_price": 0
        },
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Tablet",
          "kfa_code": "94029436",
          "pack_price": 0
        }
      ],
      "product_template": {
        "name": "Loperamide Hydrochloride 2 mg Tablet",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001154",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Loperamide Hydrochloride 2 mg Tablet"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000211",
          "zat_aktif": "Loperamide",
          "updated_at": "2022-10-11 07:59:18",
          "kekuatan_zat_aktif": "2 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 4,
          "name": "Dewasa: 4 - 2 mg",
          "period": 0,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 2,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 0,
          "updated_at": "2022-11-12 15:06:26",
          "period_ucum": null,
          "display_name": "Dewasa: 4 - 2 mg",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93003027",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Loperamide Hydrochloride 2 mg Kapsul (MIDIX)",
      "kfa_code": "93003027",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-10-27 06:29:51",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Kapsul"
      },
      "dosage_form": {
        "code": "BS019",
        "name": "Kapsul"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL8910901401A1",
      "nama_dagang": "MIDIX",
      "manufacturer": "ITRASAL",
      "registrar": "ITRASAL",
      "generik": false,
      "rxterm": 7683,
      "dose_per_unit": 1,
      "fix_price": 815.2,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": 2,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A07",
        "name": "ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A07D",
        "name": "ANTIPROPULSIVES",
        "level": "3",
        "comment": null,
        "parent_code": "A07"
      },
      "atc_l4": {
        "code": "A07DA",
        "name": "Antipropulsives",
        "level": "4",
        "comment": null,
        "parent_code": "A07D"
      },
      "atc_l5": {
        "code": "A07DA03",
        "name": "Loperamide",
        "level": "5",
        "comment": null,
        "parent_code": "A07DA"
      },
      "description": "<p>Loperamide HCl merupakan antispasmodik dimana mekanisme kerjanya yang pasti belum dapat dijelaskan.</p><p>Secara invitro dan pada binatang Loperamide menghambat motilitas/peristaltik usus dengan mempengaruhi secara langsung otot sirkular dan longitudinal dinding usus.</p><p>Secara invitro dan pada hewan coba, Lopermaide memperlambat motilitas saluran cerna dan mempengaruhi pergerakan air dan elektrolit di usus besar. Pada manusia, Loeramide memperpanjang waktu transit isi saluran cerna. Loperamide menurunkan volume feses, meningkatkan viskositas dan kepadatan feses dan menghentikan kehilangan cairan dan elektrolit.</p>",
      "indication": "<p>Diare akut yang tidak diketahui penyebabnya dan diare kronik.</p>",
      "warning": "<ul><li><p>Hati - hati pemberian pada penderita insufiensi hati dan penyakit ginjal seperti gagal ginjal.</p></li><li><p>Tidak dianjurkan diberikan pada diare akut karena infeksi E. Coli, Salmonella, Shigella.</p></li><li><p>Jangan diberikan pada hari pertama diare, karena kotoran justru harus dikeluarkan.</p></li><li><p>Jangan digunakan melebihi dosis yang dianjurkan karena bisa menyebabkan konstipasi.</p></li><li><p>Jangan digunakan jika diare diikuti dengan demam tinggu atau jika tinja mengandung darah.</p></li><li><p>Jauhkan dari jagkauan anak - anak.</p></li><li><p>Pada keadaan overdosis dapat diberikan Naloxon bila terjadi gejala atau tanda yang mirip keracunan morfin.</p></li><li><p>Hati - hati penggunaan pada wanita hamil dan menyusui.</p></li></ul>",
      "side_effect": "<ul><li><p>Flatulen, konstipasi, mual, muntah, nyeri abdomen.</p></li><li><p>Rekasi hipersensitif termasuk kemerahan pada kulit.</p></li><li><p>Letih, mengantuk, pusing, megaolon toksik.</p></li></ul>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93003027",
          "name": "Loperamide Hydrochloride 2 mg Kapsul",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL8910901401A1",
          "name": "MIDIX",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Kapsul",
          "kfa_code": "94003222",
          "pack_price": 6600
        },
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Kapsul",
          "kfa_code": "94003221",
          "pack_price": 66000
        }
      ],
      "product_template": {
        "name": "Loperamide Hydrochloride 2 mg Kapsul",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001498",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Loperamide Hydrochloride 2 mg Kapsul"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000211",
          "zat_aktif": "Loperamide",
          "updated_at": "2022-10-14 15:10:19",
          "kekuatan_zat_aktif": "2 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 4,
          "name": "Dewasa: 4.0 mg",
          "period": 0,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 0,
          "updated_at": "2022-10-27 06:44:15",
          "period_ucum": null,
          "display_name": "Dewasa: 4.0 mg",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001113",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Esomeprazole Sodium 40 mg Serbuk Injeksi (DEXA MEDICA)",
      "kfa_code": "93001113",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-02-29 08:08:58",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Vial"
      },
      "dosage_form": {
        "code": "BS049",
        "name": "Serbuk Injeksi"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "P",
        "name": "Parenteral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL1905061944A1",
      "nama_dagang": "ESOMEPRAZOLE SODIUM",
      "manufacturer": "FERRON PAR PHARMACEUTICALS",
      "registrar": "DEXA MEDICA",
      "generik": true,
      "rxterm": 5064,
      "dose_per_unit": 1,
      "fix_price": 10450,
      "het_price": 93700,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "49979766",
      "score_tkdn": 52.8,
      "score_bmp": 0,
      "score_tkdn_bmp": 52.8,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "30 mg - P"
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A02",
        "name": "DRUGS FOR ACID RELATED DISORDERS",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A02B",
        "name": "DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)",
        "level": "3",
        "comment": null,
        "parent_code": "A02"
      },
      "atc_l4": {
        "code": "A02BC",
        "name": "Proton pump inhibitors",
        "level": "4",
        "comment": null,
        "parent_code": "A02B"
      },
      "atc_l5": {
        "code": "A02BC05",
        "name": "Esomeprazole",
        "level": "5",
        "comment": null,
        "parent_code": "A02BC"
      },
      "description": "<p>Esomeprazole, penghambat pompa proton, merupakan isomer-S dari Omeprazole. Esomeprazole adalah basa lemah yang dikonsentrasikan dan dikonversi menjadi bentuk aktif di lingkungan yang sangat asam pada secretory canaliculi sel parietal. Esomeprazole secara spesifik menghambat enzim H/K-ATPase, pompa asam dan sekresi asam basa serta sekresi asam yang terstimulasi. Esomeprazole menghambat tahapan akhir produksi asam, sehingga menghasilkan penghambatan sekresi asam lambung yang poten dan dalam jangka waktu yang lama.<br></p>",
      "indication": "<p>Esomeprazole injeksi diindikasikan untuk:</p><p>Pengobatan antisekret lambung ketika pemberian oral tidak dimungkinkan, seperti pada: </p><ul><li><p>Penyakit refluks gastroesofageal (GERD) pada pasien dengan esofagitis dan/atau gejala berat dari refluks.</p></li><li><p>Ulkus lambung yang disebabkan terapi dengan obat anti-inflamasi nonsteroid.</p></li></ul>",
      "warning": "<ul><li><p>Setiap gejala yang mengkhawatirkan (seperti penurunan berat badan yang signifikan, berulang, disfagia, hematemesis atau melena) dan bila diduga adanya ulkus pada lambung, muntah yang keparahan harus dikesampingkan, karena pengobatan dengan Esomeprazole akan meringankan gejala dan menunda diagnosis </p></li><li><p>Pengobatan dengan menggunakan penghambat pompa proton dapat meningkatkan risiko infeksi saluran cema, seperti Salmonella dan Campylobacter.</p></li><li><p>Penggunaan secara bersamaan Esomeprazole dengan Alazanavir tidak direkomendasikan. Apabila kombinasi antara Atazanavir dengan penghambat pompa proton tidak bisa dihindari, maka pemantauan klinis yang ketat direkomendasikan dengan peningkatan dosis Atazanavir hingga 400 mg dengan 100 mg Ritonavir. Esomeprazole tidak boleh melebihi 20 mg. </p></li><li><p> Esomeprazole merupakan penghambat CYP2C19. Kemungkinan interaksi dengan obat yang dimetabolisme oleh CYP2C19 harus dipertimbangkan ketika memulai dan mengakhiri pengobatan dengan Esomeprazole. Diketahui adanya interaksi antara Clopidogrel dan Omeprazole. Relevansi klinis untuk interaksi tersebut tidak diketahui secara pasti. Sebagai perhatian, penggunaan bersamaan Esomeprazole dengan Clopidogrel harus dikurang</p></li></ul>",
      "side_effect": "<ul><li><p>Reaksi efek samping berikut telah terindentifikasi atau diduga. Tidak ditemukan hubungan dengan dosis.</p></li><li><p>Gangguan sistem darah dan limfatik: Jarang : leukopenia, trombositopenia. Sangat jarang : agranulositosis, pansitopenia.</p></li><li><p>Gangguan sistem kekebalan Jarang: reaksi hipersensitivitas misalnya, angioedema, anafilaksis/syok. reaksi</p></li><li><p>Gangguan metabolisme dan nutrisi : Tidak sering: edema perifer. Jarang: hiponatremia. Sangat jarang : hipomagnesemia. </p></li><li><p>Gangguan kejiwaan: Tidak sering: Insomnia. Jarang : agitasi, bingung, depresi. Sangat jarang agresif, halusinasi.</p></li><li><p>Gangguan sistem saraf: Sering: sakit kepala. Tidak sering: pusing, parestesia, mengantuk. Jarang: gangguan indra pengecap. </p></li><li><p>Gangguan penglihatan: Jarang penglihatan kabur.</p></li><li><p>Gangguan telinga dan labirin: Tidak sering: vertigo,</p></li><li><p>Gangguan pernapasan, thorak dan mediastinum: Jarang: bronkospasme. </p></li><li><p>Gangguan pencemaan: Sering: nyeri perut, konstipasi, diare, perut kembung, mual/muntah. Jarang: mulut kering Sangat jarang: stomatitis, kandidiasis saluran cerna. </p></li><li><p>Gangguan Hepatobiliari. Tidak sering: peningkatan enzim hati. Jarang: hepatitis dengan atau tanpa ikterus. Sangat jarang: kegagalan hepatik, ensefalopati pada pasien yang sudah menderita penyakit hati sebelumnya.</p></li><li><p>Gangguan kulit dan jaringan subkutan : Sering: reaksi pada tempat pemberian. Tidak sering: dermatitis, pruritus, ruam, urtikaria. Jarang: alopesia, fotosensitivitas. Sangat jarang: eritema multiformis, sindrom Stevens-Johnson, toxic epidermal necrolysis (TEN).</p></li><li><p>Gangguan muskuloskeletal, jaringan ikat dan tulang Jarang: artralgia, mialgia. Sangat jarang kelemahan otot</p></li><li><p>Gangguan sistem ginjal dan urin: Sangat jarang: nefritis interstitia. Gangguan sistem reproduksi dan payudara: Sangat jarang: ginekomastia,</p></li><li><p>Gangguan umum dan lokasi penyuntikan: Jarang malaise, berkeringat.</p></li></ul>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001113",
          "name": "Esomeprazole 40 mg Serbuk Injeksi",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL1905061944A1",
          "name": "ESOMEPRAZOLE SODIUM",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/1478033?lang=id&type=province",
          "code": "1478033",
          "name": "Esomeprazole Sodium/ Esomeprazol serbuk Inj. 40 mg (i.v)",
          "source_name": "LKPP"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/48892683?lang=id&type=province",
          "code": "48892683",
          "name": "ESOMEPRAZOLE SODIUM 40 MG",
          "source_name": "LKPP"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/49979766?lang=id&type=province",
          "code": "49979766",
          "name": "Esomeprazole Sodium/ Esomeprazol serbuk Inj. 40 mg (i.v)",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Vial",
          "kfa_code": "94001291",
          "pack_price": 0
        }
      ],
      "product_template": {
        "name": "Esomeprazole Sodium 40 mg Serbuk Injeksi",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000348",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Esomeprazole Sodium 40 mg Serbuk Injeksi"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000344",
          "zat_aktif": "Esomeprazole",
          "updated_at": "2022-07-05 16:10:33",
          "kekuatan_zat_aktif": "40 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 20,
          "name": "Dewasa: 20 - 40 mg; tiap 1 hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 40,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-10-26 08:31:35",
          "period_ucum": "hari",
          "display_name": "Dewasa: 20 - 40 mg; tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001378",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Omeprazole Sodium 40 mg Serbuk Injeksi (PHAPROS)",
      "kfa_code": "93001378",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-08-06 04:26:40",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Vial"
      },
      "dosage_form": {
        "code": "BS050",
        "name": "Serbuk Injeksi Liofilisasi"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "P",
        "name": "Parenteral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL1819933644A1",
      "nama_dagang": "OMEPRAZOLE SODIUM",
      "manufacturer": "FERRON PAR PHARMACEUTICALS",
      "registrar": "PHAPROS Tbk",
      "generik": true,
      "rxterm": 9101,
      "dose_per_unit": 1,
      "fix_price": 534.6,
      "het_price": 17552,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "48085060",
      "score_tkdn": 52.7,
      "score_bmp": 12.3,
      "score_tkdn_bmp": 65,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "20 mg - P"
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A02",
        "name": "DRUGS FOR ACID RELATED DISORDERS",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A02B",
        "name": "DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)",
        "level": "3",
        "comment": null,
        "parent_code": "A02"
      },
      "atc_l4": {
        "code": "A02BC",
        "name": "Proton pump inhibitors",
        "level": "4",
        "comment": null,
        "parent_code": "A02B"
      },
      "atc_l5": {
        "code": "A02BC01",
        "name": "Omeprazole",
        "level": "5",
        "comment": null,
        "parent_code": "A02BC"
      },
      "description": "<p>Omeprazole merupakan anti sekresi, turunan benzimidazole, yang bekerja menekan sekresi asam lambung dengan menghambat aktivitas enzim H/K ATPase (pompa proton) pada permukaan kelenjar sel parietal gastrik pada pH &lt; 4. Omeprazole yang berikatan dengan proton (H) secara cepat akan diubah menjadi sulfonamide, suatu penghambat pompa proton yang aktif. Penggunaan Omeprazole secara oral menghambat sekresi asam lambung basal dan stimulasi pentagastrik.</p>",
      "indication": "<ul><li><p>Pengobatan jangka pendek tukak duodenal dan yang tidak responsif terhadap obat-obat antagonis reseptor H2.</p></li><li><p>Pengobatan jangka pendek tukak lambung</p></li><li><p>Pengobatan refluks esofagitis erosif/ulceratif yang telah didiagnosa melalui endoskopi. Pengobatan jangka lama pada sindroma Zollinger Ellison.</p></li></ul>",
      "warning": "<p><br></p>",
      "side_effect": "<p>Omeprazole umumnya dapat ditoleransi dengan baik. Pada dosis besar dan penggunaan yang lama kemungkinan dapat menstimulasi pertumbuhan sel ECL (enterochromaffin-like cells). Pada penggunaan jangka panjang perlu diperhatikan adanya pertumbuhan bakteri yang berlebihan di saluran cerna<br></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001378",
          "name": "Omeprazole Sodium 40 mg Serbuk Injeksi",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL1819933644A1",
          "name": "OMEPRAZOLE SODIUM",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/1480614?lang=id&type=province",
          "code": "1480614",
          "name": "Omeprazol/Omeprazole/ Omeoprazole Sodium serb injeksi 40 mg",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Dus isi 10",
          "uom_id": "Vial",
          "kfa_code": "94001562",
          "pack_price": 5346
        }
      ],
      "product_template": {
        "name": "Omeprazole Sodium 40 mg Serbuk Injeksi",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000733",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Omeprazole Sodium 40 mg Serbuk Injeksi"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000343",
          "zat_aktif": "OMEPRAZOLE",
          "updated_at": "2022-07-05 16:02:01",
          "kekuatan_zat_aktif": "40 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 20,
          "name": "Dewasa: 20 - 40 mg; 1 - 1 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 0,
          "qty_high": 40,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-25 02:30:22",
          "period_ucum": "hari",
          "display_name": "Dewasa: 20 - 40 mg; 1 - 1 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 1,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001293",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Lansoprazole 30 mg Kapsul Lepas Tunda (BERNOFARM)",
      "kfa_code": "93001293",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2023-10-06 06:00:41",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Kapsul"
      },
      "dosage_form": {
        "code": "BS021",
        "name": "Kapsul Pelepasan Lambat"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL0502337403A1",
      "nama_dagang": "LANSOPRAZOLE",
      "manufacturer": "BERNOFARM",
      "registrar": "BERNOFARM",
      "generik": true,
      "rxterm": 7251,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": 2045.42,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "30 mg - O"
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A02",
        "name": "DRUGS FOR ACID RELATED DISORDERS",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A02B",
        "name": "DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)",
        "level": "3",
        "comment": null,
        "parent_code": "A02"
      },
      "atc_l4": {
        "code": "A02BC",
        "name": "Proton pump inhibitors",
        "level": "4",
        "comment": null,
        "parent_code": "A02B"
      },
      "atc_l5": {
        "code": "A02BC03",
        "name": "Lansoprazole",
        "level": "5",
        "comment": null,
        "parent_code": "A02BC"
      },
      "description": "<p>Lansoprazole mengurangi sekresi asam lambung dengan menghambat pompa proton H+/K+ adenosine triphosphatase (ATP-ase) dari sel parietal mukosa lambung. Dosis tunggal Lansoprazole 30 mg dapat menghambat stimulasi sekresi asam sekitar 80%</p>",
      "indication": "<p>Pengobatan jangka pendek penyakit duodenal ulcer dan reflux oesophagitis.</p><p><br></p><p>Cara Pemberian :</p><p>Lansoprazole diberikan sekali sehari untuk mencapai efek penghambatan asam yang optimal dan hilangnya gejala-gejala, Lansoprazole sebaiknya diberikan pada pagi hari sebelum makan. kapsul harus ditelan. tidak boleh digerus atau dikunyah. Pengobatan jangka panjang tidak dianjurkan.</p>",
      "warning": "<ul><li><p>Hati-hati penggunaan Lansoprazole pada wanita hamil.</p></li></ul><ul><li><p>Seperti umumnya pengobatan dengan obat golongan anti ulkus, kemungkinan keganasan harus disingkirkan bila dicurigai adanya ulkus gaster, karena pemberian Lansoprazole akan meredakan gejala-gejala dan memperlambat diagnosa.</p></li><li><p>Pada ibu yang sedang menyusui, bila penggunaan Lansoprazole benar-benar dianggap perlu maka pemberian ASI harus dihentikan</p></li></ul>",
      "side_effect": "<ul><li><p>Dapat terjadi diare, sakit kepala, dizziness, gangguan pada kulit, symptom pada saluran pernapasan.</p></li><li><p>Meningkatkan secara sementara nilai enzim hati, hematokrit, konsentrasi hemoglobin, ekskresi protein urinary dan asam urat.</p></li><li><p>Nyeri abdomen, dyspepsia, mual, muntah, kembung, sembelit, mulut kering, lelah, pusing.</p></li><li><p>Jarang (pernah dilaporkan) : perubahan angka hematologi, seperti : trombositopenia. eonosifilia, leucopenia.</p></li><li><p>Reaksi lain mencakup arthralgia, myalgia, depresi, edema, perifer dan jarang sekali paraesthesia atau penghilatan kabur, vertigo, gangguan rasa, rasa bingung dan halusinasi.</p></li><li><p>Jarang dilaporkan gynecomastia dan impotensi</p></li></ul>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001293",
          "name": "Lansoprazole 30 mg Kapsul Lepas Tunda",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL0502337403A1",
          "name": "LANSOPRAZOLE",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Kapsul",
          "kfa_code": "94015027",
          "pack_price": 20454
        },
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Kapsul",
          "kfa_code": "94015026",
          "pack_price": 204542
        }
      ],
      "product_template": {
        "name": "Lansoprazole 30 mg Kapsul Lepas Tunda",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000236",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Lansoprazole 30 mg Kapsul Lepas Tunda"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000252",
          "zat_aktif": "LANSOPRAZOLE",
          "updated_at": "2022-06-25 03:08:06",
          "kekuatan_zat_aktif": "30 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 30,
          "name": "Dewasa: 30.0 mg; tiap 1 hari; selama 4 minggu",
          "period": 1,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 4,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-10-15 09:41:51",
          "period_ucum": "hari",
          "display_name": "Dewasa: 30.0 mg; tiap 1 hari; selama 4 minggu",
          "duration_max": 0,
          "duration_ucum": "minggu",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002169",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Loratadine 10 mg Tablet (INCLARIN)",
      "kfa_code": "93002169",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-10-26 10:13:40",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS066",
        "name": "Tablet"
      },
      "controlled_drug": {
        "code": "2",
        "name": "Obat Bebas Terbatas"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL9417609210A1",
      "nama_dagang": "INCLARIN",
      "manufacturer": "INTERBAT",
      "registrar": "INTERBAT",
      "generik": false,
      "rxterm": 7691,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": null,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "10 mg - O"
      },
      "atc_l1": {
        "code": "R",
        "name": "RESPIRATORY SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "R06",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "R"
      },
      "atc_l3": {
        "code": "R06A",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "3",
        "comment": null,
        "parent_code": "R06"
      },
      "atc_l4": {
        "code": "R06AX",
        "name": "Other antihistamines for systemic use",
        "level": "4",
        "comment": null,
        "parent_code": "R06A"
      },
      "atc_l5": {
        "code": "R06AX13",
        "name": "Loratadine",
        "level": "5",
        "comment": null,
        "parent_code": "R06AX"
      },
      "description": "<p><span style='font-size:11.0pt;line-height:107%;\nfont-family:\"Times New Roman\",\"serif\";mso-fareast-font-family:Calibri;\nmso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:\nEN-US;mso-bidi-language:AR-SA'>Loratadine merupakan suatu antihistamin\ntrisiklik yang bekerja lama dengan aktivitas antagonis selektif terhadap\nreseptor H1 perifer tanpa efek sedasi sentral atau efek antikolinergik.</span><br></p>",
      "indication": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:7.75pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:\njustify;text-indent:-9.0pt;line-height:normal;mso-list:l0 level1 lfo1;\ntab-stops:2.0in 153.0pt 2.25in\">     <span style='font-family:\"Times New Roman\",\"serif\"; mso-bidi-font-size:12.0pt;'>-</span>    <span style='font-family:\"Times New Roman\",\"serif\"; mso-bidi-font-size:12.0pt;'>Mengurangi gejala-gejala yang berkaitan\ndengan rinitis alergik, seperti bersin-bersin, pilek dan rasa gatal dan\nterbakar pada mata.</span><br> <span style='font-family: \"Times New Roman\", \"serif\"; line-height: 107%;'>-     Juga mengurangi gejala-gejala dengan tanda-tanda urtikaria kronik serta penyakit dermatologik alergi lain.</span><br></p>",
      "warning": "<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:7.75pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-7.75pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\"; mso-fareast-font-family:\"Times New Roman\";'>-<span style='font-family: \"Times New Roman\"; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;'>  \n</span></span><!--[endif]--><span style='font-family:\"Times New Roman\",\"serif\";'>Pasien\ndengan gangguan hati yang berat harus diberikan dosis permulaan yang lebih\nrendah, karena hal ini kemungkinan dapat mengurangi bersihan Loratadine,\ndianjurkan dosis awal 5 mg sehari atau 10 mg setiap 2 hari.</span></p><p></p><p></p><p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:7.75pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-7.75pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\"; mso-fareast-font-family:\"Times New Roman\";'>-<span style='font-family: \"Times New Roman\"; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;'>  \n</span></span><!--[endif]--><span style='font-family:\"Times New Roman\",\"serif\";'>Khasiat\ndan keamanan penggunaan Loratadine pada anak-anak usia dibawah 2 tahun belum\nditetapkan.</span></p><p></p><p></p><p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:7.75pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-7.75pt;line-height:normal;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\"; mso-fareast-font-family:\"Times New Roman\";'>-<span style='font-family: \"Times New Roman\"; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;'>  \n</span></span><!--[endif]--><span style='font-family:\"Times New Roman\",\"serif\";'>Keamanan\npemakaian Loratadine selama kehamilan belum ditetapkan, hanya diberikan bila\npotensi manfaat lebih besar dari potensi resiko terhadap janin.</span></p><p></p><p></p><p>\n\n\n\n\n\n<span style='font-family: \"Times New Roman\", \"serif\"; line-height: 107%;'></span>-   <span style='font-family: \"Times New Roman\", \"serif\"; line-height: 107%;'>Hati-hati bila diberikan pada wanita yang sedang menyusui , karena Loratadine diekskresikan dalam air susu ibu.</span><br></p>",
      "side_effect": "<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:7.75pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-7.75pt;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\"; mso-fareast-font-family:\"Times New Roman\";'>-<span style='font-family: \"Times New Roman\"; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;'>  \n</span></span><!--[endif]--><span style='font-family:\"Times New Roman\",\"serif\";'>Loratadine\ntidak memperlihatkan efek sedatif yang secara klinis bermakna pada pemberian\ndosis 10 mg sehari.</span></p><p></p><p></p><p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:7.75pt;margin-bottom:.0001pt;mso-add-space:auto;\ntext-align:justify;text-indent:-7.75pt;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style='font-family:\"Times New Roman\",\"serif\"; mso-fareast-font-family:\"Times New Roman\";'>-<span style='font-family: \"Times New Roman\"; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;'>  \n</span></span><!--[endif]--><span style='font-family:\"Times New Roman\",\"serif\";'>Efek\nsamping yang dilaporkan : lelah, sakit kepala, somnolensi, mulut kering,\ngangguan pencernaan, nausea, gastritis, dan gejala alergi yang menyerupai ruam.</span></p><p></p><p></p><p>\n\n\n\n<span style='font-family: \"Times New Roman\", \"serif\"; line-height: 107%;'>-   Pernah dilaporkan\nterjadinya alopesia, anafilaksis, fungsi hati abnormal dan takiaritmia\nsupraventikuler walaupun jarang.</span><br></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002169",
          "name": "Loratadine 10 mg Tablet",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL9417609210A1",
          "name": "INCLARIN",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94006612",
          "pack_price": 0
        },
        {
          "qty": 50,
          "name": "Dus isi 50",
          "uom_id": "Tablet",
          "kfa_code": "94006613",
          "pack_price": 0
        }
      ],
      "product_template": {
        "name": "Loratadine 10 mg Tablet",
        "state": "valid",
        "bmhp": false,
        "active": true,
        "kfa_code": "92000238",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Loratadine 10 mg Tablet"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000255",
          "zat_aktif": "LORATADINE",
          "updated_at": "2022-06-25 06:20:47",
          "kekuatan_zat_aktif": "10 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 0.5,
          "name": "Anak: 0.5 - 1 Tablet 1 hari",
          "period": 1,
          "qty_uom": "Tablet",
          "category": "child",
          "duration": 0,
          "qty_high": 1,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 0,
          "updated_at": "2022-11-22 04:36:46",
          "period_ucum": "hari",
          "display_name": "Anak: 0.5 - 1 Tablet 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 1,
          "name": "Dewasa: 1.0 Tablet; tiap 1 hari",
          "period": 1,
          "qty_uom": "Tablet",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-22 04:36:46",
          "period_ucum": "hari",
          "display_name": "Dewasa: 1.0 Tablet; tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93007336",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Desloratadine 5 mg Tablet Salut Selaput (DESFUMED)",
      "kfa_code": "93007336",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-11-08 16:25:46",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "gram",
        "cs_code": "g"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS077",
        "name": "Tablet Salut Selaput"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL1439202517A1",
      "nama_dagang": "DESFUMED",
      "manufacturer": "MEGA LIFESCIENCES INDONESIA",
      "registrar": "MEGA LIFESCIENCES INDONESIA",
      "generik": false,
      "rxterm": 4230,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "5 mg - O"
      },
      "atc_l1": {
        "code": "R",
        "name": "RESPIRATORY SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "R06",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "2",
        "comment": null,
        "parent_code": "R"
      },
      "atc_l3": {
        "code": "R06A",
        "name": "ANTIHISTAMINES FOR SYSTEMIC USE",
        "level": "3",
        "comment": null,
        "parent_code": "R06"
      },
      "atc_l4": {
        "code": "R06AX",
        "name": "Other antihistamines for systemic use",
        "level": "4",
        "comment": null,
        "parent_code": "R06A"
      },
      "atc_l5": {
        "code": "R06AX27",
        "name": "Desloratadine",
        "level": "5",
        "comment": null,
        "parent_code": "R06AX"
      },
      "description": "<p>Desloratadine, metabolit aktif utama loratadine, adalah antihistamin non-sedasi, kerja panjang. Ini secara selektif memblokir reseptor histamin H1 perifer.<br></p>",
      "indication": "<p><b>Rinitis alergi, Urtikaria</b></p><p><b><br></b></p><p>Dewasa: 5 mg sekali sehari. Pasien dengan rinitis alergi intermiten harus dikelola sesuai dengan evaluasi riwayat penyakit, pengobatan dapat dihentikan setelah gejala teratasi dan dimulai kembali saat muncul kembali; dalam kasus rinitis alergi persisten, pengobatan berkelanjutan dapat dipertimbangkan selama periode paparan alergen. </p><p><br></p><p>Anak: 1-5 tahun Sebagai larutan oral atau sirup: 1,25 mg sekali sehari; 6-11 tahun Sebagai tab orodispersibel, larutan oral atau sirup: 2,5 mg sekali sehari; 12 tahun Sama seperti dosis dewasa.</p>",
      "warning": "<p>Pasien dengan riwayat medis atau keluarga gangguan kejang. Pasien dengan metabolisme desloratadine yang lambat atau buruk mungkin memiliki peningkatan risiko efek samping. Gangguan ginjal dan hati. Anak-anak. Kehamilan dan menyusui.<br></p>",
      "side_effect": "<p>Signifikan: Peningkatan risiko kejang (terutama pada anak-anak). Sangat jarang, reaksi hipersensitivitas (misalnya anafilaksis).</p><p>Gangguan gastrointestinal: Mulut kering; diare (terutama pada anak &lt;2 tahun).</p><p>Gangguan umum dan kondisi tempat pemberian: Kelelahan; demam (terutama pada anak &lt;2 tahun).</p><p>Gangguan sistem saraf: Sakit kepala.</p><p>Gangguan psikiatri: Insomnia (terutama pada anak &lt;2 tahun).</p><p>Gangguan pernapasan, toraks dan mediastinum: Faringitis; infeksi saluran pernapasan atas, batuk (terutama pada anak &lt;2 tahun).</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93007336",
          "name": "Desloratadine 5 mg Tablet Salut Selaput",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL1439202517A1",
          "name": "DESFUMED",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94008843",
          "pack_price": 7040
        },
        {
          "qty": 20,
          "name": "Dus isi 20",
          "uom_id": "Tablet",
          "kfa_code": "94008842",
          "pack_price": 140800
        }
      ],
      "product_template": {
        "name": "Desloratadine 5 mg Tablet Salut Selaput",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001543",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Desloratadine 5 mg Tablet Salut Selaput"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000813",
          "zat_aktif": "DESLORATADINE",
          "updated_at": "2022-10-17 02:29:01",
          "kekuatan_zat_aktif": "5 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 1,
          "name": "Dewasa: 1.0 Tablet; tiap 1 hari",
          "period": 1,
          "qty_uom": "Tablet",
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-11-08 16:22:26",
          "period_ucum": "hari",
          "display_name": "Dewasa: 1.0 Tablet; tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002880",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Salbutamol 100 mcg Cairan Inhalasi (SALBULIN)",
      "kfa_code": "93002880",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2023-08-25 07:29:12",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "mikrogram",
        "cs_code": "ug"
      },
      "uom": {
        "name": "Canister"
      },
      "dosage_form": {
        "code": "BS033",
        "name": "Larutan Inhalasi"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "Inhal",
        "name": "Inhalasi (dihirup)"
      },
      "produksi_buatan": "import",
      "nie": "DKI1745700139A1",
      "nama_dagang": "SALBULIN",
      "manufacturer": "JEWIM PHARMACEUTICAL (SHANDONG) CO. LTD",
      "registrar": "IMEDCO DJAJA",
      "generik": false,
      "rxterm": 761,
      "dose_per_unit": 1,
      "fix_price": 113664,
      "het_price": 113664,
      "farmalkes_hscode": null,
      "tayang_lkpp": false,
      "kode_lkpp": "688495",
      "score_tkdn": 0,
      "score_bmp": 0,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": null
      },
      "atc_l1": {
        "code": "R",
        "name": "RESPIRATORY SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "R03",
        "name": "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
        "level": "2",
        "comment": null,
        "parent_code": "R"
      },
      "atc_l3": {
        "code": "R03C",
        "name": "ADRENERGICS FOR SYSTEMIC USE",
        "level": "3",
        "comment": null,
        "parent_code": "R03"
      },
      "atc_l4": {
        "code": "R03CC",
        "name": "Selective beta-2-adrenoreceptor agonists",
        "level": "4",
        "comment": null,
        "parent_code": "R03C"
      },
      "atc_l5": {
        "code": "R03CC02",
        "name": "Salbutamol",
        "level": "5",
        "comment": null,
        "parent_code": "R03CC"
      },
      "description": "<p>Bahan aktif obat adalah salbutamol sulfate. Berat molekul salbutamol sulphate 576,7 dengan formula empiris (C13H21NO3)2.H2SO4. Salbutamol sulphate merupakan serbuk kristalin berwarna putih hingga putih gading. Bahan ini larut di air dan agak larut dalam etanol. Aerosol inhalasi salbutamol (bebas CFC) merupakan unit aerosol dosis terukur bertekanan untuk inhalasi oral. Produk ini mengandung suspensi mikrokristalin salbutamol sulphate dalam propelan HFA-134a (1,1,1,2-Tetrafluoroethane), ethanol, and oleic acid. Setiap dosis mengandung 120 mcg salbutamol sulphate setara dengan 100 mcg salbutamol. Setiap canister berisi 200 dosis. Disarankan untuk menyemprotkan ke udara sebanyak 4 kalo sebelum menggunakan alat ini untuk pertama kali dan bila alat ini sudah tidak digunakan selama lebih dari 2 minggu.</p><p>Produk ini tidak mengundang chlorofluorocarbon (CFC) sebagai propelan.</p>",
      "indication": "<p>Untuk penanganan bronkospasma dalam pasien dengan penyakit obstruksi saluran nafas yang reversible. Bentuk inhaler dapat digunakan untuk serangan dipsnea akut.<br><br></p><p>Dosis dan Aturan Pakai :</p><p>Dewasa :</p><ul><li><p>1 hingga 2 inhalasi sebagai dosis tunggal untuk bronkospasma akut.</p></li><li><p>2 inhalasi dalam 3 atau 4 kali sehari untuk pemeliharaan atau profilaksis</p></li></ul><p><br></p><p>Anak-anak :</p><ul><li><p>1 inhalasi untuk bronkospasma akut</p></li><li><p>1 inhalasi dalam 3 atau 4 kali sehari untuk <span style=\"color: rgb(0, 0, 0); font-size: inherit; font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit; text-align: inherit;\">pemeliharaan atau profilaksis (dosis dapat ditingkatkan hingga 2 inhalasi jika diperlukan)</span></p></li></ul>",
      "warning": "<ul><li><p>Salbutamol harus digunakan dengan perhatian pada pasien dengan penyakit kardiovaskular, hipertiroid, diabetes mellitus, dan pasien dengan kelainan konvulasi</p></li><li><p>Ketika efektivitas dosis yang biasa digunakan berkurang atau waktu kerja obat berkurang, dilarang meningkatkan dosis atau frekuensi penggunaan, segera hubungi dokter.</p></li><li><p>Penggunaan pada wanita hamil atau menyusui. tidak direkomendasikan.</p></li><li><p>Potensi hipokalemia serius telah dilaporkan pada pasien yang menggunakan terapi beta 2-antagonis. Hipokalemia juga dapat muncul pada pasien dengan hipoksia dan pasien yang diterapi dengan turunan xantin, steroid, diuretic dan penggunaan laksatif jangka panjang. Penggunaan terap beta 2-antagonis harus diperhatikan pada pasien tersebut dan tingkat serum potassium harus diawasi.</p></li></ul>",
      "side_effect": "<p>Gugup, tremor, mual, pusing, palpitasi, takikardia, tekanan darah tinggi. </p><p>Urticaria, angioedema, orofaringeal edema jarang terjadi setelah inhalasi.</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002880",
          "name": "Salbutamol 100 mcg Cairan Inhalasi",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKI1745700139A1",
          "name": "SALBULIN",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/688495?lang=id&type=province",
          "code": "688495",
          "name": "Salbutamol Sulphate Inhaler",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 1,
          "name": "Dus isi 1",
          "uom_id": "Canister",
          "kfa_code": "94003341",
          "pack_price": 113664
        }
      ],
      "product_template": {
        "name": "Salbutamol 100 mcg Cairan Inhalasi",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000327",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Salbutamol 100 mcg Cairan Inhalasi"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000326",
          "zat_aktif": "SALBUTAMOL",
          "updated_at": "2022-07-05 12:39:50",
          "kekuatan_zat_aktif": "100 ug"
        }
      ],
      "dosage_usage": [
        {
          "qty": 100,
          "name": "Dewasa: 100 - 200 mcg; 1 - 1 kali tiap 1 False; selama 1 - 1 hari",
          "period": 1,
          "qty_uom": "mcg",
          "category": "adult",
          "duration": 1,
          "qty_high": 200,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 1,
          "updated_at": "2022-12-13 04:11:52",
          "period_ucum": null,
          "display_name": "Dewasa: 100 - 200 mcg; 1 - 1 kali tiap 1 False; selama 1 - 1 hari",
          "duration_max": 1,
          "duration_ucum": "hari",
          "frequency_max": 1,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93001541",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Salbutamol Sulfate 2 mg/5 mL Sirup (IMFARMIND FARMASI INDUSTRI)",
      "kfa_code": "93001541",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2025-01-17 03:58:55",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milliliter",
        "cs_code": "mL"
      },
      "uom": {
        "name": "Botol"
      },
      "dosage_form": {
        "code": "BS055",
        "name": "Sirup"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL1909611737A1",
      "nama_dagang": "SALBUTAMOL SULFATE",
      "manufacturer": "IMFARMIND FARMASI INDUSTRI",
      "registrar": "IMFARMIND FARMASI INDUSTRI",
      "generik": true,
      "rxterm": 761,
      "dose_per_unit": 12,
      "fix_price": 19335,
      "het_price": 19335,
      "farmalkes_hscode": null,
      "tayang_lkpp": true,
      "kode_lkpp": "1480562",
      "score_tkdn": 34.5,
      "score_bmp": 0,
      "score_tkdn_bmp": 34.5,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": 60,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "12 mg - O"
      },
      "atc_l1": {
        "code": "R",
        "name": "RESPIRATORY SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "R03",
        "name": "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
        "level": "2",
        "comment": null,
        "parent_code": "R"
      },
      "atc_l3": {
        "code": "R03C",
        "name": "ADRENERGICS FOR SYSTEMIC USE",
        "level": "3",
        "comment": null,
        "parent_code": "R03"
      },
      "atc_l4": {
        "code": "R03CC",
        "name": "Selective beta-2-adrenoreceptor agonists",
        "level": "4",
        "comment": null,
        "parent_code": "R03C"
      },
      "atc_l5": {
        "code": "R03CC02",
        "name": "Salbutamol",
        "level": "5",
        "comment": null,
        "parent_code": "R03CC"
      },
      "description": "<p><span style='color: rgb(24, 27, 30); font-family: \"Open Sans\", sans-serif; font-size: 16px; text-align: justify;'> </span><br></p>",
      "indication": "<p><span style='color: rgb(24, 27, 30); font-family: \"Open Sans\", sans-serif; text-align: justify;'><br></span></p>",
      "warning": "<p style='margin-bottom: 1em; padding: 0px; font-size: 16px; line-height: 1.5rem; color: rgb(24, 27, 30); font-family: \"Open Sans\", sans-serif; text-align: justify;'><em style=\"margin: 0px; padding: 0px;\"><br></em></p>",
      "side_effect": "<p><span style='color: rgb(24, 27, 30); font-family: \"Open Sans\", sans-serif; font-size: 16px; text-align: justify;'> </span><br></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93001541",
          "name": "Salbutamol 2 mg / 5 mL Sirup",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL1909611737A1",
          "name": "SALBUTAMOL SULFATE",
          "source_name": "NIE BPOM"
        },
        {
          "url": "https://e-katalog.lkpp.go.id/katalog/produk/detail/1480562?lang=id&type=province",
          "code": "1480562",
          "name": "Salbutamol sulfate/ Salbutamol sir 2 mg/5 mL\t",
          "source_name": "LKPP"
        }
      ],
      "packaging_ids": [
        {
          "qty": 50,
          "name": "Botol isi 50",
          "uom_id": "Botol",
          "kfa_code": "94029708",
          "pack_price": 0
        }
      ],
      "product_template": {
        "name": "Salbutamol Sulfate 2 mg/5 mL Sirup",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000885",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Salbutamol Sulfate 2 mg/5 mL Sirup"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000326",
          "zat_aktif": "SALBUTAMOL",
          "updated_at": "2022-08-01 17:22:46",
          "kekuatan_zat_aktif": "2 mg/5 mL"
        }
      ],
      "dosage_usage": [
        {
          "qty": 2.5,
          "name": "Anak: 2.5 - 5 mL; 3 - 4 kali tiap 1 per hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-19 01:35:38",
          "period_ucum": "per hari",
          "display_name": "Anak: 2.5 - 5 mL; 3 - 4 kali tiap 1 per hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Anak: 5.0 mL; 3 - 4 kali tiap 1 per hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "child",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-19 01:35:38",
          "period_ucum": "per hari",
          "display_name": "Anak: 5.0 mL; 3 - 4 kali tiap 1 per hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Dewasa: 5 - 7.5 mL; 3 - 4 kali tiap 1 per hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "adult",
          "duration": 0,
          "qty_high": 7.5,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-19 01:35:38",
          "period_ucum": "per hari",
          "display_name": "Dewasa: 5 - 7.5 mL; 3 - 4 kali tiap 1 per hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        },
        {
          "qty": 5,
          "name": "Lainnya: 5.0 mL; 3 - 4 kali tiap 1 per hari",
          "period": 1,
          "qty_uom": "mL",
          "category": "other",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2022-10-19 01:35:38",
          "period_ucum": "per hari",
          "display_name": "Lainnya: 5.0 mL; 3 - 4 kali tiap 1 per hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 4,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002166",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Vildagliptin 50 mg / Metformin 850 mg Tablet Salut Selaput (GALVUSMET)",
      "kfa_code": "93002166",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2024-10-09 07:17:15",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS077",
        "name": "Tablet Salut Selaput"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL1930413117B1",
      "nama_dagang": "GALVUSMET",
      "manufacturer": "NOVARTIS PHARMA PRODUKTIONS GMBH",
      "registrar": "NOVARTIS INDONESIA",
      "generik": false,
      "rxterm": 13438,
      "dose_per_unit": 1,
      "fix_price": 11034.5,
      "het_price": 11034.5,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": null
      },
      "atc_l1": {
        "code": "A",
        "name": "ALIMENTARY TRACT AND METABOLISM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "A10",
        "name": "DRUGS USED IN DIABETES",
        "level": "2",
        "comment": null,
        "parent_code": "A"
      },
      "atc_l3": {
        "code": "A10B",
        "name": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
        "level": "3",
        "comment": null,
        "parent_code": "A10"
      },
      "atc_l4": {
        "code": "A10BD",
        "name": "Combinations of oral blood glucose lowering drugs",
        "level": "4",
        "comment": null,
        "parent_code": "A10B"
      },
      "atc_l5": {
        "code": "A10BD08",
        "name": "Metformin and vildagliptin",
        "level": "5",
        "comment": null,
        "parent_code": "A10BD"
      },
      "description": "<p><span style=\"caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: medium; -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\">50 mg/850 mg: yellow, ovaloid beveled edge, film-coated tablet imprinted with \"NVR\" on one side and \"SEH\" on the other side.</span><br></p>",
      "indication": "<h2 style=\"text-indent: 0cm; margin-left: 0cm;\"><span lang=\"EN-GB\">Indications<p></p></span></h2><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Galvusmet is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes mellitus </span><span lang=\"EN-GB\" style=\"font-family: Sabon, serif; font-size: 11pt;\">(T2DM)</span><span lang=\"EN-GB\"> whose diabetes is not adequately controlled on metformin hydrochloride or vildagliptin alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets.</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Galvusmet is also indicated for use in combination with insulin, when maximal tolerated dose of insulin with maximal tolerated dose of metformin as an adjunct to diet and exercise do not provide adequate glycaemic control.</span><br><br><span lang=\"EN-GB\"></span></p><p></p><p></p><h2 style=\"text-indent: 0cm; margin-left: 0cm;\"><span lang=\"EN-GB\">Dosage and administration</span><span lang=\"EN-US\"><p></p></span></h2><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin: 12pt 0cm 3pt 3cm; font-size: medium; text-indent: -3cm; break-after: avoid; font-weight: bold; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Dosage</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">The use of antihyperglycemic therapy in the management of type 2 diabetes should be individualized on the basis of effectiveness and tolerability. When using Galvusmet, do not exceed the maximum daily dose of vildagliptin (100 mg).</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-GB\">The recommended starting dose of Galvusmet should be based on the patient’s condition and/or current regimen of vildagliptin and/or metformin hydrochloride.</span><span lang=\"EN-US\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 12pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-GB\">Starting dose for patients inadequately controlled on vildagliptin and metformin monotherapy</span><span lang=\"EN-US\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Based on the patient’s current dose of metformin, Galvusmet may be initiated at either the 50 mg/500 mg, 50 mg/850 mg or 50 mg/1000 mg tablet strength twice daily, one tablet in the morning and the other in the evening. The recommended daily dose is 100 mg vildagliptin plus 2000 mg metformin hydrochloride. </span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 12pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-GB\">Starting dose for patients switching from combination therapy of vildagliptin plus metformin hydrochloride as separate tablets</span><span lang=\"EN-US\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Patients receiving vildagliptin and metformin from separate tablets may be switched to Galvusmet containing the same doses of each component.</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 12pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Use in combination with insulin: </span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-GB\">The dose of Galvusmet should provide vildagliptin dosed as 50 mg twice daily (100 mg total daily dose) and a dose of metformin similar to the dose already being taken</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Doses higher than 100 mg of vildagliptin are not recommended.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 12pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">General target population</span><span class=\"CommentChar\" style='font-family: \"MS Mincho\"; color: rgb(191, 48, 181); font-style: italic;'><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Adults 18 years of age and above</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-GB\"></span></p><p> </p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Special populations</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Renal impairment</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">GFR should be assessed before initiation of treatment with metformin-containing products (such as Galvusmet) and at least annually thereafter. In patients at increased risk of further progression of renal impairment and in the elderly, renal function should be assessed more frequently, e.g. every 3 to 6 months.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">The maximum daily dose of metformin should preferably be divided into 2 to 3 daily doses. Factors that may increase the risk of lactic acidosis (see section Warnings and precautions) should be reviewed before considering initiation of metformin-containing products (such as Galvusmet) in patients with GFR &lt; 60 ml/min. Galvusmet is contraindicated in patients with GFR &lt; 30 ml/min because of its metformin component (see section Contraindications).</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">The following dosing recommendations apply to metformin and vildagliptin, used separately or in combination, in patients with renal impairment. If no adequate strength of Galvusmet is available, individual components should be used instead of the fixed dose combination.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 12pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\" style=\"font-family: Arial, sans-serif;\">Table 1 Dose adjustments in patients with renal impairment</span></p><p></p><p></p><div align=\"center\" style=\"caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><table class=\"MsoNormalTable\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"463\" style=\"border: none;\"><tbody><tr style=\"height: 13.85pt;\"><td width=\"70\" valign=\"top\" style=\"width: 52.15pt; border: 1pt solid windowtext; padding: 0cm 5.4pt; height: 13.85pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\">GFR ml/min</span><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\"></span></p><p></p><p></p></td><td width=\"249\" valign=\"top\" style=\"width: 187pt; border-top-width: 1pt; border-right-width: 1pt; border-bottom-width: 1pt; border-style: solid solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-bottom-color: windowtext; padding: 0cm 5.4pt; height: 13.85pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\">Metformin</span><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\"></span></p><p></p><p></p></td><td width=\"144\" valign=\"top\" style=\"width: 108.25pt; border-top-width: 1pt; border-right-width: 1pt; border-bottom-width: 1pt; border-style: solid solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-bottom-color: windowtext; padding: 0cm 5.4pt; height: 13.85pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\">Vildagliptin</span><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\"></span></p><p></p><p></p></td></tr><tr style=\"height: 36.65pt;\"><td width=\"70\" valign=\"top\" style=\"width: 52.15pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt; height: 36.65pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN-US\">60‑89</span><span lang=\"EN\"></span></p><p></p><p></p></td><td width=\"249\" valign=\"top\" style=\"width: 187pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 36.65pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\">Maximum daily dose is 3000 mg*</span><span lang=\"EN-US\">.</span><span lang=\"EN\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\">Dose reduction may be considered if renal function declines.</span><span lang=\"EN\"></span></p><p></p><p></p></td><td width=\"144\" valign=\"top\" style=\"width: 108.25pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 36.65pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN-US\" style=\"color: rgb(51, 51, 51);\">Maximal daily dose is 100 mg.</span><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\"></span></p><p></p><p></p></td></tr><tr style=\"height: 25.6pt;\"><td width=\"70\" valign=\"top\" style=\"width: 52.15pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt; height: 25.6pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN-US\">45‑59</span><span lang=\"EN\"></span></p><p></p><p></p></td><td width=\"249\" valign=\"top\" style=\"width: 187pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 25.6pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"NL\">Starting</span><span lang=\"EN-US\"> dose is 500 mg or 750 mg with a </span><span lang=\"EN\">maximum daily dose of </span><span lang=\"EN-US\">1000 mg*.</span><span lang=\"EN-US\"></span></p><p></p><p></p></td><td width=\"144\" rowspan=\"3\" valign=\"top\" style=\"width: 108.25pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 25.6pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"NL\">Maximal daily dose is 50 mg.</span><span lang=\"EN\" style=\"color: rgb(51, 51, 51);\"></span></p><p></p><p></p></td></tr><tr style=\"height: 25.6pt;\"><td width=\"70\" valign=\"top\" style=\"width: 52.15pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt; height: 25.6pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\">30‑44</span><span lang=\"EN-US\"></span></p><p></p><p></p></td><td width=\"249\" valign=\"top\" style=\"width: 187pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 25.6pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"NL\">It is not recommended to initiate metformin, but metformin can be maintained in patients already treated </span><span lang=\"EN-US\">with a </span><span lang=\"EN\">maximum daily dose of 1000 mg.</span><span lang=\"NL\"></span></p><p></p><p></p></td></tr><tr style=\"height: 25.6pt;\"><td width=\"70\" valign=\"top\" style=\"width: 52.15pt; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt; height: 25.6pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\">&lt;30</span></p><p></p><p></p></td><td width=\"249\" valign=\"top\" style=\"width: 187pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 25.6pt;\"><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 2pt 0cm 0cm; font-size: 12pt; break-after: avoid;'><span lang=\"EN\">Metformin is contraindicated.</span><span lang=\"NL\"></span></p><p></p><p></p></td></tr></tbody></table></div><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\" style=\"font-size: 11pt;\">*if metformin doses higher than those achievable with Galvusmet alone are considered necessary.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 12pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Hepatic impairment</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Galvusmet should not be used in patients with hepatic impairment, including those with pre-treatment alanine aminotransferase (ALT) or aspartate aminotransferase (AST) &gt; 3 times the upper limit of normal (ULN).<i></i></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 12pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Geriatric patients (≥ 65 years)</span><span lang=\"EN-US\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">As metformin is excreted via the kidneys, and elderly patients tend to exhibit decreased renal function, elderly patients taking metformin-containing products (such as Galvusmet) should have their renal function monitored regularly (see section Warnings and precautions). Galvusmet has not been studied in patients older than 75 years. Therefore the use of Galvusmet is not recommended in this population.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 12pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Paediatric patients (&lt; 18 years)</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Galvusmet is not recommended for use in children and adolescents due to a lack of data on safety and efficacy.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin: 12pt 0cm 3pt 3cm; font-size: medium; text-indent: -3cm; break-after: avoid; font-weight: bold; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Method of administration</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">For oral use</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Galvusmet should be given with meals to reduce the gastrointestinal side effects associated with metformin hydrochloride.</span></p><p></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">If a dose of Galvusmet is missed, it should be taken as soon as the patient remembers. A double dose should not be taken on the same day.</span></p>",
      "warning": "<p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\" style=\"font-size: 14pt;\">Warnings and precautions </span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><i><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Galvusmet</span></i></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Galvusmet is not a substitute for insulin in patients requiring insulin.  Galvusmet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. </span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><i><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Vildagliptin</span></i></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; margin-bottom: 3pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Skin disorders</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Skin lesions, including blistering and ulceration have been reported with vildagliptin in extremities of monkeys in non-clinical toxicology studies. Although skin lesions were not observed at an increased incidence in clinical trials, there was limited experience in patients with diabetic skin complications. Therefore, in keeping with routine care of the diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin-left: 84.95pt; font-size: medium; text-indent: -84.95pt; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Hepatic impairment</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">A small numerical imbalance of reports of generally asymptomatic elevated transaminases was reported in patients treated with vildagliptin 100 mg daily in controlled clinical trials (see Adverse drug reactions). Therefore, as per routine clinical practice, it is recommended that liver function tests be performed prior to the initiation of treatment with vildagliptin and periodically thereafter. Patients who develop increased transaminase levels should be monitored with a second liver function evaluation to confirm the finding and be followed up thereafter with frequent liver function tests until the abnormality/abnormalities return to normal. Should an increase in AST or ALT of 3x the ULN or greater persist, withdrawal of therapy with vildagliptin is recommended.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Patients with hepatic impairment should not be treated with Galvusmet.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Heart Failure</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-bottom: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">A clinical study of vildagliptin in patients with New York Heart Association (NYHA) functional class I-III showed that treatment with vildagliptin was not associated with a change in left-ventricular function or worsening of pre-existing congestive heart failure (CHF) versus placebo. Clinical experience in patients with NYHA functional class III treated with vildagliptin is still limited and results are inconclusive (see section Clinical studies).</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">There is no experience of vildagliptin use in clinical studies in patients with NYHA functional class IV and therefore use is not recommended in these patients.</span><span lang=\"EN-US\" style=\"font-size: 9.5pt;\"></span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><i><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Metformin Hydrochloride</span></i></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin-top: 6pt; margin-left: 84.95pt; font-size: medium; text-indent: -84.95pt; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><a name=\"_Toc49930644\"></a><a name=\"_Toc49930991\"></a><a name=\"_Toc49932306\"></a><a name=\"_Toc50284649\"></a><a name=\"_Toc50284943\"></a><a name=\"_Toc50284995\"></a><a name=\"_Toc50285039\"></a><a name=\"_Toc50359291\"></a><a name=\"_Toc50362093\"></a><a name=\"_Toc50362129\"></a><a name=\"_Toc50362188\"></a><a name=\"_Toc50363650\"></a><a name=\"_Toc50363711\"></a><a name=\"_Toc50363745\"></a><a name=\"_Toc50884884\"></a><a name=\"_Toc50884912\"></a><a name=\"_Toc50884940\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Lactic Acidosis</span></a></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span class=\"TextChar\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Lactic acidosis is a very rare but serious metabolic complication that most often occurs with acute worsening of renal function, or cardiorespiratory illness or sepsis. Metformin accumulation occurs with acute worsening of renal function and increases the risk of lactic acidosis. </span></span><span lang=\"EN-GB\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-GB\">In case of dehydration (e.g. due to severe diarrhea or vomiting, fever or reduced fluid intake), the patient should stop taking metformin-containing products (such as Galvusmet) and seek immediate medical attention.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-GB\">Medicinal products that can acutely impair renal function (such as antihypertensives, diuretics and NSAIDs) should be initiated with caution in patients treated with metformin-containing products (such as Galvusmet). Other risk factors for lactic acidosis are excessive alcohol intake, hepatic impairment, inadequately controlled diabetes, ketosis, prolonged fasting and any conditions associated with hypoxia, as well as concomitant use of medicinal products that may cause lactic acidosis (see section Contraindications and section Interactions). </span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><i><span lang=\"EN-GB\">Diagnosis of lactic acidosis</span></i></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Patients and/or caregivers should be informed of the risk of lactic acidosis. Lactic acidosis is characterised by acidotic dyspnoea, abdominal pain, muscle cramps, asthenia and hypothermia followed by coma. If suspected symptoms occur, the patient should stop taking metformin – containing products (such as Galvusmet) and seek immediate medical attention. Diagnostic laboratory findings are decreased blood pH</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">(&lt; 7.35), increased plasma lactate levels (&gt;5 mmol/L) and an increased anion gap and lactate/pyruvate ratio. If metabolic acidosis is suspected, treatment with metformin-containing products (such as Galvusmet) should be discontinued and the patient should be immediately hospitalised (see section Overdosage)</span><span lang=\"EN-GB\">.</span><span lang=\"EN-GB\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 12pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Cardiac failure</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Metformin is contraindicated in patients with heart failure, therefore Galvusmet is contraindicated in this patient population (see section Contraindications).</span><span lang=\"EN-US\"></span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 12pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Monitoring of renal function</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">GFR should be assessed before treatment initiation and regularly thereafter (see section Dosing regimen and administration). Metformin-containing products (such as Galvusmet) are contraindicated in patients with GFR &lt; 30 ml/min and should be temporarily discontinued in the presence of conditions that alter renal function (see section Contraindications).</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Metformin hydrochloride is known to be substantially excreted by the kidneys, and the risk of metformin hydrochloride accumulation and lactic acidosis increases with the degree of renal function impairment. Since advancing age is associated with reduced renal function, metformin-containing products (such as Galvusmet) should be carefully titrated in the elderly to establish the minimum dose for adequate glycemic effect, and renal function should be monitored regularly (see section Dosage regimen and administration and section Contraindications).</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Renal impairment in elderly patients is frequent and asymptomatic. Special caution should be exercised in situations where renal function may become impaired, for example when initiating antihypertensive or diuretic therapy or when starting treatment with an NSAID.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin-left: 0cm; font-size: medium; text-indent: 0cm; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Interactions</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin-top: 6pt; margin-left: 0cm; font-size: medium; text-indent: 0cm; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Concomitant medications that may affect renal function or metformin hydrochloride disposition</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Concomitant medications that may affect renal function, result in significant haemodynamic change or interfere with the disposition of metformin hydrochloride, such as cationic drugs that are eliminated by renal tubular secretion should be used with caution (see section Interactions).</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin-left: 0cm; font-size: medium; text-indent: 0cm; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Administration of intravascular iodinated contrast materials<i></i></span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Intravascular administration of iodinated contrast agents may lead to contrast-induced nephropathy, resulting in metformin accumulation and increased risk of lactic acidosis. Metformin-containing products (such as Galvusmet) should be discontinued prior to or at the time of the imaging procedure and not restarted until 48 hours subsequent to the procedure and reinstituted only after renal function has been re-evaluated and found to be stable (see section Dosage regimen and administration and section Interactions).</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin-left: 0cm; font-size: medium; text-indent: 0cm; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Hypoxic states  </span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Cardiovascular collapse (shock), acute congestive heart failure, acute myocardial infarction and other conditions characterized by hypoxaemia have been associated with lactic acidosis and may also cause prerenal azotmeia. If such events occur in patients receiving metformin-containing products (such as Galvusmet), the medication should be promptly discontinued.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\" style=\"font-size: 11pt;\"></span></p><p> </p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-bottom: 3pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Surgical procedures</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Metformin-containing products (such as Galvusmet) must be discontinued at the time of surgery under general, spinal or epidural anaesthesia (except minor procedures not associated with restricted intake of food and fluids) and may be restarted no earlier than 48 hours following surgery or until the patient’s oral nutrition has resumed and renal function has been re-evaluated and found to be stable.  </span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Alcohol intake</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Alcohol is known to potentiate the effect of metformin hydrochloride on lactate metabolism.  Patients should be warned against excessive alcohol intake while receiving metformin-containing products (such as Galvusmet).</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Alcohol intoxication is associated with an increased risk of lactic acidosis, particularly in cases of fasting, malnutrition or hepatic impairment.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Patients with hepatic impairment</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Since impaired hepatic function has been associated with some cases of lactic acidosis, a risk associated with metformin hydrochloride, metformin-containing products (such as Galvusmet) should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Vitamin B<span style=\"position: relative; font-size: 12px; line-height: 0; vertical-align: baseline; bottom: -0.25em;\">12</span> levels</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Metformin has been associated with a decrease in serum vitamin B<span style=\"position: relative; font-size: 12px; line-height: 0; vertical-align: baseline; bottom: -0.25em;\">12 </span>levels without clinical manifestations, in approximately 7% of patients. Such a decrease, is very rarely associated with anaemia and appears to be rapidly reversible with discontinuation of metformin hydrochloride and/or vitamin B<span style=\"position: relative; font-size: 12px; line-height: 0; vertical-align: baseline; bottom: -0.25em;\">12</span> supplementation.  Measurement of haematological parameters on at least an annual basis is advised for patients receiving metformin-containing products (such as Galvusmet) and any apparent abnormalities should be appropriately investigated and managed. Certain individuals (e.g., those with inadequate vitamin B<span style=\"position: relative; font-size: 12px; line-height: 0; vertical-align: baseline; bottom: -0.25em;\">12</span> or calcium intake or absorption) appear to be predisposed to developing subnormal vitamin B<span style=\"position: relative; font-size: 12px; line-height: 0; vertical-align: baseline; bottom: -0.25em;\">12</span> levels. In these patients, routine serum vitamin B<span style=\"position: relative; font-size: 12px; line-height: 0; vertical-align: baseline; bottom: -0.25em;\">12</span> measurements at minimally two-to-three-year intervals may be useful.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Change in clinical status of patients with previously controlled type 2 diabetes</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">A patient with type 2 diabetes previously well-controlled on Galvusmet who develops laboratory abnormalities or clinical illness (especially vague and poorly defined illness) should promptly be evaluated for ketoacidosis and/or lactic acidosis. If acidosis of either form occurs, Galvusmet must be stopped immediately and appropriate measures initiated.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Hypoglycaemia</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Hypoglycaemia does not usually occur in patients receiving Galvusmet alone, but could occur when caloric intake is deficient, when strenuous exercise is not compensated by caloric supplementation, or ethanol use. Elderly, debilitated or malnourished patients and those with adrenal or pituitary insufficiency or alcohol intoxication are susceptible to hypoglycaemic effects. Hypoglycaemia may be difficult to recognize in the elderly and in people taking beta-adrenergic blocking drugs. </span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Loss of control of blood glucose</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin-top: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">When a patient stabilized on any diabetic regimen is exposed to stress such as fever, trauma, infection, surgery, etc., a temporary loss of glycaemic control may occur. At such times, it may be necessary to withhold Galvusmet and temporarily administer insulin. Galvusmet may be reinstituted after the acute episode is resolved.</span></p>",
      "side_effect": "<p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\" style=\"font-size: 14pt;\">Adverse drug reactions</span></p><p></p><p></p><h2 style=\"margin-bottom: 6pt;\"><span lang=\"EN-US\" style='font-family: \"Times New Roman\", serif; font-size: 12pt;'>Summary of the safety profile</span><span lang=\"EN-US\" style='font-family: \"Times New Roman\", serif; font-size: 12pt;'><p></p></span></h2><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin: 6pt 0cm 3pt 84.95pt; font-size: medium; text-indent: -84.95pt; break-after: avoid; font-weight: bold; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><i><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Galvusmet</span></i></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">There have been no therapeutic clinical trials conducted with </span><span lang=\"EN-GB\">Galvusmet</span><span lang=\"EN-GB\">. However, bioequivalence of </span><span lang=\"EN-GB\">Galvusmet</span><span lang=\"EN-GB\"> with co-administered vildagliptin and metformin has been demonstrated (see section Pharmacokinetics properties). The data presented here relate to the co-administration of vildagliptin and metformin, where vildagliptin has been added to metformin. There have been no studies of metformin added to vildagliptin.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">The majority of adverse reactions were mild and transient, not requiring treatment discontinuations. No association was found between adverse reactions and age, ethnicity, duration of exposure or daily dose. Rare cases of angioedema have been reported on vildagliptin at a similar rate to controls. A greater proportion of cases were reported when vildagliptin was administered in combination with an ACE inhibitor. The majority of events were mild in severity and resolved with ongoing vildagliptin treatment</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">In comparative controlled add-on therapy studies, the incidence of hypoglycaemia in patients receiving vildagliptin in combination with metformin was 0.9% and 0.4% in patients receiving placebo and metformin.</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Gastrointestinal adverse reactions including diarrhoea and nausea are known to occur very commonly during the introduction of metformin hydrochloride. In the vildagliptin clinical program (n =2,264) the rate of diarrhoea and nausea was 2.5% and 2.6 % respectively as compared to2.9% for both in the placebo group (n = 347) and 26.2% and 10.3%, respectively, in the metformin hydrochloride group (n = 252).</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Overall, gastrointestinal symptoms were reported in 12.9% of patients treated with the combination of vildagliptin and metformin hydrochloride compared to 18.1% of patients treated with metformin hydrochloride alone.</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\"></span></p><p> </p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm 0cm 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Tabulated summary of adverse drug reactions from clinical trials</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Adverse reactions reported in patients who received vildagliptin in double-blind studies as an add-on to metformin and as monotherapy, are listed below, for each indication, by MedDRA system organ class and absolute frequency. Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention (CIOMS III): very common (≥1/10); common (≥1/100 to &lt;1/10); uncommon (≥1/1,000 to &lt;1/100); rare (≥1/10,000 to &lt;1/1,000); very rare</span><span lang=\"EN-US\"></span><span lang=\"EN-US\">(&lt;1/10,000).</span></p><p></p><p></p><h6 style=\"font-family: Arial, sans-serif; margin: 12pt 0cm 12pt 3cm; font-size: 11pt; text-indent: -3cm; break-after: avoid; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;\"><span lang=\"EN-GB\" style=\"font-size: 12pt;\">Table 1:             Other adverse reactions reported in patients who received vildagliptin as add-on therapy to metformin compared to placebo plus metformin in double-blind studies (N=441)<p></p></span></h6><table class=\"MsoNormalTable\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"611\" style=\"caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); text-indent: 0px; -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; margin-left: 5.4pt; border: none;\"><thead><tr><td width=\"611\" colspan=\"3\" valign=\"top\" style=\"width: 458.45pt; border-top-width: 1pt; border-right-width: 1pt; border-left-width: 1pt; border-style: solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Nervous system disorders</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"40\" valign=\"top\" style=\"width: 30pt; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Common</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Headache, tremor, dizziness</span></p><p></p><p></p></td></tr><tr><td width=\"40\" valign=\"top\" style=\"width: 30pt; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Uncommon</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Fatigue</span></p><p></p><p></p></td></tr><tr><td width=\"611\" colspan=\"3\" valign=\"top\" style=\"width: 458.45pt; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Gastrointestinal disorders</span></p><p></p><p></p></td></tr><tr><td width=\"40\" valign=\"top\" style=\"width: 30pt; border-style: none none solid solid; border-left-width: 1pt; border-left-color: windowtext; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; border-style: none none solid; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Common</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt; break-after: avoid;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Nausea</span></p><p></p><p></p></td></tr></thead></table><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\" style=\"font-size: 11pt;\"></span></p><p> </p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">In controlled clinical trials with the combination of vildagliptin 100 mg daily plus metformin, no withdrawal due to adverse reactions was reported in either the vildagliptin 100 mg daily plus metformin or the placebo plus metformin treatment groups.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">In clinical trials, weight did not change from baseline when vildagliptin 100 mg daily was added to metformin (+0.2 kg and -1.0 kg for vildagliptin and placebo, respectively).</span><span lang=\"EN-US\"></span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Long term clinical studies of up to 2 years in duration did not show any additional safety signals or unforeseen risks when vildagliptin was added on to metformin.</span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin: 12pt 0cm 3pt 3cm; font-size: medium; text-indent: -3cm; break-after: avoid; font-weight: bold; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Combination with insulin</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">In controlled clinical studies using vildagliptin 50 mg twice daily in combination with insulin, with or without concomitant metformin, the overall incidence of withdrawals due to adverse reactions was 0.3% in the vildagliptin treatment group and there were no cases of withdrawal in the placebo group.</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">The incidence of hypoglycemia was similar in both treatment groups (14.0% in the vildagliptin group vs 16.4 % in the placebo group). Two patients reported severe hypoglycemic events in the vildagliptin group, and 6 patients - in the placebo group. </span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin: 6pt 0cm 0cm; font-size: medium; text-indent: 0cm; break-after: avoid; font-weight: bold; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;\"><span lang=\"EN-US\" style='font-family: \"Times New Roman\", serif; font-weight: normal;'>At the end of the study, the effect on mean body weight was neutral (+ 0.6 kg change from baseline in the vildagliptin group and no weight change in the placebo group).</span></p><p></p><p></p><h6 style=\"font-family: Arial, sans-serif; margin: 12pt 0cm 3pt 3cm; font-size: 11pt; text-indent: -3cm; break-after: avoid; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;\"><a name=\"_Toc374988687\"><span lang=\"EN-US\" style=\"font-size: 12pt;\">Table 2              Adverse reactions reported in patients who received Galvus 50 mg twice daily in combination with insulin (with or without metformin (n=371)</span></a><span lang=\"EN-GB\" style=\"font-size: 12pt;\"><p></p></span></h6><table class=\"MsoNormalTable\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\" width=\"618\" style=\"caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); text-indent: 0px; -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><tbody><tr style=\"height: 9.85pt;\"><td width=\"618\" colspan=\"3\" valign=\"top\" style=\"width: 463.85pt; border-top-width: 1pt; border-right-width: 1pt; border-left-width: 1pt; border-style: solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-US\">Nervous system disorders</span><span lang=\"EN-GB\"></span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"47\" valign=\"top\" style=\"width: 35.4pt; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\" style=\"font-family: Arial, sans-serif;\"></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Common</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Headache </span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"618\" colspan=\"3\" valign=\"top\" style=\"width: 463.85pt; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Gastrointestinal disorders</span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"47\" valign=\"top\" style=\"width: 35.4pt; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\" style=\"font-family: Arial, sans-serif;\"></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Common</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Nausea, gastrooesophageal reflux disease </span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"47\" valign=\"top\" style=\"width: 35.4pt; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\" style=\"font-family: Arial, sans-serif;\"></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Uncommon</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Diarrhoea, flatulence </span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"618\" colspan=\"3\" valign=\"top\" style=\"width: 463.85pt; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">General disorders and administration site conditions</span><span lang=\"EN-GB\"></span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"47\" valign=\"top\" style=\"width: 35.4pt; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\" style=\"font-family: Arial, sans-serif;\"></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Common</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Chills </span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"618\" colspan=\"3\" valign=\"top\" style=\"width: 463.85pt; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Investigations</span><span lang=\"EN-GB\"></span></p><p></p><p></p></td></tr><tr style=\"height: 9.85pt;\"><td width=\"47\" valign=\"top\" style=\"width: 35.4pt; border-style: none none solid solid; border-left-width: 1pt; border-left-color: windowtext; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\" style=\"font-family: Arial, sans-serif;\"></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; border-style: none none solid; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Common</span></p><p></p><p></p></td><td width=\"443\" valign=\"top\" style=\"width: 332.45pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt; height: 9.85pt;\"><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: 12pt; text-align: justify;'><span lang=\"EN-GB\">Blood glucose decreased </span></p><p></p><p></p></td></tr></tbody></table><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin: 12pt 0cm 3pt; font-size: medium; text-indent: 0cm; break-after: avoid; font-weight: bold; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><i><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Vildagliptin</span></i></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Adverse reactions for vildagliptin component from monotherapy double blind studies are presented in Table 3.</span></p><p></p><p></p><h6 style=\"font-family: Arial, sans-serif; margin: 12pt 0cm 12pt 3cm; font-size: 11pt; text-indent: -3cm; break-after: avoid; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style=\"font-size: 12pt;\">Table 3:             Adverse reactions reported in patients who received vildagliptin as monotherapy in double-blind studies (N=2,264)<p></p></span></h6><table class=\"MsoNormalTable\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" style=\"caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); text-indent: 0px; -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; margin-left: 5.4pt; border: none;\"><tbody><tr style=\"break-inside: avoid;\"><td width=\"605\" colspan=\"3\" valign=\"top\" style=\"width: 16cm; border-top-width: 1pt; border-right-width: 1pt; border-left-width: 1pt; border-style: solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Nervous system disorders</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Common</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Dizziness</span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Uncommon</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Headache</span></p><p></p><p></p></td></tr><tr style=\"break-inside: avoid;\"><td width=\"605\" colspan=\"3\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Gastrointestinal disorders</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Common</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Constipation</span></p><p></p><p></p></td></tr><tr style=\"break-inside: avoid;\"><td width=\"605\" colspan=\"3\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Musculoskeletal and connective tissue disorders</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Common</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Arthralgia</span></p><p></p><p></p></td></tr><tr><td width=\"605\" colspan=\"3\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Infections and infestations</span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Very rare</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Upper respiratory tract infection, nasopharyngitis</span></p><p></p><p></p></td></tr><tr><td width=\"605\" colspan=\"3\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Vascular disorders</span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none solid solid; border-left-width: 1pt; border-left-color: windowtext; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" valign=\"top\" style=\"width: 99.25pt; border-style: none none solid; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Uncommon</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Oedema peripheral</span></p><p></p><p></p></td></tr></tbody></table><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\"></span></p><p> </p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">None of the adverse reactions reported for the vildagliptin monotherapy were observed at clinically significantly higher rates when vildagliptin was administered concomitantly with metformin. </span><span lang=\"EN-GB\">In comparative controlled monotherapy studies,hypoglycaemia was uncommon in patients receiving vildagliptin as monotherapy (0.4%) and in patients receiving metformin hydrochloride (0.4%). </span><span lang=\"EN-US\">Vildagliptin is weight neutral when administered as monotherapy or in combination with metformin.</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">In controlled monotherapy trials of up to one year in duration, the incidence of ALT or AST elevations &gt;3 X ULN (classified as present on at least 2 consecutive measurements or at the final on-treatment visit) was 0.3%, 0.9 % and 0.3% for vildagliptin 50 mg once daily, vildagliptin 100 mg daily (administered as single and divided doses) and placebo respectively. These elevations in transaminases were generally asymptomatic, non-progressive in nature and not associated with cholestasis or jaundice.</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm 0cm 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">In clinical trials, weight did not change from baseline when vildagliptin 100 mg daily was administered as monotherapy (-0.3 kg and -1.3 kg for vildagliptin and placebo, respectively).</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\">Long term clinical studies of up to 2 years did not show any additional safety signals or unforeseen risks with vildagliptin monotherapy.</span></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\"></span></p><p> </p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm 0cm 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Adverse drug reactions from spontaneous reports and literature cases - post-marketing experience (frequency not known)</span></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">The following adverse drug reactions have been derived from post-marketing experience with Galvusmet via spontaneous case reports and literature cases. Because these reactions are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency, which is therefore categorized as not known.</span><span lang=\"EN-US\"></span></p><p></p><p></p><ul type=\"disc\" style=\"margin-top: 0cm; margin-bottom: 0cm; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><li class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-US\">Hepatitis reversible upon drug discontinuation (see also section Warnings and precautions).<p></p></span></li><li class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-US\">Urticaria, </span><span lang=\"EN-GB\">bullous and exfoliative skin lesions, including bullous pemphigoid</span><span lang=\"EN-US\"><p></p></span></li><li class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-GB\">Pancreatitis</span><span lang=\"EN-US\"><p></p></span></li><li class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-US\">Arthralgia, sometimes severe<p></p></span></li></ul><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-US\"> </span><span lang=\"EN-US\"></span></p><p></p><p></p><p class=\"Nottoc-headings\" style=\"font-family: Arial, sans-serif; margin: 6pt 0cm 3pt 84.95pt; font-size: medium; text-indent: -84.95pt; break-after: avoid; font-weight: bold; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><i><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Metformin Hydrochloride</span></i></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><span lang=\"EN-GB\">Known adverse reactions for the metformin component are summarized in Table 4.</span><i><span lang=\"EN-GB\"></span></i></p><p></p><p></p><h6 style=\"font-family: Arial, sans-serif; margin: 6pt 0cm 6pt 84.95pt; font-size: 11pt; text-indent: -84.95pt; break-after: avoid; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;\"><span lang=\"EN-GB\" style=\"font-size: 12pt;\">Table 4:             Known adverse reactions for metformin<p></p></span></h6><table class=\"MsoNormalTable\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" style=\"caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); text-indent: 0px; -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; margin-left: 5.4pt; border: none;\"><tbody><tr style=\"break-inside: avoid;\"><td width=\"605\" colspan=\"5\" valign=\"top\" style=\"width: 16cm; border-top-width: 1pt; border-right-width: 1pt; border-left-width: 1pt; border-style: solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Metabolism and Nutrition disorders</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" colspan=\"3\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Very common</span></p><p></p><p></p><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Very Rare</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Decrease appetite</span></p><p></p><p></p><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt; text-align: justify;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Lactic acidosis</span></p><p></p><p></p></td></tr><tr><td width=\"605\" colspan=\"5\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Nervous system disorders</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" colspan=\"3\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Common</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Dysgeusia</span></p><p></p><p></p></td></tr><tr style=\"break-inside: avoid;\"><td width=\"605\" colspan=\"5\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Gastrointestinal disorders</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" colspan=\"3\" valign=\"top\" style=\"width: 99.25pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Very Common</span></p><p></p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Flatulence, nausea, vomiting, diarrhoea, abdominal pain</span></p><p></p><p></p><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td></tr><tr style=\"break-inside: avoid;\"><td width=\"605\" colspan=\"5\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Hepatobiliary disorders</span></p><p></p><p></p></td></tr><tr style=\"break-inside: avoid;\"><td width=\"40\" colspan=\"2\" valign=\"top\" style=\"width: 30pt; border-style: none none none solid; border-left-width: 1pt; border-left-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"128\" valign=\"top\" style=\"width: 96pt; border: none; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Very Rare</span></p><p></p><p></p></td><td width=\"437\" colspan=\"2\" valign=\"top\" style=\"width: 327.6pt; border-style: none solid none none; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Hepatitis**</span></p><p></p><p></p></td></tr><tr style=\"break-inside: avoid;\"><td width=\"605\" colspan=\"5\" valign=\"top\" style=\"width: 16cm; border-style: none solid; border-left-width: 1pt; border-left-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Skin and subcutaneous tissue disorders</span></p><p></p><p></p><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>          Very rare                 Skin reactions such as erythema, pruritus, urticarial</span></p><p></p><p></p><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Investigations</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr><td width=\"38\" valign=\"top\" style=\"width: 1cm; border-style: none none solid solid; border-left-width: 1pt; border-left-color: windowtext; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"132\" colspan=\"3\" valign=\"top\" style=\"width: 99.25pt; border-style: none none solid; border-bottom-width: 1pt; border-bottom-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Very rare</span></p><p></p><p></p><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm; font-size: 12pt;\"><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p> </p><p></p></td><td width=\"435\" valign=\"top\" style=\"width: 326pt; border-style: none solid solid none; border-bottom-width: 1pt; border-bottom-color: windowtext; border-right-width: 1pt; border-right-color: windowtext; padding: 0cm 5.4pt;\"><p class=\"Table\" style=\"font-family: Arial, sans-serif; margin: 0cm 0cm 3pt; font-size: 12pt;\"><span lang=\"EN-US\" style='font-family: \"Times New Roman\", serif;'>Decrease of vitamin B12 absorption*, </span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'>Liver function test abnormalities</span><span lang=\"EN-GB\" style='font-family: \"Times New Roman\", serif;'></span></p><p></p><p></p></td></tr><tr height=\"0\"><td width=\"38\" style=\"border: none;\"></td><td width=\"2\" style=\"border: none;\"></td><td width=\"128\" style=\"border: none;\"></td><td width=\"2\" style=\"border: none;\"></td><td width=\"435\" style=\"border: none;\"></td></tr></tbody></table><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><i><span lang=\"EN-GB\" style=\"font-size: 11pt;\">*A decrease of vitamin B12 absorption with decrease of serum levels has very rarely been observed in patients treated long-term with metformin and appears to generally not be of clinical significance. Consideration of such aetiology is recommended if a patient presents with megaloblastic anaemia.</span></i><i><span lang=\"EN-GB\" style=\"font-size: 14pt;\"></span></i></p><p></p><p></p><p class=\"Text\" style='font-family: \"Times New Roman\", serif; margin: 6pt 0cm; font-size: medium; text-align: justify; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto;'><i><span lang=\"EN-GB\" style=\"font-size: 11pt;\">**Isolated cases of liver function test abnormalities or hepatitis resolving upon metformin discontinuation have been reported.</span></i></p><p></p><p></p><p></p><p class=\"MsoNormal\" style='font-family: \"Times New Roman\", serif; margin-top: 6pt; font-size: medium; caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); -webkit-tap-highlight-color: rgba(26, 26, 26, 0.3); -webkit-text-size-adjust: auto; text-align: justify;'><span lang=\"EN-US\">Gastrointestinal adverse effects occur most frequently during initiation of therapy and resolve spontaneously in most cases. To prevent them, it is recommended that metformin be taken in 2 daily doses during or after meals. A slow increase in the dose may also improve gastrointestinal tolerability.</span></p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002166",
          "name": "VILDAGLIPTIN 50 MG/METFORMIN 500 MG KAPLET SALUT SELAPUT",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKI1467508817B1",
          "name": "GALVUSMET",
          "source_name": "NIE BPOM"
        },
        {
          "url": null,
          "code": "DKL1930413117B1",
          "name": "GALVUSMET",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Strip isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94002421",
          "pack_price": 110345
        },
        {
          "qty": 30,
          "name": "Dus isi 30",
          "uom_id": "Tablet",
          "kfa_code": "94002422",
          "pack_price": 331034
        }
      ],
      "product_template": {
        "name": "Vildagliptin 50 mg / Metformin 850 mg Tablet Salut Selaput",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001243",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Vildagliptin 50 mg / Metformin 850 mg Tablet Salut Selaput"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000209",
          "zat_aktif": "METFORMIN",
          "updated_at": "2022-10-12 05:37:05",
          "kekuatan_zat_aktif": "850 mg"
        },
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000690",
          "zat_aktif": "Vildagliptin",
          "updated_at": "2022-10-12 05:37:05",
          "kekuatan_zat_aktif": "50 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 0,
          "name": "Dewasa: 0.0 False",
          "period": 0,
          "qty_uom": null,
          "category": "adult",
          "duration": 0,
          "qty_high": 0,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 0,
          "updated_at": "2022-11-04 10:18:30",
          "period_ucum": null,
          "display_name": "Dewasa: 0.0 False",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93002767",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Nystatin 500.000 IU Tablet Salut Gula (LUCAS DJAJA)",
      "kfa_code": "93002767",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2022-10-14 08:40:56",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "internasional unit",
        "cs_code": "[IU]"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS075",
        "name": "Tablet Salut Gula"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "GKL2013614616A1",
      "nama_dagang": "NYSTATIN",
      "manufacturer": "PHAPROS Tbk",
      "registrar": "LUCAS DJAJA",
      "generik": true,
      "rxterm": 8945,
      "dose_per_unit": 1,
      "fix_price": null,
      "het_price": null,
      "farmalkes_hscode": null,
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "g",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "1.5 MU - O"
      },
      "atc_l1": {
        "code": "G",
        "name": "GENITO URINARY SYSTEM AND SEX HORMONES",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "G01",
        "name": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
        "level": "2",
        "comment": null,
        "parent_code": "G"
      },
      "atc_l3": {
        "code": "G01A",
        "name": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
        "level": "3",
        "comment": null,
        "parent_code": "G01"
      },
      "atc_l4": {
        "code": "G01AA",
        "name": "Antibiotics",
        "level": "4",
        "comment": null,
        "parent_code": "G01A"
      },
      "atc_l5": {
        "code": "G01AA01",
        "name": "Nystatin",
        "level": "5",
        "comment": null,
        "parent_code": "G01AA"
      },
      "description": "<p>KOMPOSISI :</p><p>Tiap tablet salut gula mengandung :</p><p>Nystatin 500.000 IU</p><p>CARA KERJA OBAT :</p><p>Nystatin merupakan antibiotika polien yang bersifat fungistatik dan fungisid.</p><p>Nystatin akan berikatan dengan gugus sterol pada membran sel jamur yang sensitif sehingga menyebabkan</p><p>berubahnya sifat permeabilitas membran sel tersebut, dengan akibat kerusakan fungsi perlindungan membran</p><p>tersebut.</p><p>Nystatin relatif tidak diserap melalui traktus gastrointestinalis sehingga pada pemberian per oral hampir</p><p>sebagian besar dijumpai bersama feses.</p><p>Dari jumlah sedikit yang diserap, akan diekskresi melalui ginjal.</p><p><br></p>",
      "indication": "<p><span style='font-family: \"Lucida Grande\", Helvetica, Verdana, Arial, sans-serif;'>INDIKASI :</span><br></p><p>Nystatin tablet salut gula diindikasikan untuk pengobatan kandidiasis membran mukosa saluran pencernaan</p><p>non-esofageal.</p><p><br></p><p>POSOLOGI :</p><p>Dosis lazimnya 3 x sehari 1-2 tablet salut gula. Pengobatan sebaiknya diteruskan hingga sekurang-kurangnya</p><p>48 jam setelah gejala klinis menghilang untuk menghindari kekambuhan.</p><p>Atau menurut petunjuk dokter.</p>",
      "warning": "<p>KONTRAINDIKASI :</p><p>Nystatin sebaiknya tidak digunakan terhadap pasien yang hipersensitif terhadap senyawa tersebut.</p><p><br></p><p>PERINGATAN/PERHATIAN :<br></p><p>Nystatin tablet salut gula tidak diindikasikan untuk pengobatan mikosis sistemik.</p><p>Sensitivitas terhadap Nystatin sangat jarang terjadi, tetapi apabila terjadi reaksi sensitisasi atau iritasi selama</p><p>pemakaian, sebaiknya pengobatan dihentikan.</p><p>Dapat diberikan pada wanita hamil, jika benar-benar dibutuhkan dan atas petunjuk dokter.</p><p>Belum diketahui apakah Nystatin diekskresikan melalui ASI. Oleh karena banyak obat diekskresikan melalui</p><p>ASI, perlu hati-hati apabila memberikan Nystatin kepada ibu menyusui.</p>",
      "side_effect": "<p>EFEK SAMPING :</p><p>Jarang ditemukan efek samping pada pemakaian Nystatin.</p><p>Setelah pemberian per oral, Nystatin dapat menimbulkan rasa mual, muntah dan diare.</p><p>Belum pernah terjadi resistensi secara klinis .</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93002767",
          "name": "Nystatin 500.000 IU Tablet Salut Gula",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "GKL2013614616A1",
          "name": "NYSTATIN",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Tablet",
          "kfa_code": "94003171",
          "pack_price": 232609
        }
      ],
      "product_template": {
        "name": "Nystatin 500.000 IU Tablet Salut Gula",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92000521",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Nystatin 500.000 IU Tablet Salut Gula"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000284",
          "zat_aktif": "Nystatin",
          "updated_at": "2022-07-07 13:24:58",
          "kekuatan_zat_aktif": "500000 [IU]"
        }
      ],
      "dosage_usage": [
        {
          "qty": 1,
          "name": "Dewasa: 1 - 2 Tablet; 3 kali tiap 1 hari",
          "period": 1,
          "qty_uom": "Tablet",
          "category": "adult",
          "duration": 0,
          "qty_high": 2,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 3,
          "updated_at": "2023-08-31 07:19:23",
          "period_ucum": "hari",
          "display_name": "Dewasa: 1 - 2 Tablet; 3 kali tiap 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  },

  {
    "search_code": "93003321",
    "search_identifier": "Kamus Farmalkes (KFA – IHS)",
    "result": {
      "name": "Simvastatin 10 mg Tablet Salut Selaput (SVT 10)",
      "kfa_code": "93003321",
      "active": true,
      "state": "valid",
      "image": null,
      "updated_at": "2023-08-28 07:12:24",
      "farmalkes_type": {
        "code": "medicine",
        "name": "Obat",
        "group": "farmasi"
      },
      "ucum": {
        "name": "milligram",
        "cs_code": "mg"
      },
      "uom": {
        "name": "Tablet"
      },
      "dosage_form": {
        "code": "BS077",
        "name": "Tablet Salut Selaput"
      },
      "controlled_drug": {
        "code": "3",
        "name": "Obat Keras"
      },
      "rute_pemberian": {
        "code": "O",
        "name": "Oral"
      },
      "produksi_buatan": "lokal",
      "nie": "DKL1008516217A1",
      "nama_dagang": "SVT 10",
      "manufacturer": "HEXPHARM JAYA LABORATORIES",
      "registrar": "HEXPHARM JAYA LABORATORIES",
      "generik": false,
      "rxterm": 11766,
      "dose_per_unit": 1,
      "fix_price": 0,
      "het_price": 1720,
      "farmalkes_hscode": "30049099",
      "tayang_lkpp": null,
      "kode_lkpp": null,
      "score_tkdn": null,
      "score_bmp": null,
      "score_tkdn_bmp": 0,
      "net_weight": null,
      "net_weight_uom_name": "mg",
      "volume": null,
      "volume_uom_name": "mL",
      "med_dev_jenis": null,
      "med_dev_subkategori": null,
      "med_dev_kategori": null,
      "med_dev_kelas_risiko": null,
      "klasifikasi_izin": null,
      "atc_ddd": {
        "name": "30 mg - O"
      },
      "atc_l1": {
        "code": "C",
        "name": "CARDIOVASCULAR SYSTEM",
        "level": "1",
        "comment": null,
        "parent_code": null
      },
      "atc_l2": {
        "code": "C10",
        "name": "LIPID MODIFYING AGENTS",
        "level": "2",
        "comment": null,
        "parent_code": "C"
      },
      "atc_l3": {
        "code": "C10A",
        "name": "LIPID MODIFYING AGENTS, PLAIN",
        "level": "3",
        "comment": null,
        "parent_code": "C10"
      },
      "atc_l4": {
        "code": "C10AA",
        "name": "HMG CoA reductase inhibitors",
        "level": "4",
        "comment": null,
        "parent_code": "C10A"
      },
      "atc_l5": {
        "code": "C10AA01",
        "name": "Simvastatin",
        "level": "5",
        "comment": null,
        "parent_code": "C10AA"
      },
      "description": "<p><span style='color: rgb(24, 27, 30); font-family: \"Open Sans\", sans-serif; text-align: justify;'> Simvastatin adalah suatu penurun kolesterol turunan redutase sintetik dan hasil fermentasi </span><span style=\"color: rgb(24, 27, 30); text-align: justify;\"><i>Aspergillus terreus</i>. Setelah pemberian oral, Simvastatin yang merupakan lakton tidak aktif, dihidrolisa menjadi bentuk beta asam hidroksi. Bentuk ini adalah metabolit utama dan menghambat 3-hidroksi-3-metilglutaril-koenzim A (HMG-CoA), suatu enzim yang mengkatalisa tahap ini dan tahap \"rate-limiting\" pada biosintesa kolesterol.</span><br>Hasil uji klinis menunjukkan bahwa Simvastatin dapat mengurangi konsentrasi kolesterol total plasma, konsentrasi kolesterol lipoprotein densitas rendh (LDL) dan konsentrasi kolesterol lipoprotein densitas sangan rendah (VLDL).</p><p>Simvastatin dapat meningkatkan kolesterol lipoprotein densitas tinggi (HDL) dan mengurangi trigliserida plasma.</p><p>Pada hewan percobaan, setelah pemberian oral, Simvastatin mempunyai selektivitas yang tinggi terhadap hati, sehingga konsentrasi di hati lebih tinggi daripada di jaringan lain.</p><p>Simvastatin mengalami ekstraksi awal di hati yang merupakan tempat kerja obat tersebut dan selanjutnya obat diekskresikan ke empedu.</p><p>Sebagai akibat ekstraksi hati yang luas dari SImvastatin, maka ketersediaan obat dalam sirkulas tubuh rendah.</p><p>Pada uji dosis tunggal, diperkirakan kurang dari 5% dosis oral Simvastatin mencapai sirkulasi tubuh sebagai penghambat aktif. Baik Simvastatin maupun beta asam hidroksi terikat pada protein plasma kira-kira 95%.</p>",
      "indication": "<p><span style='color: rgb(24, 27, 30); font-family: \"Open Sans\", sans-serif; text-align: justify;'>Penurunan kadar kolesterol total dan LDL pada penderita hiperkolesterolemia primer, jika respon terhadap diet dan tindakan non farmakologik lain tidak memadai.</span><br>Menurunkan kadar LDl kolesterol yang meningkat pada penderita dengan kombinasi hiperkolesterolemia dan hipertrigliseridemia dimana hiperkolesterolemia merupakan ketidaknormalan yang utama (tipe IIB hiperlipoproteinemia)</p><p>Sebelum memulai pengobatan, penyebab hiperkolesterolemia sekunder harus dihilangkan terlebih dahulu (misal : diabetes melitus tak terkontrol, hipotiroidisme, sindrom nefrotik, disproteinemia, penyakit hati obstruktif, terapi kolesterol dengan obat lain dan alkohisme), serta harus dilakukan pengukuran konsetrasi lipid total, HDL-kolesterol dan trigliserida dalam darah.</p><p><br></p>",
      "warning": "<div class=\"tab-desc m-b-30\" style=\"margin-bottom: 30px; color: rgb(83, 83, 83); font-family: GothamRounded, sans-serif; font-size: 12px;\"><ul><li><h6 style=\"font-weight: 500; font-size: 12px; font-family: GothamRounded, sans-serif;\">Setelah pengobatan dimulai akan terdapat sedikit peningkatan transaminase serum yang bersifat sementara, sehingga pemberian obat tidak perlu dihentikan.</h6></li><li><h6 style=\"font-weight: 500; font-size: 12px; font-family: GothamRounded, sans-serif;\">Pemeriksaan fungsi hati sebaiknya dilakukan sebelum pengobatan dimulai dan dilakukan secara periodik untuk semua penderita</h6></li><li><h6 style=\"font-weight: 500; font-size: 12px; font-family: GothamRounded, sans-serif;\">Hati-hati pemakaian obat pada penderita yang mengkonsumsi alkohol dalam jumlah banyak dan atau penderita dengan riwayat penyakit hati</h6></li><li><h6 style=\"font-weight: 500; font-size: 12px; font-family: GothamRounded, sans-serif;\">Tidak dianjurkan penggunaan pada anak-anak dan remaja, karena khasiat dan keamanannya belum terbukti</h6></li><li><h6 style=\"font-weight: 500; font-size: 12px; font-family: GothamRounded, sans-serif;\">Simvastatin dapat meningkatkan prevalensi kekeruhan lensa yang biasanya terjadi akibat penuaan</h6></li><li><h6 style=\"font-weight: 500; font-size: 12px; font-family: GothamRounded, sans-serif;\">Simvastatin hanya mempunyai efek penurun trigliserida sedang dan tidak diiindikasikan jika hipetrigliserida merupakan faktor abnormalitas utama (hiperlipidemia tipe I, IV, dan V)</h6></li></ul></div>",
      "side_effect": "<p><span style=\"color: rgb(83, 83, 83); font-family: GothamRounded, sans-serif; font-size: 12px;\">Simvastatin pada umumnya dapat ditoleransi dengan baik, efek samping biasanya ringan dan sementara. Efek samping berikut dilaporkan terjadi setelah pemberian obat golongan statin :</span><br>Neurologis : gangguan saraf kranial tertentu, tremor, vertigo, menurunnya daya ingat, parestesia, kelumpuhan saraf perifer dan neuropati perifer</p><p>Reaksi hipersensitivitas</p><p>Gastrointestinal : pankreatitis, anoreksia, muntah</p><p>Kulit : alopesia</p><p>Reproduksi : ginekomastia, gairah berkurang, disfungsi ereksi</p><p>Mata : katarak progresif, oftalmoplegia</p><p>Efek samping lain yang dilaporkan : nyeri abdomen, konstipasi, flatulen, astenia, sakit kepala, miopati (jarang)</p><p>Pernah dilaporkan : muntah, diare, ruam kulit, dispepsia, rabdomiolisis (jarang), hepatitis, angioneurotik udema pada kasus-kasus tertentu.</p><p>Dari hasil pemeriksaan laboratorium ditemukan peningkatan kadar serum transaminase yang nyata dan menetap (jarang terjadi). Pemeriksaan abnormalitas fungsi hati pada umumnya ringan dan bersifat sementara.</p><p>Telah dilaporkan bahwa peningkatan kadar kreatinin fosfokinase dalam serum yang berasal dari otot rangka.</p>",
      "identifier_ids": [
        {
          "url": null,
          "code": "93003321",
          "name": "Simvastatin 10 mg Tablet Salut Selaput",
          "source_name": "Kamus Farmalkes (KFA – IHS)"
        },
        {
          "url": null,
          "code": "DKL1008516217A1",
          "name": "SVT 10",
          "source_name": "NIE BPOM"
        }
      ],
      "packaging_ids": [
        {
          "qty": 10,
          "name": "Blister isi 10",
          "uom_id": "Tablet",
          "kfa_code": "94004638",
          "pack_price": 17200
        },
        {
          "qty": 100,
          "name": "Dus isi 100",
          "uom_id": "Tablet",
          "kfa_code": "94004637",
          "pack_price": 172000
        }
      ],
      "product_template": {
        "name": "Simvastatin 10 mg Tablet Salut Selaput",
        "state": "valid",
        "bmhp": null,
        "active": true,
        "kfa_code": "92001681",
        "updated_at": "2025-05-06 12:16:34",
        "display_name": "Simvastatin 10 mg Tablet Salut Selaput"
      },
      "active_ingredients": [
        {
          "state": "valid",
          "active": true,
          "kfa_code": "91000359",
          "zat_aktif": "SIMVASTATIN",
          "updated_at": "2022-10-18 08:31:30",
          "kekuatan_zat_aktif": "10 mg"
        }
      ],
      "dosage_usage": [
        {
          "qty": 5,
          "name": "Dewasa: 5 - 10 mg; selama 1 hari",
          "period": 0,
          "qty_uom": "mg",
          "category": "adult",
          "duration": 1,
          "qty_high": 10,
          "qty_ucum": null,
          "use_ucum": false,
          "frequency": 0,
          "updated_at": "2022-11-22 06:08:45",
          "period_ucum": null,
          "display_name": "Dewasa: 5 - 10 mg; selama 1 hari",
          "duration_max": 0,
          "duration_ucum": "hari",
          "frequency_max": 0,
          "body_weight_max": 0,
          "body_weight_min": 0
        }
      ],
      "tags": [],
      "replacement": {
        "product": null,
        "template": null
      },
      "cvx_info": {}
    }
  }
]
